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Abstract: 
People with Multiple Sclerosis (MS) present with a wide range of symptoms including 
sensory, motor and visual impairment as well as cognitive dysfunction and fatigue. 
Many of these symptoms affect mobility and balance and have been shown to be 
associated with falls risk among this population. It is known that falls are prevalent 
among people with MS, with a high rate of multiple falls and injurious falls. While 
much is known about the factors and serious consequences associated with falls, as of 
yet there is no reliable stand-alone clinical measure or multivariable model suitable to 
assess falls risk in a busy clinic setting. Thus, the aim of this thesis was to develop a 
simple falls risk screening model suitable for use in everyday clinical practice.  
To understand what clinical measures of balance are currently useful in identifying 
falls risk in MS, a systematic review and meta-analysis was carried out. There was 
significant heterogeneity across the included studies and discriminative ability of the 
measures is commonly not reported. The Timed Up and Go (TUG) did show 
significant difference between fallers and non-fallers in retrospective study designs, is 
commonly used and does not require specialist equipment, and thus was investigated 
in a prospective cohort that monitored falls using diaries for 3 months.  
The association between dual task cost and falls was explored in more depth by 
examining objectively measured dual task cost and subjective problems dual tasking. 
Different patterns of cognitive -motor interference and their association to faller status 
was also analysed. Results showed that objectively measured dual task cost is not 
associated with an increased falls risk but self-report problems of difficulty doing two 
things at once doubled the risk of falling with an associated risk ratio of 2.07 (CI 1.15-
3.71).  
From the main longitudinal study multiple clinical and objective variables were 
analysed to determine the model with the greatest sensitivity and best discriminative 
ability for identifying falls risk in people with MS. Following multivariable regression 
analysis, the model with the greatest sensitivity (88%) and predictive validity (AUC = 
0.72, 95% CI 0.62-0.82), included the variables of history of a fall, no visual problems, 
problems with bladder control and a slower speed on the TUG.  
 
The clinical implications arising from this research are important; firstly, all healthcare 
professionals working with people with MS should ask about history of falls, visual 
problems, problems with bladder control and difficulty dual tasking. Clinicians should 
not rely on a clinical measure of balance alone to identify falls risk but consider a 
multivariable model that would be more sensitive and provide more useful 
information. Future research should validate this falls risk model using a larger sample 
size, with a wider range of EDSS levels and disease subtypes. Following validation, 
implementation could be carried out and if used successfully in daily clinical practice 
this model could help prioritise waiting lists and enable earlier access to fall prevention 
interventions at the most appropriate time point for that individual.   
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Thesis Outline: 
This thesis is a traditional thesis where each chapter is in the form of a research paper, 
framed by an introduction and discussion chapter. There are seven chapters in total, of 
which four (chapters 2-5) are papers that have either been published, are under review 
or accepted for publication in peer reviewed journals.  The first chapter is the 
introduction, the second chapter is a systematic literature review and meta-analysis 
examining current clinical measures of balance and their use in identifying falls risk 
in Multiple Sclerosis (MS), the third chapter examines the discriminative ability and 
clinical utility of the Timed Up and Go (TUG) and TUG-cognitive, the fourth chapter 
examines the association between dual task cost and falls in people with MS, the fifth 
chapter explains how the final falls risk model was developed and reports on its 
sensitivity and discriminative ability, the sixth chapter examines further potential 
factors that may explain the variance of the model and the final chapter comprises a 
discussion and conclusion.  
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Chapter 1: 
Introduction  
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This introduction chapter will give background information about the topic being 
investigated i.e. the development of a falls risk screening tool for use in Multiple 
Sclerosis (MS). The points for consideration in this chapter include the prevalence and 
monitoring of falls in MS, the consequences of falls in this population, the known risk 
factors associated with falls in MS and the importance of identifying those at risk of 
falls to enable earlier falls prevention interventions. Certain risk factors such as 
balance impairment and cognitive impairment will be examined more closely and the 
assessment of these variables in relation to falls risk will be discussed. The clinical 
context in relation to identification of risk and treatment prioritisation will be explored, 
as will certain methodological aspects regarding risk prediction such as discriminative 
ability and clinical utility. The introduction will conclude with the aims and objectives 
of the thesis.  
 
Prevalence and symptoms of MS- 
MS is the leading cause of disability in young and middle-aged people in the 
developed world with a global prevalence of 33 per 100, 000 and a total of 2.3 million 
people with MS worldwide making it one of the most common neurological disorders 
in young adults (Koch-Henriksen and Sørensen 2010; Browne et al. 2014). There are 
over 9,000 people with MS living in Ireland with a societal cost of 429 million euro 
per year (Carney et al. 2018) including direct medical and non-medical costs and 
indirect costs such as productivity losses due to sick leave, inability to maintain gainful 
employment and early retirement. MS typically has a very heterogeneous presentation 
with a wide range of systems affected by the disease including balance, co-ordination, 
muscle tone, sensation, cognition and vision. The range of symptoms and impairments 
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present will vary depending on the location of lesions within the central nervous 
system (CNS). The most common clinical symptoms reported when first attending a 
healthcare professional include sensory (40% of people with MS present with 
numbness, tingling, burning pain), motor (39% present with weakness, stiffness, 
altered coordination), visual (30%) and fatigue (30% present with an overwhelming 
lack of physical or mental energy that interferes with daily activities) (Multiple 
Sclerosis International Federation, 2013. Atlas of MS 2013: Mapping Multiple 
Sclerosis around the World. ).  Although the CNS has some potential for recovery and 
repair, this repair is often incomplete and results in irreversible damage and concurrent 
brain atrophy (Rocca et al. 2003). This brain atrophy starts early, proceeds throughout 
the course of the disease and accelerates at a much faster rate than seen in people 
without MS (De Stefano et al. 2010). 
 
Prevalence of falls in MS- 
These common motor and sensory impairments may alter an individual’s gait and 
mobility performance and are often associated with fall risk (Peterson et al. 2007; 
Sosnoff et al. 2011). Falls are prevalent in this population with a large multi-site study 
( n= 537) that combined data from four different  countries demonstrating 56% fall at 
least once within a three month period and of those fallers 37% are frequent fallers 
reporting two or more falls, with a total of 1721 falls reported over the three month 
study period (Nilsagård et al. 2015). In smaller studies even higher rates of falling 
have been reported with Gunn et al ( n= 148) reporting 70% having one or more falls 
with a total of 672 falls over a three month period (Gunn et al. 2013a), Cameron et al 
reporting 71% fallers (2013) and Tijsma et al reporting 60% fallers, of which 55% had 
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3 or more falls (2017). The latter two studies both had longer follow up periods of 
prospective falls monitoring for 6 months. People with MS fall more, are more likely 
to suffer injurious falls and have different fall circumstances compared to their healthy 
peers, with 71% of people with MS falling versus 41%  of healthy controls over a 6-
month study period (Mazumder et al. 2014).  
 
Defining falls and fallers in MS- 
In research to date on falls in MS there are a variety of faller classifications utilised 
with some researchers defining a faller as a person with 1 or more falls (Nilsagård et 
al. 2009b; Coote et al. 2013; Ytterberg et al. 2013) and other researchers defining 
fallers on the basis of two or more falls (Gunn et al. 2013a; Hoang et al. 2016a; Kalron 
and Allali 2017). Likewise there is a wide range of fall definitions utilised; with some 
defining a fall as ‘an unexpected event that results in the person ending up on the 
ground, floor, or any lower surface’ (Cameron et al. 2013; Forsberg et al. 2016; Tajali 
et al. 2017), others defining it as ‘unintentionally coming to the ground or other lower 
level and other than a consequence of sustaining a violent blow, loss of consciousness, 
sudden onset of paralysis as in stroke or epileptic or seizure‘ (Hoang et al. 2016a) and 
still others defining it ‘as any unexpected loss of balance that resulted in whole body 
contact with the ground’ (Kasser et al. 2014). In some studies the fall definition used 
is not stated (Jacobs and Kasser 2012; Kalron 2016). This heterogeneity in fall 
definition and classification can make comparison between studies difficult. The 
International MS Falls Prevention Research network (IMSFPRN) has recommended 
prospective monitoring of falls using falls diaries for a minimum three-month period, 
that fallers be classified as participants experiencing one or more falls during the study 
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period and a fall be defined as ‘an unexpected event in which the participant comes to 
rest on the ground, floor or lower level’ as used by the Prevention of Falls Network 
Europe (ProFaNE) (Coote et al. 2014). 
 
Consequences of falls in MS- 
The consequences of falls for people with MS are far reaching and can have a 
significant societal and personal impact. Injurious falls are highly prevalent with 
previous cross-sectional studies with large cohorts surveyed reporting injurious falls 
rates of  34-50%  and that fear of falls and osteoporosis are significantly associated 
with injurious falls requiring medical attention (Peterson et al. 2008; Matsuda et al. 
2011). A population based cohort study found that people with MS have a threefold 
higher risk of hip fracture than age and gender matched peers with a greater risk for 
those prescribed steroids in the previous six months (Bazelier et al. 2011). Three 
studies using prospective falls reporting have reported on injurious fall rates over a six 
month follow-up period with rates varying from 42-58% (Cameron et al. 2013; Hoang 
et al. 2014; Mazumder et al. 2014). Injurious falls can result in increased healthcare 
utilisation and  decreased labour force productivity which both contribute to the high 
socio-economic cost associated with MS (Carney et al. 2018) . These high rates of 
injurious falls are much greater than those seen in the elderly where rates of 23% 
(Welmer et al. 2017) to 30% (Pohl et al. 2014) have been reported and post stroke 
where rates of 10% have been reported (Tilson et al. 2012).  
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People with MS who are experiencing worsening mobility and more progressive 
disease are at a higher risk of falls (Nilsagård et al. 2015), which may result in 
increased healthcare utilisation; not just for the management of injurious falls but for 
physiotherapy or occupational therapy falls prevention interventions and for home 
adaptations and carer support. The total societal cost of MS includes direct medical 
and non-medical costs, as well as intangible costs and in Europe the overall annual 
coast has been estimated at 15.5 billion euro (Kobelt et al. 2006). In Ireland, a report 
published by the MS Society of Ireland demonstrated the overall annual societal cost 
attributable to MS is 429.15 million euro and there is a direct relationship between 
healthcare resource use and disability severity, with costs increasing as disability 
progresses (Carney et al. 2018). Of the nationally representative sample (n= 594) 
surveyed for the Irish report, 40% of respondents utilised physiotherapy, 16% utilised 
occupational therapy, 25% had home adaptations and 16% had some form of home 
help/carer.  
 
On a personal level the high rate of falls and high levels of fear of falling experienced 
by a person with MS may lead to activity curtailment and further reductions in physical 
fitness and endurance (Peterson et al. 2007; Matsuda et al. 2012). Fear of falling is 
defined as “a lasting concern about falling that results in an individual avoiding 
activities that he/she remains capable of performing” (Tinetti and Powell 1993). 
Previous studies in MS have shown a very high level of fear of falling with 63.5% of 
a large study cohort (N= 1064) reporting fear of falling and 82% of that group 
curtailing their activities because of that fear (Peterson et al. 2007). In contrast to 
physical variables, psycho-social variables such as fear of falling and low falls self-
efficacy tend to receive less attention in falls prevention interventions, despite being 
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common among people with MS who have experienced falls (Comber et al. 2017). 
Comber et al found that 92% of their cross-sectional sample expressed fear of falls 
with an associated curtailment of activities seen in 79% of respondents and a 
significant correlation demonstrated between falls self-efficacy (scored on the Falls 
Efficacy Scale international (FESI)) and the number of falls. Falls self-efficacy, 
defined as one’s perceived sense of control over falling, has been shown to be an 
important mediating factor on fear of falling and when measured using the FESI has 
been shown to be significantly associated with future recurrent falls in a longitudinal 
study (Mazumder et al. 2015). Recent research has shown a significantly slower gait 
speed in non-fallers with fear of falling in comparison to fearless fallers (Kalron and 
Allali 2017) and highlights the fact that  fear of falling may be just as limiting as actual 
falls and is a construct worth examining in further detail.  
 
Previous cross-sectional data from people with MS who use a mobility aid 
demonstrated a lower quality of life in fallers (Coote et al. 2013) and prospective data 
from a larger study cohort has shown that greater fear of falls is associated with a 
greater risk of falls and lower quality of life (Vister et al. 2017). Lower quality of life, 
in turn has higher associated socio-economic costs, and contributes significantly to the 
intangible costs and burden for the person with MS related to issues around self-care, 
pain, anxiety and depression (Carney et al. 2018).  
 
Having a chronic progressive condition such as MS places a significant burden on the 
individual and the unmet needs of people with this condition have been highlighted in 
previous studies. Limited access to physiotherapy services for those requiring 
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neurological rehabilitation has been demonstrated in Australia with an imbalance 
between increasing service demands and limited physiotherapy capacity (Adams et al. 
2015). In the UK, a survey of people with MS demonstrated that advice about exercise 
was the most requested information source (Somerset et al. 2001) and that lack of 
information about physiotherapy services and excessive waiting list times was one of 
the most negative aspects of their overall management (Markwick et al. 2014). In a 
profiling study of physiotherapy services for people with MS in Ireland it was found 
there was a very short duration of physiotherapy received (mean of 3.6 hours) (Coote 
et al. 2010), far less than the 8-12 hours received by participants in studies that have 
demonstrated positive benefits of physiotherapy and exercise interventions (Cattaneo 
et al. 2007; Hoang et al. 2016b; Hugos et al. 2016). A more recent study exploring the 
unmet needs of people with MS in Ireland found that 52% of the cohort reported MS 
related unmet needs and physiotherapy was the most frequently reported unmet need 
(Lonergan et al. 2015). A sensitive falls risk tool of the type developed in this thesis 
may be useful in identifying risk earlier, prioritising wait list times and enabling earlier 
access to physiotherapy services.  
 
Risk factors associated with falls in people with MS- 
There is a growing body of evidence examining the factors associated with falls in MS 
but as yet there are a limited number of studies using the gold standard method of 
prospective falls recording. Previous cross sectional studies have found various factors 
to be associated with falls including slower gait speed, impaired balance, fatigue, older 
age, worse disability level, increased use of assistive devices and decreased walking 
endurance (Sosnoff et al. 2011; Coote et al. 2013; Ytterberg et al. 2013). The use of 
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retrospective recall for falls data is a definite limitation in these studies, as is the older 
age group (all have a mean age of greater than 50 years) indicating findings are not 
applicable to a younger, milder disease cohort.  
 
Prior to the design of the study protocol for this PhD in March 2015, the number of 
prospective studies examining falls risk prediction in MS was limited. Some studies 
explored the discriminative ability and sensitivity of clinical variables/measures alone 
(Nilsagård et al. 2009b; Dibble et al. 2013) and others compared clinical measures to 
more complex measures such as static and dynamic posturography (Cameron et al. 
2013; Prosperini et al. 2013). These studies have conflicting results with some studies 
recommending measures such as the Berg Balance Scale for identifying falls risk 
(Nilsagård et al. 2009b; Dibble et al. 2013) while others report low sensitivity levels 
for the Berg and found static posturography to be more sensitive and accurate for 
identifying falls risk (Prosperini et al. 2013). All four studies examined the Expanded 
Disability Status Scale (EDSS) score and while it was shown to be significantly 
different between fallers and non-fallers (Prosperini et al. 2013)  two of the studies 
found it to have low levels of predictive accuracy (Cameron et al. 2013; Dibble et al. 
2013), while a different study found the odds of falling were doubled for each degree 
of increased EDSS score (Nilsagård et al. 2009b). Cameron et al found that a history 
of falls was the best predictor of future falls and was just as reliable as more complex 
or more time consuming assessments (Cameron et al. 2013) but their cohort was small 
(n=52) and was predominantly the relapse-remitting  form of MS with a younger age 
than other similar studies on this topic.  
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Still others examined the sensitivity of multivariable models that included simple 
clinical variables such as EDSS score, Ashworth score, reported leg pain, and slower 
walking speed in combination with more complicated variables that require specialist 
equipment such as gait analysis, strength assessment using the Biodex Multipoint 
System and the Physiological Profile Assessment (Kasser et al. 2011; Gunn et al. 
2013a; Hoang et al. 2014). These falls risk prediction models have varying levels of 
sensitivity and specificity ranging from 48% to 81% and 56% to 88%  respectively 
with area under the receiving operating characteristic curve (AUC) values of 0.71 and 
0.73 (reported for two models (Gunn et al. 2013a; Hoang et al. 2014)). Differences in 
study methodology including the use of different fall definitions, different faller 
classifications, varying follow up time points and different outcome measures make 
comparison of findings difficult. More importantly few studies report both clinical 
utility, in the form of sensitivity and specificity, and discriminative ability in the form 
of AUC values together, with some studies reporting neither but instead simply 
examining differences between fallers and non-fallers or reporting odds ratio values. 
Unfortunately, this heterogeneity in methodological procedures makes study 
comparison difficult and limits the applicability and strength of the results.   
 
Two recent systematic reviews have examined the combined literature in relation to 
factors associated with increased risk of falls in MS. The first review included 8 studies 
(only 2 of which used prospective falls monitoring) with a total of 1929 participants 
and found that impairments in balance and cognition, progressive MS and use of a 
mobility aid are all associated with an increased risk of falls (Gunn et al. 2013b). A 
further review with 15 studies  (of which 3 used prospective falls monitoring) 
including 2425 participants found that in comparison to non-fallers, fallers had longer 
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disease duration, more progressive disease, slower gait speed, worse scores on clinical 
balance measures and static posturography (Giannì et al. 2014). However, this latter 
review combined both prospective and cross-sectional study data in their meta-
analysis which weakens the significance of their findings. While there is no doubt that 
our knowledge on factors associated with falls is growing, less is known about 
circumstances surrounding falls and their association to commonly used clinical 
measures of balance and gait.  
 
Balance assessment using the TUG- 
Balance impairment is a known risk factor for falls in MS, but it is unclear whether 
balance measures currently in use are sensitive enough to predict those at risk of 
falling. Various physical tests of gait and balance and self-report questionnaires have 
been shown to correlate with falls risk in MS (Cattaneo et al. 2006; Nilsagard et al. 
2007; Nilsagård et al. 2012) but it is unclear if these measures can reliably predict 
those at risk of falling. One clinical measure that is widely used in clinical practice to 
differentiate between fallers and non-fallers is the Timed Up and Go (TUG). For 
assessment of falls risk the TUG would appear to have good face validity as it involves 
walking, turning and transition from a standing to seated position which are all 
mobility manoeuvres previously shown to be associated with falls in people with MS 
(Nilsagård et al. 2009a; Gunn et al. 2014). The TUG has been recommended as a 
screening test for falls risk by the American Geriatrics Society/British Society of 
Gerontology Guidelines (2011) and has been shown to have good validity (Sebastião 
et al. 2016) and reliability (Nilsagard et al. 2007) in MS populations. Furthermore, the 
TUG is quick and easy to administer requiring no specialist training or equipment 
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(Podsiadlo and Richardson 1991) and is well known and commonly used by 
physiotherapists working in the Irish healthcare system (O' Donovan 2011). The 
IMSFPRN recommend that MS falls prevention studies should use measures that 
capture transitions and walking and that can incorporate dual tasking (Cattaneo et al. 
2014); the TUG and TUG-Cognitive cover these suggested domains and have also 
been recommended for use in MS research and clinical practice by the American 
Physical Therapy Association Evidence Database to Guide Effectiveness task force 
(Potter et al. 2014) and are therefore investigated further in this thesis. 
 
Dual Task Cost (DTC) and association with falls risk-  
Another risk factor associated with falls in MS is cognitive impairment (Gunn et al. 
2013b) and this symptom is prevalent in MS, present in up to 70% of people with the 
condition (Rao et al. 1991) across all disease stages and in all clinical sub types 
(Amato et al. 2006). The main type of impairments seen are slower information 
processing, poor sustained attention and altered working memory (Benedict et al. 
2002) all of which are relevant when functioning in a dual task capacity with resultant 
cognitive-motor interference. Cognitive-motor interference (CMI) is common in MS 
(Leone et al. 2015) and refers to the decline in performance of cognitive and/or motor 
tasks when they are performed simultaneously (dual-task), relative to the performance 
of each task individually (Plummer et al. 2013).  People with relapse remitting MS 
have been shown to have decreased postural stability under dual task conditions 
(Butchard-MacDonald et al. 2017) and altered gait patterns including slower velocity, 
altered step length, increased double support time and altered cadence (Motl et al. 
2014; Leone et al. 2015). The deterioration in performance associated with CMI is 
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expressed as dual-task cost (DTC) (Wajda and Sosnoff 2015) and has been shown to 
be associated with falls in people with MS (Wajda et al. 2013; Etemadi 2016). In 
elderly populations DTC has been examined as a potential predictor of falls (Yamada 
et al. 2011; Muir-Hunter and Wittwer 2016) with deterioration in gait during dual 
tasking specifically associated with falls risk. Thus, DTC is a potential variable 
warranting further investigation in relation to falls risk in MS.  
 
Identification of risk and treatment prioritisation- 
As falls are a significant problem for people with MS, with detrimental consequences 
and negative impacts on quality of life it is imperative to try and provide falls 
prevention interventions at the most appropriate time when falls risk is becoming 
apparent and interventions may be of most benefit. Currently the healthcare system in 
Ireland is unequal with access to services often dependent on a person’s geographical 
location rather than their medical need. For people with MS, access to falls prevention 
interventions is through the Health Services Executive (HSE) via their hospital or 
through their GP/primary care service or through availing of supplementary services 
as provided by MS Ireland (the Multiple Sclerosis Society of Ireland). Recent plans 
for reform within the HSE recommend timely access to all health and social care 
according to medical need and has a strong focus on prevention and public health 
(Burke et al. 2018). It is not yet clear from the current evidence base how to identify 
those at risk of falls and in need of intervention.  
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The IMSFPRN published recommendations on who to target for falls prevention trials 
and recommended having broad inclusion criteria and including people of all ages, 
people with and without mobility aids, people with varied levels of cognitive ability 
but of a sufficient level to participate in the intervention of the study and people with 
a history of falls (Cameron et al. 2014). However, on a practical level due to limited 
resources, clinicians need to be able to identify those at greatest risk using a simple 
falls risk tool and refer the most appropriate people to the intervention programmes.  
 
Risk Prediction-  
Prediction models are a useful tool for healthcare personnel to help inform decision 
making and provide guidance in relation to treatment options and onward referral to 
other services at an appropriate time point (Collins et al. 2015). Prediction models are 
tools that use a combination of predictor variables, and are inherently multivariable, 
to estimate the probability that an outcome will occur in an individual (Moons et al. 
2009). Logistic regression modelling is the most widely used statistical technique for 
binary medical outcomes (in this case presence or absence of faller status) (Steyerberg 
2009) and traditional methods for assessing the performance of prediction models 
include discrimination focusing on the area under the receiving operating 
characteristic curve statistic (AUC) value and goodness of fit statistics for calibration 
(Steyerberg et al. 2010).  
 
Discrimination is the ability of a measure to differentiate between individuals with and 
without falls and is quantified using the AUC value. The larger the AUC value the 
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greater the predictive ability of the measure in question (Hanley and McNeil 1982). 
The AUC measures the average true positive rate (predicted falls that actually 
occurred) over all false positive rates (predicted falls that did not actually occur).The 
AUC can have any value between 0 and 1 with an AUC value of 0.5 representing 
chance, values between 0.7 and 0.9 representing moderate discrimination and a value 
of 1 representing perfect discrimination (Moons et al. 2015).  
 
In relation to a prediction model to be used as a falls screening tool, clinical utility is 
assessed using the summary estimates of sensitivity and specificity. In clinical 
practice, balance screening tools with high sensitivity (≥80%) are preferable to safely 
‘rule-out’ those at low risk of a subsequent fall (as opposed to diagnostic tools that 
generally demonstrate high specificity)(Riddle and Stratford 1999). Thus, a falls risk 
prediction model with an AUC value of greater than 0.7 and sensitivity of greater than 
80% would be acceptable to use to identify and prioritise those most in need of falls 
prevention interventions.  
 
To summarise this introduction chapter; it is accepted that falls are a major problem 
for people with MS and have far reaching consequences that include personal, societal 
and economic aspects. While more is now known about risk factors associated with 
falls, there is currently no simple falls prediction model available that has been 
specifically designed for everyday clinical practice using methodological procedures 
that examine indices of discrimination and clinical utility in the form of AUC values 
and sensitivity levels. Thus, the main aim of this thesis is to develop a falls risk 
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assessment tool for people with MS that is suitable for use in a busy clinic setting and 
that demonstrates acceptable levels of discrimination and clinical utility.  
 
The specific objectives of the thesis are to – 
1) Summarise the totality of evidence from observational studies regarding the 
association between clinical assessments of balance and falls in people with 
Multiple Sclerosis in the form of a systematic review and meta-analysis.  
2) Determine the sensitivity and discriminative ability of the Timed Up and Go test 
(TUG) and TUG-Cognitive in isolation using prospectively collected falls data.  
3) Determine the extent of cognitive motor-interference (CMI) in fallers and non-
fallers, by examining the variable of dual task cost by means of objective and 
subjective measures and its association with falls risk in people with MS.  
4) Develop a simple falls risk screening tool/prediction model suitable for use in a 
busy clinic setting, by analysing which combination of subjective and objective 
variables has the highest sensitivity and predictive validity for identifying falls 
risk in people with MS. 
5) Examine potential factors that may further explain the variance in the final falls 
prediction model using information from 1) a narrative review of the current 
prospective studies examining falls risk in MS, 2) data about the causes and 
context of falls from information collected using the falls diaries in the 
longitudinal study, and 3) opinions from clinicians on falls prevention 
interventions and assessment collected from qualitative interviews.  
 
 
17 
 
References: 
Adams, R., Jones, A., Lefmann, S. and Sheppard, L. (2015) 'Rationing is a reality in 
rural physiotherapy: a qualitative exploration of service level decision-
making', BMC Health Services Research, 15(1), 121. 
 
Amato, M.P., Zipoli, V. and Portaccio, E. (2006) 'Multiple sclerosis-related cognitive 
changes: a review of cross-sectional and longitudinal studies', Journal of the 
Neurological Sciences, 245(1-2), 41-46. 
 
Anonymous (2011) 'Summary of the updated American Geriatrics Society/British 
Geriatrics Society clinical practice guideline for prevention of falls in older 
persons', JOURNAL - AMERICAN GERIATRICS SOCIETY, 59(1), 148. 
 
Bazelier, M.T., van Staa, T., Uitdehaag, B.M.J., Cooper, C., Leufkens, H.G.M., 
Vestergaard, P., Bentzen, J. and de Vries, F. (2011) 'The Risk of Fracture in 
Patients With Multiple Sclerosis: The UK General Practice Research 
Database', Journal of Bone and Mineral Research, 26(9), 2271-2279. 
 
Benedict, R.H.B., Fischer, J.S., Archibald, C.J., Arnett, P.A., Beatty, W.W., Bobholz, 
J., Chelune, G.J., Fisk, J.D., Langdon, D.W., Caruso, L., Foley, F., LaRocca, 
N.G., Vowels, L., Weinstein, A., DeLuca, J., Rao, S.M. and Munschauer, F. 
(2002) 'Minimal Neuropsychological Assessment of MS Patients: A 
Consensus Approach', The Clinical Neuropsychologist, 16(3), 381-397. 
 
Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B.V. and 
Thompson, A.J. (2014) 'Atlas of Multiple Sclerosis 2013: A growing global 
problem with widespread inequity', Neurology, 83(11), 1022-1024. 
 
Burke, S., Barry, S., Siersbaek, R., Johnston, B., Ní Fhallúin, M. and Thomas, S. 
(2018) 'Sláintecare – A ten-year plan to achieve universal healthcare in 
Ireland', Health Policy. 
 
Butchard-MacDonald, E., Paul, L. and Evans, J.J. (2017) 'Balancing the Demands of 
Two Tasks: An Investigation of Cognitive–Motor Dual-Tasking in Relapsing 
Remitting Multiple Sclerosis', Journal of the International 
Neuropsychological Society, 09/22, 1-12. 
 
Cameron, M., Coote, S. and Sosnoff, J.J. (2014) 'Whom to Target for Falls-Prevention 
Trials: Recommendations from the International MS Falls Prevention 
Research Network', Int J MS Care, 16(4), 203-7. 
 
Cameron, M.H., Thielman, E., Mazumder, R. and Bourdette, D. (2013) 'Predicting 
falls in people with multiple sclerosis: fall history is as accurate as more 
complex measures', Mult Scler Int, 496325. 
 
Carney, P., O’Boyle, D., Larkin, A., McGuigan, C. and O’Rourke, K. (2018) 'Societal 
costs of multiple sclerosis in Ireland', Journal of Medical Economics, 21(5), 
425-437. 
18 
 
 
Cattaneo, D., Jonsdottir, J. and Coote, S. (2014) 'Targeting Dynamic Balance in Falls-
Prevention Interventions in Multiple Sclerosis: Recommendations from the 
International MS Falls Prevention Research Network', Int J MS Care, 16(4), 
198-202,. 
 
Cattaneo, D., Jonsdottir, J., Zocchi, M. and Regola, A. (2007) 'Effects of balance 
exercises on people with multiple sclerosis: a pilot study', CLINICAL 
REHABILITATION, 21(9), 771-781. 
 
Cattaneo, D., Regola, A. and Meotti, M. (2006) 'Validity of six balance disorders 
scales in persons with multiple sclerosis', Disabil Rehabil, 28(12), 789-95. 
 
Collins, G.S., Reitsma, J.B., Altman, D.G. and Moons, K.G.M. (2015) 'Transparent 
Reporting of a multivariable prediction model for Individual Prognosis Or 
Diagnosis (TRIPOD): The TRIPOD StatementThe TRIPOD Statement', 
Annals of Internal Medicine, 162(1), 55-63. 
 
Comber, L., Coote, S., Finlayson, M., Galvin, R., Quinn, G. and Peterson, E. (2017) 
'An exploration of fall-related, psychosocial variables in people with multiple 
sclerosis who have fallen', British journal of occupational therapy, 80(10), 
587-595. 
 
Coote, S., Hogan, N. and Franklin, S. (2013) 'Falls in people with multiple sclerosis 
who use a walking aid: Prevalence, factors, and effect of strength and balance 
interventions', Arch Phys Med Rehabil, 94(4), 616. 
 
Coote, S., McKeown, G., Shannon, M. and Group, f.t.P.I.i.M.S. (2010) 'A Profiling 
Study of People with Multiple Sclerosis Who Access Physiotherapy Services 
in Ireland', International Journal of MS Care, 12(3), 115-121. 
 
Coote, S., Sosnoff, J.J. and Gunn, H. (2014) 'Fall Incidence as the Primary Outcome 
in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the 
International MS Falls Prevention Research Network', Int J MS Care, 16(4), 
178-84. 
 
De Stefano, N., Giorgio, A., Battaglini, M., Rovaris, M., Sormani, M., Barkhof, F., 
Korteweg, T., Enzinger, C., Fazekas, F. and Calabrese, M. (2010) 'Assessing 
brain atrophy rates in a large population of untreated multiple sclerosis 
subtypes', Neurology, 74(23), 1868-1876. 
 
Dibble, L.E., Lopez-Lennon, C., Lake, W., Hoffmeister, C. and Gappmaier, E. (2013) 
'Utility of disease-specific measures and clinical balance tests in prediction of 
falls in persons with multiple sclerosis', J Neurol Phys Ther, 37(3), 99-104. 
 
Etemadi, Y. (2016) 'Dual task cost of cognition is related to fall risk in patients with 
multiple sclerosis: A prospective study', CLINICAL REHABILITATION, 31 
(2), 278-284.  
 
19 
 
Forsberg, A., von Koch, L. and Nilsagård, Y. (2016) 'Effects on Balance and Walking 
with the CoDuSe Balance Exercise Program in People with Multiple Sclerosis: 
A Multicenter Randomized Controlled Trial', Mult Scler Int, 2016, 7076265. 
 
Giannì, C., Prosperini, L., Jonsdottir, J. and Cattaneo, D. (2014) 'A systematic review 
of factors associated with accidental falls in people with multiple sclerosis: a 
meta-analytic approach', Clin Rehabil, 28(7), 704-716. 
 
Gunn, H., Creanor, S., Haas, B., Marsden, J. and Freeman, J. (2013a) 'Risk factors for 
falls in multiple sclerosis: an observational study', Mult Scler, 19(14), 1913-
1922. 
 
Gunn, H., Creanor, S., Haas, B., Marsden, J. and Freeman, J. (2014) 'Frequency, 
Characteristics, and Consequences of Falls in Multiple Sclerosis: Findings 
From a Cohort Study', Archives of Physical Medicine and Rehabilitation, 
95(3), 538-545. 
 
Gunn, H., Newell, P., Haas, B., Marsden, J.F. and Freeman, J.A. (2013b) 
'Identification of risk factors for falls in multiple sclerosis: A systematic review 
and meta-analysis', Phys Ther, 93(4), 504. 
 
Hanley, J.A. and McNeil, B.J. (1982) 'The meaning and use of the area under a receiver 
operating characteristic (ROC) curve', Radiology, 143(1), 29-36. 
 
Hoang, P., Baysan, M., Gunn, H., Cameron, M., Freeman, J., Nitz, J., Low Choy, N.L. 
and Lord, S.R. (2016a) 'Fall risk in people with MS: A Physiological Profile 
Assessment study', Multiple Sclerosis Journal – Experimental, Translational 
and Clinical, 2, 2055217316641130. 
 
Hoang, P., Schoene, D., Gandevia, S., Smith, S. and Lord, S.R. (2016b) 'Effects of a 
home-based step training programme on balance, stepping, cognition and 
functional performance in people with multiple sclerosis–a randomized 
controlled trial', Multiple Sclerosis Journal, 22(1), 94-103. 
 
Hoang, P.D., Cameron, M.H., Gandevia, S.C. and Lord, S.R. (2014) 
'Neuropsychological, Balance, and Mobility Risk Factors for Falls in People 
With Multiple Sclerosis: A Prospective Cohort Study', Archives of Physical 
Medicine & Rehabilitation, 95(3), 480-486. 
 
Hugos, C.L., Frankel, D., Tompkins, S.A. and Cameron, M. (2016) 'Community 
Delivery of a Comprehensive Fall-Prevention Program in People with Multiple 
Sclerosis: A Retrospective Observational Study', International Journal of MS 
Care, 18(1), 42-48. 
 
Jacobs, J.V. and Kasser, S.L. (2012) 'Balance impairment in people with multiple 
sclerosis: Preliminary evidence for the Balance Evaluation Sytems Test', Gait 
& Posture, 36(3), 414. 
 
20 
 
Kalron, A. (2016) 'Symmetry in vertical ground reaction force is not related to walking 
and balance difficulties in people with multiple sclerosis', Gait & Posture, 47, 
48-50. 
 
Kalron, A. and Allali, G. (2017) 'Gait and cognitive impairments in multiple sclerosis: 
the specific contribution of falls and fear of falling', Journal of Neural 
Transmission. 
 
Kasser, S.L., Jacobs, J.V., Foley, J.T., Cardinal, B.J. and Maddalozzo, G.F. (2011) 'A 
prospective evaluation of balance, gait, and strength to predict falling in 
women with multiple sclerosis', Archives of Physical Medicine and 
Rehabilitation, 92(11), 1840. 
 
Kasser, S.L.P., Jacobs, J.V.P., Littenberg, B.M.D., Foley, J.T.P., Cardinal, B.J.P. and 
Maddalozzo, G.F.P. (2014) 'Exploring Physical Activity in Women with 
Multiple Sclerosis: Associations with Fear of Falling and Underlying 
Impairments', American Journal of Physical Medicine & Rehabilitation, 93(6), 
461-469. 
 
Kobelt, G., Berg, J., Lindgren, P., Fredrikson, S. and Jönsson, B. (2006) 'Costs and 
quality of life of patients with multiple sclerosis in Europe', Journal of 
Neurology, Neurosurgery &amp;amp; Psychiatry, 77(8), 918. 
 
Koch-Henriksen, N. and Sørensen, P.S. (2010) 'The changing demographic pattern of 
multiple sclerosis epidemiology', The Lancet Neurology, 9(5), 520-532. 
 
Leone, C., Patti, F. and Feys, P. (2015) 'Measuring the cost of cognitive-motor dual 
tasking during walking in multiple sclerosis', Multiple Sclerosis Journal, 
21(2), 123-131. 
 
Lonergan, R., Kinsella, K., Fitzpatrick, P., Duggan, M., Jordan, S., Bradley, D., 
Hutchinson, M. and Tubridy, N. (2015) 'Unmet needs of multiple sclerosis 
patients in the community', Multiple Sclerosis and Related Disorders, 4(2), 
144-150. 
 
Markwick, R., Singleton, C. and Conduit, J. (2014) 'The perceptions of people with 
multiple sclerosis about the NHS provision of physiotherapy services', 
Disability And Rehabilitation, 36(2), 131-135. 
 
Matsuda, P.N., Shumway-Cook, A., Bamer, A.M., Johnson, S.L., Amtmann, D. and 
Kraft, G.H. (2011) 'Falls in multiple sclerosis', PM & R: The Journal Of Injury, 
Function, And Rehabilitation, 3(7), 624-632. 
 
Matsuda, P.N., Shumway-Cook, A., Ciol, M.A., Bombardier, C.H. and Kartin, D.A. 
(2012) 'Understanding Falls in Multiple Sclerosis: Association of Mobility 
Status, Concerns About Falling, and Accumulated Impairments', Phys Ther, 
92(3), 407-415. 
 
Mazumder, R., Lambert, W.E., Nguyen, T., Bourdette, D.N. and Cameron, M.H. 
(2015) 'Fear of falling is associated with recurrent falls in people with multiple 
21 
 
sclerosis: a longitudinal cohort study', International Journal of MS Care, 
17(4), 164-170. 
 
Mazumder, R., Murchison, C., Bourdette, D. and Cameron, M. (2014) 'Falls in People 
with Multiple Sclerosis Compared with Falls in Healthy Controls', PLoS ONE, 
9(9), e107620. 
 
 Moons, K.G.M., Altman, D.G., Reitsma, J.B., Ioannidis, J.P.A., Macaskill, P., 
Steyerberg, E.W., Vickers, A.J., Ransohoff, D.F. and Collins, G.S. (2015) 
'Transparent Reporting of a multivariable prediction model for Individual 
Prognosis Or Diagnosis (TRIPOD): Explanation and ElaborationThe TRIPOD 
Statement: Explanation and Elaboration', Annals of Internal Medicine, 162(1), 
W1-W73. 
 
Moons, K.G.M., Royston, P., Vergouwe, Y., Grobbee, D.E. and Altman, D.G. (2009) 
'Prognosis and prognostic research: what, why, and how?', BMJ, 338. 
 
Motl, R.W., Sosnoff, J.J., Dlugonski, D., Pilutti, L.A., Klaren, R. and Sandroff, B.M. 
(2014) 'Walking and cognition, but not symptoms, correlate with dual task cost 
of walking in multiple sclerosis', Gait & Posture, 39(3), 870-874. 
 
Muir-Hunter, S.W. and Wittwer, J.E. (2016) 'Dual-task testing to predict falls in 
community-dwelling older adults: a systematic review', Physiotherapy, 
102(1), 29-40. 
 
Multiple Sclerosis International Federation, 2013. Atlas of MS 2013: Mapping 
Multiple Sclerosis around the World.  
 
Nilsagård, Y., Carling, A. and Forsberg, A. (2012) 'Activities-specific balance 
confidence in people with multiple sclerosis', Mult Scler Int, 613925-613925. 
 
Nilsagård, Y., Denison, E., Gunnarsson, L.-G. and Boström, K. (2009a) 'Factors 
perceived as being related to accidental falls by persons with multiple 
sclerosis', Disability And Rehabilitation, 31(16), 1301-1310. 
 
Nilsagård, Y., Gunn, H., Freeman, J., Hoang, P., Lord, S., Mazumder, R. and 
Cameron, M. (2015) 'Falls in people with MS—an individual data meta-
analysis from studies from Australia, Sweden, United Kingdom and the United 
States', Mult Scler, 21(1), 92-100. 
 
Nilsagård, Y., Lundholm, C., Denison, E. and Gunnarsson, L.G. (2009b) 'Predicting 
accidental falls in people with multiple sclerosis - A longitudinal study', Clin 
Rehabil, 23(3), 259-269. 
 
Nilsagard, Y., Lundholm, C., Gunnarsson, L.-G. and Denison, E. (2007) 'Clinical 
relevance using timed walk tests and ‘timed up and go’ testing in persons with 
Multiple Sclerosis', Physiotherapy Research International, 12(2), 105-114. 
 
O' Donovan, M. (2011) 'A Survey of the Current Physiotherapy Management of 
People with Multiple Sclerosis', Unpublished Thesis (University of Limerick). 
22 
 
 
Peterson, E.W., Cho, C.C. and Finlayson, M.L. (2007) 'Fear of falling and associated 
activity curtailment among middle aged and older adults with multiple 
sclerosis', Mult Scler, 13(9), 1168-1175. 
 
Peterson, E.W., Cho, C.C., von Koch, L. and Finlayson, M.L. (2008) 'Injurious Falls 
Among Middle Aged and Older Adults With Multiple Sclerosis', Archives of 
Physical Medicine and Rehabilitation, 89(6), 1031-1037. 
 
Plummer, P., Eskes, G., Wallace, S., Giuffrida, C., Fraas, M., Campbell, G., Clifton, 
K. and Skidmore, E.R. (2013) 'Cognitive-motor interference during functional 
mobility after stroke: state of the science and implications for future research', 
Archives of Physical Medicine and Rehabilitation, 94(12), 2565-2574. e6. 
 
Podsiadlo, D. and Richardson, S. (1991) 'The timed “Up and Go”: a test of basic 
functional mobility for frail elderly persons', J Am Geriatr Soc, 39, 142-148. 
 
Pohl, P., Nordin, E., Lundquist, A., Bergström, U. and Lundin-Olsson, L. (2014) 
'Community-dwelling older people with an injurious fall are likely to sustain 
new injurious falls within 5 years-a prospective long-term follow-up study', 
BMC Geriatrics, 14(1), 120. 
 
Potter, K., Cohen, E.T., Allen, D.D., Bennett, S.E., Brandfass, K.G., Widener, G.L. 
and Yorke, A.M. (2014) 'Outcome measures for individuals with multiple 
sclerosis: recommendations from the American Physical Therapy Association 
Neurology Section Task Force', Physical Therapy, 94(5), 593-608. 
 
Prosperini, L., Fortuna, D., Giannì, C., Leonardi, L. and Pozzilli, C. (2013) 'The 
diagnostic accuracy of static posturography in predicting accidental falls in 
people with multiple sclerosis', NEUROREHABIL NEURAL REPAIR, 27(1), 
45-52. 
 
Rao, S.M., Leo, G.J., Bernardin, L. and Unverzagt, F. (1991) 'Cognitive dysfunction 
in multiple sclerosis. I. Frequency, patterns, and prediction', Neurology, 41(5), 
685-691. 
 
Riddle, D.L. and Stratford, P.W. (1999) 'Interpreting Validity Indexes for Diagnostic 
Tests: An Illustration Using the Berg Balance Test', Physical Therapy, 79(10), 
939-948. 
 
Rocca, M.A., Mezzapesa, D.M., Falini, A., Ghezzi, A., Martinelli, V., Scotti, G., 
Comi, G. and Filippi, M. (2003) 'Evidence for axonal pathology and adaptive 
cortical reorganization in patients at presentation with clinically isolated 
syndromes suggestive of multiple sclerosis', Neuroimage, 18(4), 847-855. 
 
Sebastião, E., Sandroff, B.M., Learmonth, Y.C. and Motl, R.W. (2016) 'Validity of 
the Timed Up and Go Test as a Measure of Functional Mobility in Persons 
With Multiple Sclerosis', Archives of Physical Medicine and Rehabilitation, 
97(7), 1072-1077. 
 
23 
 
Somerset, M., Campbell, R., Sharp, D.J. and Peters, T.J. (2001) 'What do people with 
MS want and expect from health-care services?', Health Expectations, 4(1), 
29-37. 
 
Sosnoff, J., Socie, M.J., Boes, M.K., Sandroff, B.M., Pula, J.H., Suh, Y., Weikert, M., 
Balantrapu, S., Morrison, S. and Motl, R.W. (2011) 'Mobility, balance and falls 
in persons with multiple sclerosis', PLoS ONE, 6(11), e28021. 
 
Steyerberg, E.W. (2009) 'Statistical Models for Prediction' in Clinical Prediction 
Models: A Practical Approach to Development, Validation, and Updating, 
New York, NY: Springer New York, 53-82. 
 
Steyerberg, E.W., Vickers, A.J., Cook, N.R., Gerds, T., Gonen, M., Obuchowski, N., 
Pencina, M.J. and Kattan, M.W. (2010) 'Assessing the performance of 
prediction models: a framework for some traditional and novel measures', 
Epidemiology (Cambridge, Mass.), 21(1), 128. 
 
Tajali, S., Shaterzadeh-Yazdi, M.-J., Negahban, H., van Dieën, J.H., Mehravar, M., 
Majdinasab, N., Saki-Malehi, A. and Mofateh, R. (2017) 'Predicting falls 
among patients with multiple sclerosis: Comparison of patient-reported 
outcomes and performance-based measures of lower extremity functions', 
Multiple Sclerosis and Related Disorders, 17, 69-74. 
 
Tijsma, M., Vister, E., Hoang, P. and Lord, S.R. (2017) 'A simple test of choice 
stepping reaction time for assessing fall risk in people with multiple sclerosis', 
Disability And Rehabilitation, 39(6), 601-607. 
 
Tilson, J.K., Wu, S.S., Cen, S.Y., Feng, Q., Rose, D.R., Behrman, A.L., Azen, S.P. 
and Duncan, P.W. (2012) 'Characterizing and identifying risk for falls in the 
LEAPS study: a randomized clinical trial of interventions to improve walking 
poststroke', Stroke, 43(2), 446-452. 
 
Tinetti, M.E. and Powell, L. (1993) 'Fear of falling and low self-efficacy: a cause of 
dependence in elderly persons', Journal of gerontology. 
 
Vister, E., Tijsma, M.E., Hoang, P.D. and Lord, S.R. (2017) 'Fatigue, Physical 
Activity, Quality of Life, and Fall Risk in People with Multiple Sclerosis', 
International Journal of MS Care, 19(2), 91-98. 
 
Wajda, D.A., Motl, R.W. and Sosnoff, J.J. (2013) 'Dual task cost of walking is related 
to fall risk in persons with multiple sclerosis', Journal of the Neurological 
Sciences, 335(1), 160-163. 
 
Wajda, D.A. and Sosnoff, J.J. (2015) 'Cognitive-motor interference in multiple 
sclerosis: a systematic review of evidence, correlates, and consequences', 
BioMed Research International, 2015(Article ID 720856). 
 
Welmer, A.-K., Rizzuto, D., Laukka, E.J., Johnell, K. and Fratiglioni, L. (2017) 
'Cognitive and Physical Function in Relation to the Risk of Injurious Falls in 
24 
 
Older Adults: A Population-Based Study', The Journals of Gerontology: Series 
A, 72(5), 669-675. 
 
Yamada, M., Aoyama, T., Arai, H., Nagai, K., Tanaka, B., Uemura, K., Mori, S. and 
Ichihashi, N. (2011) 'Dual‐task walk is a reliable predictor of falls in robust 
elderly adults', Journal of the American Geriatrics Society, 59(1), 163-164. 
 
Ytterberg, C., Einarsson, U., Holmqvist, L.W. and Walker Peterson, E. (2013) 'A 
population-based study of fall risk factors among people with multiple 
sclerosis in Stockholm county', J REHABIL MED, 45(5), 452. 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
 
Chapter 2:  
The Ability of Clinical Balance 
Measures to Identify Falls Risk in 
Multiple Sclerosis: A Systematic 
Review and Meta-Analysis 
Paper Status: published in Clinical Rehabilitation  
 
Gillian Quinn, Laura Comber, Rose Galvin, Susan Coote. 
 
 
 
 
 
26 
 
Authors’ Contributions: 
The author of this thesis (GQ) contributed to the paper as follows- 
• Identified the research question.  
• Determined the search terms and inclusion/exclusion criteria in discussion 
with co-author Susan Coote. 
• Ran the systematic search. 
• Completed data extraction. 
• Assisted with the statistical analysis with co-author Rose Galvin. 
• Wrote the paper and submitted for publication. 
 
LC assisted with quality assessment of the included studies and manuscript 
preparation. RG assisted with statistical analysis and manuscript preparation. SC 
participated in study concept and design and assisted with manuscript preparation. All 
authors read and approved the final manuscript.  
 
 
 
 
 
 
 
27 
 
Abstract 
 
Objective 
To determine the ability of clinical measures of balance to distinguish fallers from 
non-fallers and to determine their predictive validity in identifying those at risk of 
falls. 
Data Sources 
AMED, CINAHL, Medline, Scopus, PubMed Central and Google Scholar. 
First search: July 2015. Final Search: October 2017. 
Review Methods 
Inclusion criteria were studies of adults with a definite Multiple Sclerosis diagnosis, a 
clinical balance assessment and method of falls recording. Data were extracted 
independently by two reviewers. Study quality was assessed using the QUADAS-2 
scale and the modified Newcastle-Ottawa Quality Assessment Scale. Statistical 
analysis was conducted for the cross-sectional studies using Review Manager 5. The 
mean difference with 95% confidence interval in balance outcomes between fallers 
and non-fallers was used as the mode of analysis.  
Results 
We included 33 studies (19 cross sectional, 5 randomised controlled trials, 9 
prospective) with a total of 3901 participants, of which 1917 (49%) were classified as 
fallers. The balance measures most commonly reported were the Berg Balance Scale, 
Timed Up and Go and Falls Efficacy Scale- International. Meta-analysis demonstrated 
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fallers perform significantly worse than non-fallers on all measures analysed except 
the Timed Up and Go Cognitive (p<0.05), but discriminative ability of the measures 
is commonly not reported.  Of those reported the Activities Balance Confidence Scale 
had the highest AUC value (0.92), but without reporting corresponding measures of 
clinical utility. 
Conclusion 
Clinical measures of balance differ significantly between fallers and non-fallers but 
have poor predictive ability for falls risk in people with Multiple Sclerosis. 
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Introduction  
 
Previous studies have found falls prevalence to be as high as 56% among people with 
Multiple Sclerosis,  with 37% of those falling classed as frequent fallers (Nilsagård et 
al. 2015). Injurious falls can be serious in this group (Bazelier et al. 2011) and both 
the high rate of falls and high levels of concern about falling may lead to activity 
curtailment and further reductions in physical fitness and endurance (Peterson et al. 
2007). Several factors have been shown to be associated with an increased risk of falls 
in Multiple Sclerosis (Giannì et al. 2014) including longer disease duration, more 
progressive disease course, use of a mobility device, slower gait speed and impaired 
balance. Having a balance impairment has a pooled odds ratio of 1.07 (95% CI 1.04 - 
1.10) for falls among people with Multiple Sclerosis (Gunn et al. 2013b) . While these 
earlier reviews (Gunn et al. 2013b; Giannì et al. 2014) have identified that impaired 
balance is associated with increased falls risk no systematic review to date has 
examined the predictive validity of the various clinical measures of balance used to 
identify falls risk.  
 
A wide range of clinical tests and self-report measures have been used to evaluate 
balance and falls risk in Multiple Sclerosis (Cattaneo et al. 2006; Cattaneo et al. 2007; 
Sosnoff et al. 2011; Cameron and Huisinga 2013) using different observational 
methods. The International Multiple Sclerosis Falls Prevention Research Network 
(IMSFPRN) recommended the assessment of dynamic balance (Cattaneo et al. 2014) 
in falls prevention research,  but it acknowledged there is not enough evidence to 
specifically recommend one measure over any other. Thus, the objective of this 
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systematic review and meta-analysis is to investigate the relationship between clinical 
balance measures and falls in people with Multiple Sclerosis. Firstly, we will examine 
if clinical balance measures demonstrate different scores in fallers and non-fallers in 
cross sectional studies of people with Multiple Sclerosis and secondly, we will 
determine the discriminative ability and clinical utility for assessing falls in 
prospective cohort studies. We hypothesise that there will be a significant difference 
between scores in fallers and non-fallers on these clinical balance measures and that 
measures with an area under the receiving operating curve statistic value of 0.7 or 
greater and a sensitivity of at least 80% will be suitable to use in identifying falls risk.  
 
Methods 
 
This study consists of a systematic review and meta-analysis. The Meta-analysis of 
Observational Studies in Epidemiology (MOOSE) (Stroup et al. 2000) standardised 
reporting guidelines were followed to ensure the standardised conduct and reporting 
of the research. The MOOSE checklist for meta-analyses of observational studies is 
available in appendix 2.1.  A systematic literature search was conducted by the primary 
author (GQ, PhD candidate), with the first search carried out in July 2015 and the final 
search carried out in October 2017, and included the following databases; AMED, 
CINAHL, Medline (through EBSCO search platform), Scopus and PubMed Central. 
Keywords were formed by examining the search strategy in other systematic reviews 
in this area and by checking citations and keywords from results of a preliminary 
search in Google Scholar. The keywords and MeSH headings utilised as search terms 
were: ‘multiple sclerosis’ OR ‘MS’ AND ‘balance’ OR ‘postural control’ OR 
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‘postural instability’ OR ‘imbalance’ OR ’stability’ AND ‘fall*’ OR ‘fall risk’. The 
search was supplemented through the searching of references lists of returned articles 
and the use of the same search terms in Google Scholar. No restrictions were placed 
on language or year of publication. See appendix 2.2 for more details of search 
strategy. 
 
Inclusion criteria were studies of adults with a definite Multiple Sclerosis diagnosis, 
use of a clinical balance measure and a method of falls reporting. Cross-sectional 
studies were included where fallers were compared to non-fallers and prospective 
cohort studies were also included where balance measures were administered prior to 
a subsequent falls event. Baseline data from randomised controlled trials was suitable 
for inclusion in the meta-analysis if authors provided the relevant data when contacted 
and if falls were an outcome of interest in the study. Studies were excluded from this 
review if laboratory-based measures only were used (e.g. limits of stability using the 
Smart Balance Master or static posturography using force platforms) or if the cohort 
consisted of a mixed neurological population. 
 
Two reviewers (GQ and SC) read the titles and/or abstracts of the identified studies 
and discarded irrelevant studies. Studies considered to be eligible for inclusion were 
read in full and their suitability for inclusion was determined independently by two 
reviewers (GQ, SC). Where disagreement occurred, discussions took place until 
consensus was reached. Authors were contacted to provide supplementary information 
when insufficient data were provided in the publication. If two studies were found to 
involve the same patient cohort, only one study was included in the meta-analysis. 
Information relating to authors and year of publication, study design and setting, 
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eligibility criteria, population demographics and outcomes of balance measures were 
extracted to provide summary tables.  
 
The quality of included prospective cohort studies was assessed using the validated 
QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Scale (Whiting et 
al. 2011). The tool considers risk of bias and applicability concerns and consists of 
four main domains- patient selection, index test, reference standard, and flow of 
patients through the study including timing of the index test and reference standard. 
Risk of bias is judged as ‘low’, ‘high’ or ‘unclear’. The quality of the cross sectional 
studies was assessed using the Newcastle-Ottawa Quality Assessment Scale adapted 
for cross sectional studies (Herzog et al. 2013). It involves three sub-sections: the 
selection of cases, the comparability of different outcome groups and the outcome 
itself. A star system is used to allow a semi-quantitative assessment of study quality 
and a maximum score of ten stars may be awarded depending on the criteria level the 
study meets in each section. Two of the authors (GQ and LC) independently assessed 
the methodological quality of the studies. Where disagreement occurred, deliberation 
took place until consensus was reached.  
 
Meta-analysis of the prospective cohort studies was not possible due to the 
heterogeneous nature of the outcomes administered and the variability in follow-up 
time-points. However, the findings of these studies are summarised relating to the 
discriminative ability and clinical utility of the balance measures. Discrimination, the 
ability of a measure to differentiate between individuals with and without falls, was 
quantified using the area under the receiver operating characteristic curve statistic. A 
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value of 0.5 represents chance, values between 0.7 and 0.9 represent moderate 
discrimination and a value of 1 represents perfect discrimination (Moons et al. 2015). 
The clinical utility of the outcome measures was assessed using the summary estimates 
of sensitivity and specificity.  
 
Statistical analysis was conducted for the cross-sectional studies with retrospectively 
collected falls data using Review Manager 5 (Version 5.3). The mean difference (MD) 
with 95% confidence interval in balance outcomes between fallers and non-fallers was 
used as the mode of analysis. We addressed the impact of sample size by estimating a 
weighting factor for each study and assigning larger effect-weights in studies with 
larger samples. Heterogeneity was examined using the I2 statistic. We used the 
Cochrane interpretation of these values where an I2 value of 30% to 60% indicates 
moderate heterogeneity and an I2 of 50% to 90% demonstrates substantial 
heterogeneity (Ryan 2014). When the pooled data indicated moderate or substantial 
heterogeneity, we completed our meta-analysis using the more conservative random-
effects modelling (REM) approach instead of the fixed-effects model (FEM). Where 
reported outcomes had a scale where a lower value is indicative of a worse outcome, 
the reported values were multiplied by -1 so that in all analyses a lower value indicated 
a better outcome (Deeks 2008). 
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Results    
Study Selection 
Figure 2.1 shows the flow of studies through the review selection process. Of the 33 
studies eligible for inclusion, nine were prospective cohort studies (Cameron et al. 
2013; Tajali et al. 2017; Vister et al. 2017) (Nilsagård et al. 2009; Dibble et al. 2013; 
Gunn et al. 2013a; Prosperini et al. 2013; Kasser et al. 2014; Hoang et al. 2016) ,19 
were cross-sectional studies (Cattaneo et al. 2002; Cattaneo et al. 2006; Sosnoff et al. 
2011; Cattaneo et al. 2012; Jacobs and Kasser 2012; Nilsagård et al. 2012; Forsberg 
et al. 2013; Kalron and Achiron 2013; Kanekar and Aruin 2013; Ytterberg et al. 2013; 
Cameron et al. 2014; Kalron 2014; Ganesan et al. 2015; van Vliet et al. 2015; Kalron 
2016b; Kalron 2016a; Kalron and Givon 2016; Ross et al. 2016; Kalron et al. 2017) 
and five were randomised controlled trials with appropriate cross sectional data (Coote 
et al. 2013; Carling et al. 2016; Cattaneo et al. 2016; Forsberg et al. 2016; Sung et al. 
2016). Twelve authors were contacted for additional data, ten of whom returned data 
in relation to twelve different studies. Both fall definition and numbers of falls needed 
to be classified as a faller varied widely across the included studies with seven 
different fall definitions reported and two faller classifications, see appendix 2.3 and 
2.4. 
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Figure 2.1: Flow of studies screened for inclusion in the review  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A detailed summary of included studies is provided in appendix 2.3 (prospective 
studies) and appendix 2.4 (cross sectional studies). Within the prospective studies the 
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(Dibble et al. 2013)  to 416 participants (Prosperini et al. 2013) with a total of 1223 
Multiple Sclerosis participants across the nine prospective studies. The range of mean 
ages reported by the prospective studies for people with Multiple Sclerosis was 30.29 
years (Tajali et al. 2017)  to 57 years (Gunn et al. 2013a)  and six of the nine studies 
reported mean disease duration with averages ranging from 4.02 years (Tajali et al. 
2017)  to 14.37 years (Dibble et al. 2013). The mean Expanded Disability Status Scale 
scores ranged from 2.8 (Cameron et al. 2013) to 5 (Nilsagård et al. 2009). The duration 
of falls recording using falls diaries or calendars varied from 3 months (Nilsagård et 
al. 2009; Gunn et al. 2013a; Prosperini et al. 2013) to 12 months (Dibble et al. 2013; 
Kasser et al. 2014). The incidence of falls across these studies ranged from 41% 
(Prosperini et al. 2013) to 71% (Cameron et al. 2013) with a mean incidence of 56% 
across the nine studies. 
 
 The participant numbers in the cross sectional studies and randomised controlled trials 
varied from 12 (Kanekar and Aruin 2013) to 402 (Kalron 2016b) with a total number 
of 2,678 across the 24 studies. The mean ages reported ranged from 40 years (Kalron 
and Achiron 2013) to 59 years (Sung et al. 2016) and mean disease duration was 
reported in 20 of these studies with averages ranging from 4.3 years (Kalron and 
Achiron 2013) to 20.85 years (Carling et al. 2016). Expanded Disability Status Scale 
score was reported by 16 studies and the mean score ranged from 1.7 (Kalron and 
Achiron 2013; Kalron 2016a) to 6.11 (Carling et al. 2016) . Fallers were identified 
using a falls history ranging from one month recall (Cattaneo et al. 2006) to 12 months 
(Sosnoff et al. 2011; Cameron et al. 2014; Kalron 2014; Ganesan et al. 2015; van Vliet 
et al. 2015; Kalron 2016b; Kalron 2016a; Kalron and Givon 2016; Kalron et al. 2017). 
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The prevalence of falls across these studies ranged from 23% (Cattaneo et al. 2012) to 
76% (van Vliet et al. 2015), with an overall prevalence of 46%.  
Balance Measures 
Self-report balance measures utilised across all studies include the Falls Efficacy Scale 
International (N=9), Activities-specific Balance Confidence Scale (N=7), Dizziness 
Handicap Inventory (N=1) and the Survey of Activities and Fear of Falling in the 
Elderly (N=1). Clinical measures included the Berg Balance Scale (N=12), Dynamic 
Gait Index (N=6), Timed Up and Go test (N=11), Timed Up and Go cognitive  (N=3), 
the mini BESTest (N=2), the Four Square Step test (FSST) (N=6),  Lindmark Motor 
Capacity Assessment subscale for balance (N=1), the Balance Evaluations System 
Test (N=1), the Equiscale test (N=1), Functional Reach (N=1), Physiological Profile 
Assessment (N=2) and the Six Spot Step test (N=1). The Berg Balance Scale and 
Timed Up and Go were the measures most commonly used and in combination with 
the Activities-Specific Balance Confidence scale, Falls Efficacy Scale International, 
Dynamic Gait Index, Four Square Step test, Timed Up and Go Cognitive and mini 
BESTest provided appropriate data for meta-analysis. 
Quality Assessment 
A detailed overview of the methodological quality of the 33 studies is provided in 
Tables 2.1a (cohort studies) and 2.1b (cross-sectional studies and randomised 
controlled trials). In the two QUADAS-2 domains of patient selection and reference 
standard, all nine prospective studies showed low risk of bias in relation to 
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applicability, indicating an appropriate cohort was studied with a suitable method of 
falls recording. No study demonstrated a low risk of bias in all domains with only one 
study (Nilsagård et al. 2009) achieving a low risk of bias in six of the seven domains. 
The total scores on the modified Newcastle Ottawa Scale ranged from 3 stars 
(Cameron et al. 2014) to 8 stars (Cattaneo et al. 2002; Coote et al. 2013) across the 
cross-sectional studies. One of the studies was classified as high risk of bias (1-3 stars) 
(Cameron et al. 2014) and nine of the studies (14%) were medium risk (4-5 stars) with 
the remaining fourteen studies (81%) classed as low risk of bias (6-9 stars).  
Table 2.1a: Methodological quality of prospective cohort studies 
Study ID RISK OF BIAS APPLICABILITY 
CONCERNS 
OVERALL 
RISK OF 
BIAS 
PATIENT  
SELECTION 
INDEX 
TEST 
REFERENCE 
STANDARD 
FLOW 
AND 
TIMING 
PATIENT 
SELECTION 
INDEX 
TEST 
REFERENCE 
STANDARD 
Cameron 
2013 
☺ ☺   ?  ☺ ☺ ☺ 
Dibble 
2013 
 ☺   ? ☺ ☺ ☺ ☺ 
Gunn 
2013 
  ? ☺   ?  ☺   ? ☺ 
Hoang 
2016 
  ? ☺   ?   ? ☺   ? ☺   ?
Kasser 
2014 
   ?   ?  ☺  ☺ 
Nilsagard 
2009 
☺ ☺   ? ☺ ☺ ☺ ☺ ☺
Prosperini 
2013 
 ☺   ? ☺ ☺ ☺ ☺ 
Tajali 
2017 
☺    ?  ☺ ☺ ☺ 
Vister 
2017 
  ? ☺   ? ☺ ☺   ? ☺   ?
☺Low Risk High Risk   ? Unclear Risk 
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In relation to the discriminative ability of the clinical measures, Table 2.2 presents the 
results of the studies.  Only two studies reported the area under the receiving operating 
characteristic curve statistic, the sensitivity, specificity and cut off value (Hoang et al. 
2016; Vister et al. 2017).  Of the ten clinical balance measures investigated in the 
cohort studies, the Berg Balance Scale was one of the most commonly reported 
measures and was the only measure with both an area under the receiver operating 
characteristic curve statistic value of greater than 0.7 (Dibble et al. 2013) and a 
sensitivity of greater than 80% (Nilsagård et al. 2009). However, another study 
reported a conflicting sensitivity score for the Berg Balance Scale of 32% (Prosperini 
et al. 2013). The other two measures with reported area under the receiver operating 
characteristic curve statistic values of greater than 0.7 were the Activities-specific 
Balance Confidence Scale and The Falls Efficacy Scale International (Tajali et al. 
2017) but with no corresponding sensitivity or specificity values. 
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Table 2.2: Discriminative Ability and Clinical Utility of Clinical Measures in 
Prospective Cohort Studies 
Study ID Clinical Measure AUC Value Sensitivity Specificity Cut Off 
Value 
Cameron 2013  
 
Activities Balance 
Confidence Scale 
 
 
Falls Efficacy Scale 
International 
0.69 (p = 
0.02) 
 
 
0.66 (p = 
0.03) 
NR 
 
 
 
NR 
NR 
 
 
 
NR 
NR 
 
 
 
NR 
Dibble 2013  
 
Activities Balance 
Confidence Scale 
 
Berg Balance Scale  
 
Timed Up and Go 
 
Functional Reach 
Test 
 
Dynamic Gait Index 
0.68 
(0.48-0.87) 
 
0.72 
(0.52-0.89) 
0.66  
(0.46-0.86) 
0.66  
(0.47-0.84) 
 
0.68 
(0.49-0.87) 
NR 
 
 
NR 
 
NR 
 
NR 
 
 
NR 
NR 
 
 
NR 
 
NR 
 
NR 
 
 
NR 
NR 
 
 
NR 
 
NR 
 
NR 
 
 
NR 
Gunn 2013  
 
Physiological 
Profile Assessment 
0.67  
(0.58-0.76) 
56% 74% NR 
Hoang 2016  Physiological 
Profile Assessment 
0.64  
 
62% 62% 2.0 
Kasser 2014  Survey of Activities 
and Fear of Falling 
in the Elderly 
NR NR NR NR 
Nilsagard 2009  
 
Four Square Step 
Test 
 
Timed up and Go 
Cognitive 
 
Berg Balance Scale 
NR 
 
 
NR 
 
 
NR 
60% 
 
 
73% 
 
 
94% 
75% 
 
 
54% 
 
 
32% 
≥ 16.9 
 
 
≥ 13.6 
 
 
≤ 55 
Prosperini 2013  Berg Balance Scale NR 32% (18-
48) 
87% (75-
94) 
≥ 44 
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Tajali 2017  Falls Efficacy Scale 
International 
 
Timed Up and Go 
 
 
Activities Balance 
Confidence Scale 
0.89 (p ˂ 
0.0001) 
 
0.65 (p = 
0.014) 
 
0.92 (p ˂ 
0.0001) 
NR 
 
 
NR 
 
 
NR 
NR 
 
 
NR 
 
 
NR 
NR 
 
 
NR 
 
 
NR 
Vister 2017 Physiological 
Profile Assessment 
 
Falls Efficacy Scale 
International 
0.60 
 
 
0.66 
57% 
 
 
72% 
60% 
 
 
53% 
2.00 
 
 
30 
 
AUC = area under the receiver operating characteristic curve statistic, NR = not 
reported. The p value or 95% confidence interval is given in brackets after the value, where 
reported.   
 
Meta-analysis of Cross-Sectional Studies- 
Results of the meta-analysis for clinical measures are displayed in Figure 2.2a. Ten 
studies used the Berg Balance Scale (Berg et al. 1989)  to compare balance across 
fallers and non-fallers (Cattaneo et al. 2006; Cattaneo et al. 2012; Coote et al. 2013; 
Kanekar and Aruin 2013; Ganesan et al. 2015; Carling et al. 2016; Cattaneo et al. 
2016; Forsberg et al. 2016; Ross et al. 2016; Sung et al. 2016). Fallers demonstrated 
significantly lower balance scores than their counterparts without a history of falls, as 
presented in Figure 2a (FEM, MD = 2.72, 95% CI {1.53-3.92}, P<0.01, I2 = 30%). 
Three of the studies (Cattaneo et al. 2012; Ganesan et al. 2015; Carling et al. 2016) 
included in the meta-analysis for this measure had an overall medium risk of bias 
based on methodological quality- score, the other eight were deemed low risk of bias 
(Newcastle Ottawa Scale score of 6 to 8).  
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Figure 2.2a: Mean difference in Berg balance score between Fallers and Non-Fallers 
 
 
The Dynamic Gait Index (DGI) (McConvey and Bennett 2005) was used in five 
studies (Cattaneo et al. 2006; Cattaneo et al. 2012; Nilsagård et al. 2012; Forsberg et 
al. 2013; Cattaneo et al. 2016). The findings from these pooled studies (Figure 2.2b) 
demonstrate that fallers report significantly lower DGI scores than non-fallers and two 
(Cattaneo et al. 2012; Nilsagård et al. 2012) of the five studies included had a medium 
risk of bias. Five of the nine studies included in meta-analysis for the Timed Up and 
Go (Podsiadlo and Richardson 1991) had a medium risk of bias, with the remaining 
studies demonstrating a low risk of bias and the pooled meta-analysis did demonstrate 
a significant difference between fallers and non-fallers on this measure (Figure 2.2c). 
 
Figure 2.2b: Mean difference in Dynamic Gait Index between Fallers and Non-Fallers 
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Figure 2.2c: Mean difference in Timed Up and Go test between Fallers and Non-Fallers 
 
 
Results for the Timed Up and Go Cognitive (Shumway-Cook et al. 2000), mini 
BESTest (Potter and Brandfass 2015) and Four-Square Step test (Dite W 2002) are 
seen in Figures 2.2d, 2.2e and 2.2f respectively. All measures showed a significant 
difference across fallers and non-fallers except for the Timed Up and Go Cognitive.  
The findings from the meta-analysis for the Timed Up and Go Cognitive, Mini 
BESTest and Four-Square Step test should be interpreted with caution as they had only 
small numbers of studies suitable for inclusion (two to four for each analysis).  
 
Figure 2.2d: Mean difference in Timed Up and Go Cognitive scores between Fallers 
and Non-Fallers 
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Figure 2.2e: Mean difference in Mini-BESTest scores between Fallers and Non-Fallers 
 
 
Figure 2.2f: Mean difference in Four Square Step test scores between Fallers and Non-
Fallers 
 
 
 
Findings from the meta-analysis for self-report measures, the Activities Specific 
Balance Confidence Scale (Powell and Myers 1995) and the Falls Efficacy Scale 
International (Yardley et al. 2005) are seen in Figure 2.3a and 2.3b. A significant 
difference across fallers and non-fallers was noted for both these measures. The meta-
analysis for both these measures included one study with an overall medium risk of 
bias and this must be remembered when interpreting the results.  
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Figure 2.3a: Mean difference in Activities Specific Balance Confidence Scale between 
Fallers and Non-Fallers 
 
 
Figure 2.3b: Mean difference in Falls Efficacy Scale International between Fallers and 
Non-Fallers 
 
 
 
Discussion  
 
In this review exploring the differences in balance between fallers and non-fallers with 
Multiple Sclerosis and the discriminative ability and clinical utility of clinical balance 
measures for falls prediction, we found a total of 33 studies suitable for inclusion. The 
most commonly reported clinical measures were the Berg Balance Scale, the Timed 
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Up and Go, Activities-specific Balance Confidence Scale and Falls Efficacy Scale 
International. These measures do demonstrate a significant difference between fallers 
and non-fallers but have conflicting sensitivity values reported and often no area under 
the receiver operating characteristic curve statistic value reported or poor 
discriminative ability demonstrated.  There is currently insufficient evidence from the 
nine prospective studies to support any balance measure as a falls prediction tool for 
people with Multiple Sclerosis.  
 
From the limited number of prospective studies, there were only three reported 
measures demonstrating an area under the receiver operating characteristic curve 
statistic value of moderate discrimination; the Activities-specific Balance Confidence 
Scale (Tajali et al. 2017), the Falls Efficacy Scale International (Tajali et al. 2017) and 
the Berg Balance Scale (Dibble et al. 2013). No study reported corresponding 
sensitivity and specificity values together with the area under the receiver operating 
characteristic curve statistic value for these measures, but two different studies did 
report conflicting sensitivity values for the Berg Balance scale with one study 
reporting a high sensitivity value (greater than 80%) (Nilsagård et al. 2009) and 
another study reporting a contrasting sensitivity value of 32% (Prosperini et al. 2013). 
This conflicting value may be due to the variance in study population in the two 
cohorts with the latter study’s participants representing a milder disease stage and a 
younger age profile  than the former study (Nilsagård et al. 2009). The Berg Balance 
Scale should not be used to identify falls risk in Multiple Sclerosis until there is a 
stronger evidence base available demonstrating good discriminative ability and 
satisfactory clinical utility.  
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Our results are somewhat similar to a previous review by Gianni et al (Giannì et al. 
2014), who found that measures such as the Berg Balance Scale and Timed Up and 
Go demonstrated poorer performance in fallers when compared to non-fallers. 
However, those authors meta-analysed data from both prospective and cross-sectional 
studies, thus diluting the validity of their pooled results. Gunn et al (2013b) looked at 
risk factors associated with falls in Multiple Sclerosis and found that balance 
impairment was associated with falling (pooled OR of 1.07,95% CI 1.04 – 1.10). Like 
our findings, they also reported low measures of sensitivity in the balance measures 
used and concluded that the use of a balance measure alone is not appropriate when 
falls screening for people with Multiple Sclerosis. Given that studies from other 
populations (Paul et al. 2013; Barry et al. 2014) suggest that a balance measure alone 
may not have sufficient clinical utility to predict falls, we suggest those measures with 
significant differences on meta-analysis should be considered for evaluation in future 
studies in combination with other clinical variables. 
 
There are a number of strengths associated with this systematic review. A robust 
methodological approach was employed to identify and select 33 unique studies 
relevant for inclusion which is higher than the previous reviews (Gunn et al. 2013b; 
Giannì et al. 2014) . We utilised rigorous methods to select and carefully appraise 
appropriate studies from a variety of databases. However, the findings need to be 
interpreted in the context of our study limitations. We originally proposed to 
investigate only prospective cohort studies; however, a scoping search indicated that 
there were a limited number of papers reporting this reference standard. We therefore 
included data from cross sectional studies comparing balance scores in people who do 
and do not report falls in this systematic review and meta-analysed that data. There 
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was a lack of standardised conduct and reporting across the included studies with 
significant heterogeneity in the range of outcomes used. A strength is that we included 
all available studies, however a limitation is that some were of low methodological 
quality. The lack of a “cut off” or definition of “good” or “excellent” for the tools used 
meant that a clear rationale for excluding studies was not available and we did not use 
a sensitivity analysis to exclude certain studies from the meta-analyses.  
 
A further limitation of this review is that we did not specify the fall definition or faller 
classification as part of our inclusion criteria. Our results demonstrate a wide variety 
of fall definitions and faller classifications and this, and lack of consideration of 
clinical heterogeneity due to Multiple Sclerosis type or level of disability weakens the 
findings from our meta-analyses.  Only nine studies in this review used the gold 
standard of prospective falls recording with diaries as recommended by falls 
prevention networks such as the Prevention of Falls Network Europe (Lamb et al. 
2005) and the International Multiple Sclerosis Falls Prevention Research Network 
(Coote et al. 2014). We used a broad range of search terms to try and find all suitable 
studies, but the large numbers returned in our initial results may have resulted in 
suitable studies being missed at the screening stage.  We chose to exclude laboratory-
based measures of balance such as posturography using force plate platforms due to 
the lack of clinical applicability. However, there is a growing body of evidence on 
their discriminative ability and clinical utility in people with Multiple Sclerosis 
(Prosperini and Pozzilli 2013) and in the use of inertial sensors and instrumented gait 
tests to detect balance impairments in this population (Spain et al. 2012; Greene et al. 
2014).  
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In conclusion, it is not currently possible to recommend any clinical balance measure 
for assessing falls risk in Multiple Sclerosis. From the small number of prospective 
studies presented in this review, it is clear that we do not have enough information 
about the predictive validity of the current measures commonly used to recommend 
any specific one. Given the multifactorial nature of falls, balance measures alone may 
not have adequate falls prediction ability. Similar to research on falls risk in older 
people (Stevens and Phelan 2013), the use of quick screening questions rather than 
results of a lengthy assessment may more reliably identify those at risk, and further 
research should consider this direction.    
 
 
Clinical Message 
• Meta-analysis shows fallers perform significantly worse than non-fallers on 
commonly used measures such as the Berg Balance Scale and Timed Up and 
Go, but the discriminative ability of these clinical measures is poor. 
• It is not possible to recommend any clinical balance measure for assessing falls 
risk in Multiple Sclerosis.  
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Abstract: 
 
Objective: 
To investigate discriminative ability and clinical utility of the Timed Up and Go under 
single and dual task conditions between fallers and non-fallers in Multiple Sclerosis. 
 
Design: 
Prospective cohort study.  
 
Setting: 
Neurology service in a tertiary hospital. 
 
Subjects: 
Participants were 101 people with Multiple Sclerosis and Expanded Disability Status 
Score of 3-6.5. One participant withdrew after the baseline assessment, data were 
analysed for 100 participants.  
 
Interventions: 
No specific intervention. 
 
Main Measures: 
Timed Up and Go and Timed Up and Go Cognitive. Three-month prospective diaries 
recorded falls. 
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Results:  
Mean age was 52.6 (SD 10.7) and 66 were female. Majority of participants had 
progressive MS (72) and 73 used a walking aid, 56 participants recorded 791 falls. 
The area under the receiver operating characteristic curve for Timed Up and Go and 
Timed Up and Go -Cognitive in distinguishing fallers (person with ≥1 fall) from non-
fallers is 0.60 and 0.57 respectively, in distinguishing multiple fallers (≥2 falls) it is 
0.46 and 0.43. A Timed Up and Go score of ≥9 seconds, has sensitivity of 0.82 and 
specificity of 0.34 to identify fallers, and sensitivity of 0.79 and specificity of 0.27 to 
identify multiple fallers. A Timed Up and Go-Cognitive score of ≥11 seconds has 
sensitivity of 0.77 and specificity of 0.30 to identify fallers and sensitivity of 0.71 and 
specificity of 0.26 to identify multiple fallers 
 
Conclusion:  
The Timed Up and Go and Timed Up and Go-Cognitive do not demonstrate sufficient 
clinical utility or discriminative ability for assessing falls risk in MS. 
 
Key Words: 
Multiple Sclerosis; Accidental Falls; Risk; Timed Up and Go 
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Introduction:  
 
Multiple Sclerosis is a chronic progressive disease with a high incidence of falls 
(Nilsagård et al. 2015). Poor balance and cognition, progressive Multiple Sclerosis 
and mobility aid use are all risk factors associated with falling (Gunn et al. 2013). The 
consequences of falls are far reaching including serious injury, fear of falls and 
associated activity curtailment, with increased healthcare utilization that contributes 
to a high socio-economic cost (Peterson et al. 2008; Larkin et al. 2015). Reliable 
screening tools are essential to allow early identification of people with Multiple 
Sclerosis who are at risk of falling and initiate more timely and appropriate falls 
prevention interventions. A recent systematic review  (Quinn et al. 2017) and meta-
analysis found that no clinical balance measure currently in use has sufficient evidence 
for its suitability in assessing falls risk in Multiple Sclerosis and noted poor 
methodological standards of included studies.  
 
One of the most common measures utilised to assess dynamic balance and functional 
mobility in Multiple Sclerosis research is the Timed Up and Go and meta-analysis 
found significant differences between fallers and non-fallers (Quinn et al. 2017) 
suggesting further investigation of this measure as a predictor of falls is warranted. 
The Timed Up and Go has been recommended as a screening test for falls risk by the 
American Geriatrics Society/British Society of Gerontology Guidelines (2011) and 
has been shown to have good validity (Sebastião et al. 2016) and reliability (Nilsagard 
et al. 2007) in Multiple Sclerosis populations. The Timed Up and Go-Cognitive 
comprises the same mobility task with an added cognitive task such as counting 
backwards or verbal fluency  and provides a simple method of assessing the dual task 
63 
 
cost of walking which has been shown to be associated with falls risk (Wajda et al. 
2013) in people with Multiple Sclerosis. Both the Timed up and Go and Timed up and 
Go-Cognitive have been recommended for use in Multiple Sclerosis research and 
clinical practice by the American Physical Therapy Association Evidence Database to 
Guide Effectiveness Task Force (Potter et al. 2014).  
  
Retrospective studies investigating falls risk assessment in Multiple Sclerosis using 
the Timed Up and Go have reported conflicting findings with one study not finding 
any significant difference between fallers (faller classification not specified) and non-
fallers (Cattaneo et al. 2006) while a more recent study (Kalron et al. 2017) with a 
larger sample size demonstrated a significant difference between non-fallers and 
multiple fallers (person with 2 or more falls). The only two prospective studies that 
have reported on the discriminative ability (ability to distinguish between fallers and 
non-fallers) of the Timed Up and Go found it has poor discriminative ability to identify 
future fallers with an area under the receiving operating curve value of less than 0.7 
(Dibble et al. 2013; Tajali et al. 2017) with no study reporting the measure as having 
both good clinical utility (assessed using the summary estimates of sensitivity and 
specificity) and good discriminative ability.  
 
This prospective cohort study aims to investigate both the discriminative ability and 
clinical utility of the Timed Up and Go under single and dual task conditions among 
people with Multiple Sclerosis with mixed condition subtypes using prospectively 
collected falls data.  
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Methods: 
 
Study design 
This was a prospective cohort study with prospectively collected falls status using 
diaries. The STROBE (STrengthening The Reporting of OBservational studies in 
Epidemiology) Statement guideline (Von Elm et al. 2007) was adhered to in the 
conduct and reporting of the study. The study was approved by the University of 
Limerick Ethics Committee and the St. Vincent’s Healthcare Group Ethics and 
Medical Research Committee.  
 
Recruitment and Eligibility 
Consecutive patients attending the MS clinic at St Vincent’s University Hospital 
Dublin were invited to participate in the study if they met the following inclusion 
criteria: (1) A neurologist confirmed diagnosis of MS, (2) an Expanded Disability 
Status Score of between 3 and 6.5 (Kurtzke 1983) indicating that they had some 
walking limitations but were still able to ambulate independently (with or without a 
mobility aid), (3) adequate cognitive function to participate in the assessment and fill 
out falls diaries for the three-month study period. Participants under 18 years, pregnant 
woman or individuals unable to provide informed consent were excluded from the 
study. There were no other exclusion criteria and participants could have other 
conditions that directly or indirectly affected walking ability and may have been on 
symptomatic treatment that affected their mobility. Recruitment and participant 
assessment was carried out between November 2014 and March 2016 with the final 
falls diaries collected in June 2016.  
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Measures/Outcomes  
The primary outcome was falls incidence as reported using prospective falls diaries 
for a three-month period. A fall was defined as ‘an unexpected event in which you 
come to rest on the ground, floor, or lower level’ (Lamb et al. 2005). The participants 
were provided with stamped self-addressed envelopes and falls diaries to be returned 
monthly. Those not returning their diaries were contacted by the researcher to remind 
them or to collect the data for that month by phone. Participants also had the option of 
a text or e-mail reminder to be sent fortnightly to optimise falls reporting. As there are 
a variety of classifications for faller status currently utilized in the literature (Matsuda 
et al. 2011) , we analysed our data using two faller classifications; those who had 1 or 
more falls and  those with multiple falls (2 or more) in the three month period.  
   
Data collected routinely at the clinic was incorporated into the data set for the study 
and included the Expanded Disability Status Score (level of disability), age, time since 
diagnosis, self-reported falls in the last 3 months, type of Multiple Sclerosis and 
walking aid(s) used. Consenting participants then completed the Timed Up and Go. 
The measures were performed in the same standardised order for every participant and 
participants were advised to walk at a fast but safe speed while in their usual footwear 
and using their usual mobility device (if applicable). This instruction was chosen as it 
has been previously used in studies examining the TUG with people with MS (Gijbels 
et al. 2010). It is acknowledged that instructions for the TUG have varied in the 
literature (Barry et al. 2014) but previous exploration of walking assessment in people 
with MS have recommended participants are instructed to walk fast in order to 
maximise effort and better assess motor fatigue (Goldman et al. 2008).  The participant 
was seated in a standard height chair with their back against the chair and was then 
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instructed to stand up, walk 3 metres to a specific mark on the ground, turn around, 
and walk back and sit in the chair again. Timing began when the participant started to 
rise from the chair and ceased when he/she was seated in the chair after walking back. 
The participant had one practice trial and then three recorded trials, with a mean value 
of the three walks used for statistical analysis. The participant then did the Timed Up 
and Go under dual task conditions with an added cognitive task of counting backwards 
in multiples of three. The starting number chosen by the research assistant was a 
randomly selected number between 20 and 100. The Timed Up and Go-Cognitive was 
assessed in the same standardised manner as the TUG.  
 
Statistical Analysis  
Descriptive statistics were generated for age, gender, disease duration, Multiple 
Sclerosis type and Expanded Disability Status Score. Timed Up and Go data was 
tested for normality using the Kolmogorov-Smirnov test and depending on distribution 
either independent sample T tests or Mann Whitney tests were used to determine the 
differences between fallers and non-fallers. Discrimination is the ability of a measure 
to differentiate between individuals with and without falls and is quantified using the 
area under the receiver operating characteristic curve statistic. Receiver operating 
curve analysis was carried out to determine this value and the optimal sensitivity and 
specificity values for the Timed Up and Go and Timed Up and Go-Cognitive. The area 
under the receiver operating characteristic curve statistic measures the average true 
positive rate (predicted falls that actually occurred) over all false positive rates 
(predicted falls that did not actually occur). It can have any value between 0 and 1 with 
a value of 0.5 representing chance, values between 0.7 and 0.9 representing moderate 
discrimination and a value of 1 representing perfect discrimination (Moons et al. 
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2015). The larger the area under the receiver operating characteristic curve statistic 
value the greater the discriminative ability of the measure in question (Hanley and 
McNeil 1982). In terms of measuring clinical utility, the sensitivity and specificity of 
the Timed Up and Go and Timed Up and Go-Cognitive were calculated. Balance 
screening tools with high sensitivity (≥80%) are preferable to safely ‘rule-out’ those 
at low risk of a subsequent fall (as opposed to diagnostic tools that generally 
demonstrate high specificity) (Riddle and Stratford 1999).  
 
Positive predictive values and likelihood ratios were also calculated. A positive 
predictive value is the proportion of individuals with test results above or equal to the 
cut-off point who were correctly classified as fallers. The specific cut offs used were 
chosen to maximise the sensitivity and specificity values as previous cut off values 
have not been recommended in this population. A negative predictive value is the 
proportion of individuals with scores below the cut-off point who were correctly 
classified as non-fallers. The likelihood ratio summarizes how many times more a 
person who experiences falls has results on the Timed Up and Go or Timed Up and 
Go-Cognitive worse than or equal to the cut-off score. A positive likelihood ratio of 
greater than 1 indicates the test result is associated with the disease or in this instance 
with faller status. A negative likelihood ratio less than 1 indicates that the result is 
associated with absence of the disease or in this instance being a non-faller (Jaeschke 
et al. 1994).  
 
As this is not an intervention trial there was no formal study size calculation, the 
sample size of 100 was chosen based on previous research in this field (Prosperini et 
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al. 2013) and was considered a feasible and realistic recruitment target. All analyses 
were performed using SPSS software, version 22. The level of significance was set as 
p < 0.05.  
 
Results: 
 
The sample included 101 people with Multiple Sclerosis (67 female), one participant 
withdrew after the baseline assessment, so data was analysed for a total of 100 
participants with three months of falls diaries. Baseline details for fallers (person with 
1 or more falls) and non-fallers (0 falls) are reported in Table 3.1. There was no 
significant difference in the Timed Up and Go or Timed Up and Go-Cognitive scores 
between fallers and non-fallers (p>0.05). If examining the baseline differences 
between multiple fallers (person with 2 or more falls) and non-fallers, there was a 
significant difference in age (p = 0.003) and disease duration (p = 0.007) with the 
multiple fallers being younger with a shorter disease duration. 
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Table 3.1: Comparison of demographic information and clinical characteristics  
of fallers (≥ 1 fall) and non-fallers (0 falls) with Multiple Sclerosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SD: Standard Deviation, MS: Multiple Sclerosis, EDSS: Expanded Disability Status Scale,  
IQR: Interquartile Range, ap value from independent samples t-test, bp value from chi  
square test for independence (continuity correction), cp value from Fisher’s exact test,  
dp value from Mann-Whitney U test. 
 
The area under the receiver operating characteristic curve statistic values with optimal 
sensitivity and specificity values, the positive predictive value and negative predictive 
value and positive likelihood ratio and negative likelihood ratio are all reported in 
Table 3.2 below.  
Characteristic All Participants 
(n=100) 
Fallers  
(n=56) 
Non-Fallers 
(n=44) 
p Value 
Age (years); mean 
(SD) [range] 
52.6 (10.78)  
[29-78] 
51.61 (11.3) 
[29-78] 
53.86 (10.1) 
[31-71] 
0.30a 
Gender; n (%)     
Male 34 22 (39.3) 12 (27.2) 0.21b 
Female 66 34 (60.7) 32 (72.7)  
MS Classification; 
n (%) 
    
Primary 
Progressive 
 
19 
 
10 (17.9) 
 
9 (20.5) 
 
0.81c 
Secondary 
Progressive 
 
53 
 
31 (55.4) 
 
22 (50) 
 
Relapsing-
Remitting 
 
24 
 
13 (23.2) 
 
11 (25) 
 
Benign 2 0 (0) 2 (4.5)  
Unknown 2 2 (3.6) 0 (0)  
Use of a Walking 
Aid; n (%) 
    
Yes 73 44 (78.6) 29 (65.9) 0.16b 
No 27 12 (21.4) 15 (34.1)  
EDSS; median 
[IQR] 
6 (2) 6 (1.5) 5.5 (2) 0.24d 
Time Since 
Diagnosis (years); 
median [IQR] 
 
14 [13.75] 
 
11 [15.5] 
 
14.25 [10.4] 
 
0.08d 
Fall in the Past 3 
Months (self 
report); n (%) 
    
Yes 50 35 (62.5) 15(34.1) 0.01b 
No 
TUG score (secs); 
median [IQR] 
TUG C score 
(secs); 
median[IQR] 
50 
 
11.56 [6] 
 
13.35 [6.8] 
21(37.5) 
 
12.0 [7.7] 
 
13.5 [10.9]  
29 (65.9) 
 
11.2 [5.2]           
 
13.0 [5] 
 
 
 
0.09d 
 
0.22d  
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Table 3.2: The AUC, sensitivity and specificity, predictive values and likelihood 
ratios for the TUG and TUG -Cognitive. 
Faller 
Classific
-ation 
AUC  
(95% 
CI) 
Cut 
off,
secs 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PV+ 
(95% 
CI) 
PV- 
(95% 
CI) 
LR+ 
(95% 
CI) 
LR- 
(95% 
CI) 
1 or 
more 
falls 
TUG  
0.60 
(0.5-
0.7) 
 
TUG 
C 0.57 
(0.5-
0.7) 
9 
 
 
 
 
11 
82.1% 
(69.6-91.1) 
 
 
 
76.8%  
(63.6-87.0) 
34.1% 
(20.5-49.9) 
 
 
 
29.6%  
(16.8-45.2) 
61.3% 
(53.4-
67.0) 
 
 
58.1%  
(52.2-
63.8) 
60.0% 
(42.8-
75.1) 
 
 
50.0%  
(34.1-
65.9) 
1.3  
(1.0-
1.6) 
 
 
1.1  
(0.9-
1.4) 
0.5  
(0.3-
1.1) 
 
 
0.8  
(0.4-
1.5) 
2 or 
more 
falls 
TUG 
0.46 
(0.4-
0.6) 
 
TUG 
C 0.43 
(0.3-
0.6) 
9 
 
 
 
 
11 
79.4% 
(62.1-91.3) 
 
 
 
70.6% 
(52.5-84.9) 
27.3% 
(17.0-39.6) 
 
 
 
25.8% 
(15.8-38.0) 
36% 
(31.0-
41.4) 
 
 
32.9% 
(46.7-
76.7) 
72% 
(54.4-
84.7) 
 
 
63.0% 
(31.3-
51.3) 
1.09 
(0.9-
1.4) 
 
 
1  
(0.7-
1.2) 
0.8  
(0.4-
1.6) 
 
 
1.1  
(0.6-
2.2) 
AUC: Area under the receiving operating curve statistic, TUG: Timed Up and Go, TUG C: Timed Up 
and Go Cognitive, PV+: Positive Predictive Value, PV-: Negative Predictive Value, LR+: Positive 
Likelihood ratio, LR-: Negative Likelihood ratio  
The 2 x 2 table used to calculate these values is shown in Table 3.3 below.    
Table 3.3: 2 x 2 Table for Timed Up and Go with a cut point of 9 seconds and a 
faller classification of ≥1 fall.   
Test 
(Timed Up 
and Go) 
Faller 
(condition 
present) 
N = Non-Faller 
(condition 
absent) 
N = Total 
Positive True 
positive 
46 False 
positive 
29 75 
Negative False 
Negative 
10 True 
Negative 
15 25 
Total  56  44 100 
 
The receiver operating characteristic curve is shown in Figure 3.1 for fallers and in 
Figure 3.2 for multiple fallers. The area under the receiver operating characteristic 
curve statistic for the Timed Up and Go and Timed Up and Go-Cognitive in 
distinguishing fallers from non-fallers is 0.60 and 0.57 respectively and is 0.46 and 
0.43 for multiple fallers.  
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Figure 3.1: Receiver Operating Curve analysis for Timed Up and Go (TUG) 
and Timed up and Go -Cognitive (TUG COG) in predicting fallers (≥1 fall) in 
Multiple Sclerosis 
 
Figure 3.2: Receiver Operating Curve analysis for Timed Up and Go (TUG) 
and Timed Up and Go-Cognitive (TUG COG) in predicting multiple fallers (≥ 2 
falls) in Multiple Sclerosis 
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Discussion:  
 
This prospective cohort study is the first to report both the discriminative ability and 
the clinical utility of the Timed Up and Go and Timed Up and Go-Cognitive for 
assessing falls risk among people with Multiple Sclerosis using prospective falls 
diaries. The findings demonstrate that both the Timed Up and Go and Timed Up and 
Go-Cognitive scores are not significantly different between fallers and non-fallers and 
the discriminative ability of these measures is poor with an area under the receiving 
operating curve value of 0.60 and 0.57 respectively. When explored using the faller 
classification of 2 or more falls the discriminative ability is reduced with an area under 
the receiving operating curve value of 0.46 and 0.43 for the Timed Up and Go and 
Timed Up and Go-Cognitive. Neither of these measures demonstrated a prediction 
accuracy high enough (greater than 0.7) to warrant their use in isolation for assessing 
falls risk in this progressive Multiple Sclerosis cohort.   
 
Our finding that the Timed Up and Go and Timed Up and Go-Cognitive scores are not 
significantly different between fallers and non-fallers, for both faller and multiple 
faller classifications, is similar to a previous prospective study examining the utility 
and predictive validity of specific clinical measures for falls risk in Multiple Sclerosis 
(Dibble et al. 2013) but differs from findings from a recent systematic review and 
meta-analysis of studies using retrospective falls reporting (Quinn et al. 2017). Other 
studies did not report clinical utility in the form of sensitivity and specificity values or 
discriminative ability (Sosnoff et al. 2011; Kalron et al. 2017). To properly examine 
the discriminative ability of a measure and its validity in identifying future risk of falls 
prospective study designs should be employed using appropriate indices of 
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discrimination and clinical utility. An area under the receiving operating curve value 
of greater than 0.7 is necessary to be of moderate discrimination and previous 
prospective studies in Multiple Sclerosis have reported similarly low discrimination 
values for the Timed Up and Go of 0.66 (Dibble et al. 2013) and 0.65 (Tajali et al. 
2017). The latter study above had a younger cohort with primarily relapsing remitting 
Multiple Sclerosis in comparison to our study sample that had mainly progressive 
Multiple Sclerosis and a median disease duration of 14 years (IRQ 13.75). This poor 
discriminative ability is evident in research on other neurological populations also 
with an area under the receiving operating curve value of 0.58 reported in a large study 
on falls risk in older people (Kojima et al. 2015) and an area under the receiving 
operating curve value of 0.65 for people with Parkinson’s disease (Kerr et al. 2010).  
 
In other neurological populations the evidence for clinical utility of the Timed Up and 
Go is conflicting. The measure has demonstrated very high sensitivity in Parkinson’s 
disease (Dibble and Lange 2006) but much lower sensitivity in people post stroke 
(Andersson et al. 2006) and in community dwelling elderly a recent systematic review 
and meta-analysis (Barry et al. 2014) found the measure had an overall sensitivity of 
31% and specificity of 74% at a cut-point of ≥13.5 seconds and that it is not a 
significant predictor of falls with an odds ratio of 1.01. No prospective study in 
Multiple Sclerosis has reported sensitivity or specificity values for the Timed Up and 
Go and only one Multiple Sclerosis study has reported sensitivity values for the Timed 
Up and Go-Cognitive (Nilsagård et al. 2009) which was similar to our values reported 
here. However, that study demonstrated a higher specificity and a higher positive 
predictive value in comparison to our results when used with a cut off value of 13.6 
seconds. The low specificity value of 29% for the Timed Up and Go-Cognitive from 
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our data may mean that some people would end up being classed as falls risk 
incorrectly and would be referred for in demand resources and falls prevention 
services that they may not actually need. Regarding clinical utility, in the form of 
sensitivity and specificity values, the current literature suggests the Timed Up and Go 
and Timed Up and Go-Cognitive are not reliable enough to use as a stand-alone 
measure of falls risk.   
 
Interestingly, no other studies of people with Multiple Sclerosis reported predictive 
values or likelihood ratios for the Timed Up and Go which is of concern when it has 
been argued that likelihood ratios are more useful clinically when discussing 
diagnostic accuracy. The further likelihood ratios are from 1 the stronger the evidence 
for the presence or absence of disease or in this instance of being a faller or non-faller 
(Deeks and Altman 2004). The only other prospective study that reports predictive 
values and likelihood ratios for the Timed Up and Go-Cognitive in relation to falls risk 
in Multiple Sclerosis had a slightly higher positive predictive value and positive 
likelihood ratio (Nilsagård et al. 2009) than our findings, but was well outside the 
range of above 10 or below 0.1 that is considered as strong evidence for ruling in or 
out conditions (Jaeschke et al. 2002). These poor likelihood ratio values demonstrated 
in Multiple Sclerosis are similar to that seen for the Timed Up and Go and Timed Up 
and Go-Cognitive in Parkinson’s disease (Dibble and Lange 2006) and suggest that 
the measure has poor diagnostic accuracy or in this context poor predictive ability for 
determining faller status. 
 
75 
 
If the Timed Up and Go is used to measure falls risk, it may need to be more 
objectively quantified using body worn sensors as has been shown to increase the 
accuracy of falls risk detection in a small prospective study of people with Parkinson’s 
disease (Greene et al. 2018). When trying to quantify falls risk, various dimensions of 
mobility across a variety of contexts may need to be investigated  and a recent study 
found self-report measures demonstrated stronger reliability than performance based 
measures such as the Timed Up and Go (Tajali et al. 2017). A measure such as the 
Timed Up and Go that only examines one aspect of performance in the form of speed 
may be too crude to fully quantify falls risk and ideally should be combined with other 
variables to improve its predictive validity. Furthermore, recent research has shown 
that the activity at the time of falling and influencing factors such as individual 
symptoms and task demands are important considerations when monitoring falls risk 
(Carling et al. 2018) and perhaps assessment in the home during a more real life 
situation may be more useful than a clinic based tool.  
 
A limitation of this study is that recruitment rate and reasons for non-participation 
cannot be clearly identified. As recruitment occurred in a busy outpatient neurology 
clinic the number of potentially eligible participants and the number of participants 
deemed eligible is unknown as this initial screening was done by the treating physician 
and participants were only introduced to the principal investigator once deemed 
appropriate. This may explain why the study sample consists of such a progressive 
cohort as the treating physician may only have considered falls risk in the more 
physically impaired clinic attendees. As the median Expanded Disability Status Score 
was 6 this indicates that some participants were using bilateral support for walking 
and this alters the balance requirements of the Timed Up and Go and limits the 
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applicability of the study findings to a less disabled Multiple Sclerosis cohort.  A 
further limitation was lack of a formal study size calculation, the sample size of 100 
was chosen based on previous research in this field (Prosperini et al. 2013) and was 
considered a feasible and realistic recruitment target. The lack of a measure for the 
dual task of cognition in conjunction with the dual task of mobility is also a limitation 
of this study. Recent studies on dual task ability and cognitive motor interference 
recommend that both the cognitive and motor aspects be assessed (Plummer and Eskes 
2015).  
 
There are many strengths associated with this study such as the large sample size and 
the robust methodology including clear reporting of both discrimination and clinical 
utility. The predominantly progressive cohort may be a limitation in that these results 
cannot be applied to people with Multiple Sclerosis with less impaired mobility. 
However, as longer disease duration and more progressive disease are strongly 
associated with an increased falls risk (Gunn et al. 2013; Giannì et al. 2014) this 
population warrants investigation. A strength is the use of prospective diaries as 
opposed to retrospective recall, but a limitation is the relatively short falls monitoring 
period as many studies in the elderly would include follow up periods of 6 months to 
2 years (Ersoy et al. 2009; Ward et al. 2015). While the accuracy of data provided by 
falls diaries may be questionable, this was minimized by using text reminders in 
conjunction with the falls diaries and telephone follow up at the end of the monthly 
reporting period to clarify any missing information.   
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In conclusion, the Timed Up and Go and Timed up and Go-Cognitive do not 
demonstrate sufficient clinical utility or discriminative ability for assessing falls risk 
in progressive Multiple Sclerosis and should not be used in isolation as a falls 
screening tool in this population. The high area under the receiving operating curve  
value associated with self-report measures (Tajali et al. 2017) must also be taken into 
account and future research should consider combining subjective variables with an 
objective performance-based measure to obtain a more reliable and valid falls 
screening tool.   
 
 
 
Clinical Message:  
• The Timed up and Go does not demonstrate sufficient clinical utility or 
discriminative ability for assessing falls risk in people with Multiple Sclerosis 
and should not be used in isolation as a falls screening tool. 
• Combining self-report variables with a performance-based measure may result 
in a more reliable screening tool.  
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Abstract: 
 
Objective: To explore the relationship between dual task cost (DTC) and falls in 
people with Multiple Sclerosis.   
 
Methods: 100 participants completed a falls screening questionnaire, Timed Up and 
Go (TUG), and TUG Cognitive (TUG-C) at baseline. DTC was the percentage change 
in performance between TUG and TUG-C. Falls were recorded prospectively for three 
months.  
 
Results: DTC was not associated with increased risk of falls (p=0.90, odds ratio=1.00). 
Answering yes to a question about problems doing two things at once increased 
likelihood of falls (risk ratio=2.07).  
 
Conclusion: A single question asking about dual tasking may be a useful screen for 
falls risk assessment.  
 
Key Words: Multiple Sclerosis, Accidental Falls, Cognitive-Motor Interference, 
Dual-Task Cost.  
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Introduction: 
 
Accidental falls are well known to be prevalent in older people; however, people aging 
with Multiple Sclerosis (MS) experience a rate of accidental falls that far exceeds that 
of healthy populations over 65 years of age. In any three month period,  50% of people 
with MS sustain a fall (Nilsagård et al. 2015). When examining falls specifically 
among middle aged and older adults with MS, 64% of the study sample reported at 
least 2 falls each year (Peterson et al. 2008) and factors associated with an increased 
falls risk in people aged 45 to 90 with MS include problems with balance or mobility 
and poor concentration or forgetfulness (Finlayson et al. 2006). The serious 
consequences of falls such as physical injury, increased care needs, and further 
physical deconditioning as a result of activity limitation secondary to fear of falling 
are far reaching with a high socio-economic associated cost (Peterson et al. 2009; 
Cameron et al. 2011).  People with MS are commonly diagnosed in their thirties and 
thus may be living with the condition for 40-50 years as MS does not affect life 
expectancy unless disability is severe (Weinshenker et al. 1989; Ragonese et al. 2008). 
People aging with MS will have to endure normal age-related changes in their health 
as well as having to cope with MS related disability and disease progression (Finlayson 
2002). Indeed, many symptoms of the natural ageing process such as decreased muscle 
strength, sensory and visual impairment, problems with balance, vision and cognition 
are all overlapping symptoms in MS (Stern et al. 2010) and mean that relatively 
“young” people with MS will present with problems similar to older adults.  
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Two of the most common symptoms of MS include motor dysfunction and a decline 
in cognitive ability (McDonald and Compston 2006). Difficulty walking has been 
reported as a significant symptom by up to 67% (Wu et al. 2007) of people with MS 
and even in the early stages of the disease, significantly altered gait patterns are evident 
in comparison to their healthy peers (Comber et al. 2017). Notably, middle aged 
cohorts (Hayes et al. 2017) have demonstrated reduced walking speeds similar to that 
of a healthy sample of 70 – 80 year olds (Casanova et al. 2010). Similarly prevalence 
of cognitive impairment has been reported to be present in up to 70% of people with 
MS (Rao et al. 1991), presenting early in the disease course and deteriorating over 
time (Langdon 2011). Limitations in mobility and cognitive functioning are both 
associated with falls in older people (Rubenstein 2006; Eriksson et al. 2008) and 
similarly the association of both walking limitations and cognitive factors with falls is 
confirmed in a recent systematic review of falls risk factors in MS (Gunn et al. 2013b). 
Among middle aged and older adults with MS interviewed about their falls experience, 
expected causes of falls such as balance and lower limb impairment were reported in 
41% and 31% of cases, but interestingly cognitive factors were reported as a cause of 
falls in 17% of cases (Peterson et al. 2013).  
 
These two factors of impaired cognition and impaired mobility together underlie the 
principle of cognitive motor interference (CMI) which is common in MS (Leone et al. 
2015) and refers to the decline in performance of cognitive and/or motor tasks when 
they are performed simultaneously (dual-task), relative to the performance of each task 
individually (Plummer et al. 2013).  The deterioration in performance associated with 
CMI is expressed as dual-task cost (DTC) (Wajda and Sosnoff 2015) and has been 
shown to be associated with falls in older people (Beauchet et al. 2008). However, 
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there is a scarcity of studies looking at the association of DTC and falls risk using 
prospective falls recording in people with MS. Previous research demonstrated 
conflicting results with one study reporting DTC is not related to falls status (Gunn et 
al. 2013a), while another more recent study found DTC is associated with an increased 
risk of recurrent falls in a 6 month period (OR = 1.23, CI = 1.02,4.45.) (Etemadi 2016).  
In studies of older people simply asking about fear of falls and their confidence in 
doing certain activities have been shown to be associated with falls risk (Howland et 
al. 1993; Myers et al. 1996) but their perceived ability to do two things at once in 
relation to falls risk has not been fully explored. Similarly, in MS, self-report problems 
with dual tasking and its potential association with falls risk has not been examined. 
In a recent review examining patterns of CMI post stroke a categorisation framework 
that identifies nine possible patterns of CMI during a cognitive-motor dual-task was 
presented (Plummer et al. 2013).  The patterns of CMI discussed include no 
interference, cognitive-related motor interference, mutual interference and mutual 
facilitation among others. No research to date has examined the patterns of cognitive 
motor interference (CMI) in people ageing with MS and whether the use of any 
specific pattern is protective or predictive of falls.  
 
Given the current shortage of prospective cohort studies examining DTC and CMI and 
their potential association with falls risk in the older MS population, the primary 
objective of this study was to explore the extent of CMI in fallers and non-fallers and 
investigate the difference between them by measuring it objectively as DTC 
percentage and subjectively as a yes/no question asking about difficulty doing two 
things at once. We further aimed to investigate the ability of objective and subjective 
measures of DTC and CMI to predict falls status using odds ratio and risk ratio. 
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Finally, we aimed to describe the different CMI patterns used among people with MS 
and examine their association with fall status.  
 
Methods: 
 
Design 
This was a prospective cohort study and as this is an observational study we followed 
the STROBE (STrengthening The Reporting of OBservational studies in 
Epidemiology) Statement guideline (von Elm et al. 2007). The study was approved by 
the University of Limerick Ethics Committee and the St. Vincent’s Healthcare Group 
Ethics and Medical Research Committee. 
 
Recruitment and Eligibility 
Consecutive patients attending a tertiary referral MS clinic at St Vincent’s University 
Hospital Dublin were invited to participate in the study if they met the following 
inclusion criteria: (1) a neurologist confirmed diagnosis of MS as per 2010 McDonald 
Criteria (Polman et al. 2011), (2) an Expanded Disability Status Score (EDSS) of 
between 3 and 6.5 (Kurtzke 1983) indicating that they had some walking limitations 
but were still able to ambulate independently (with or without a mobility aid), (3) 
adequate cognitive function to participate in the assessment  and fill out falls diaries 
for the three-month study period. Participants under 18 years, pregnant woman or 
individuals unable to provide informed consent were excluded from the study. 
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Recruitment and participant assessment was carried out between November 2014 and 
March 2016 with the final falls diaries collected in June 2016.  
 
Baseline Measures 
Demographic information, MS classification subtype, EDSS score and disease 
duration were recorded from the medical records during the baseline assessment. 
Consenting participants then completed a falls screening questionnaire which included 
yes/no questions about fear of falls, use of a mobility aid, history of falls in the past 
three months, and problems doing two things at once among others. The questionnaire 
items were based on a review of the literature on factors associated with and predictive 
of falls in MS. Participants then completed the objective measures, the Timed Up and 
Go (TUG), under single and dual task conditions. The  TUG has been shown to be a 
valid measure of functional mobility in MS patients (Sebastião et al. 2016) with good 
construct validity when assessing walking and balance performance among people 
with MS (Kalron et al. 2017). Previous research found that more than 80% of falls in 
the MS population occurred during transfers, while 60% occurred during walking 
(Matsuda et al. 2011). The TUG incorporates both types of mobility task, so its face 
validity appears good in relation to determining falls status and it has been previously 
used to assess  dual task ability in people with MS (Ciol et al. 2017).   
 
The TUG-Cognitive (TUG-C) was performed after the TUG and consisted of the 
participant completing the same mobility test, while simultaneously performing a 
cognitive task. For this study, the cognitive task consisted of serial subtraction in 
multiples of three from a randomly chosen number between 20 and 100. Serial 
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subtraction was selected as it has a stable cognitive load throughout the duration of the 
test (Yogev et al. 2008). Dual-tasking ability was also measured subjectively as 
individuals were asked about their self-perceived dual-tasking ability as part of the 
falls screening questionnaire: ‘Do you have problems doing two things at once: yes, 
or no?’. The measures were performed in the same standardised order for every 
participant and participants were advised to walk as quickly and safely as possible 
while in their usual footwear and using their usual mobility device (if applicable). The 
participant was seated in a standard height chair with their back against the chair and 
was then instructed to stand up, walk 3 metres to a specific mark on the ground, turn 
around, and walk back and sit in the chair again. Timing began when the participant 
started to rise from the chair and ceased when he/she was seated in the chair after 
walking back. The participant had one practice trial and then three recorded trials, with 
a mean value of the three walks used for statistical analysis. 
 
Dual Task Cost (DTC) 
DTC was calculated using the previously published equation, where ST = single task 
and DT = dual task (Kirkland et al. 2015) : 
𝐷𝑇𝐶 =
𝑆𝑇 − (𝐷𝑇)
𝑆𝑇
 × 100 
Therefore, for this study, DTC was calculated and expressed as a percentage, with a 
larger percentage change value indicating a worse performance, with the following 
equation: 
𝐷𝑇𝐶 =
(𝑇𝑈𝐺) − (𝑇𝑈𝐺 − 𝐶)
𝑇𝑈𝐺
 × 100 
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To determine the patterns of CMI three assessors (two physiotherapists with 20 and 3 
years of experience respectively, and a final year physiotherapy student) observed the 
pattern of interference during the TUG-C of the first 12 participants. Following this, 
the assessors met to agree on categories, with six different patterns identified. The 
pattern of the remaining participants was recorded based on their use of one of the 
following six patterns: 
Pattern 1: no changes in gait, numbers correct  
Pattern 2: no changes in gait, numbers incorrect 
Pattern 3: changes in gait, numbers incorrect 
Pattern 4: stop, think and say number, take step  
Pattern 5: synchronise step and think 
Pattern 6: changes in gait, numbers correct 
 
Falls 
Falls incidence was calculated using prospective falls diaries for a three-month period, 
as recommended by the International MS Falls Prevention Research Network 
(IMSFPRN) (Coote et al. 2014) where participants recorded if they had a fall and the 
number of falls per day.  A fall was defined as ‘an unexpected event in which you 
come to rest on the ground, floor, or lower level’ (Lamb et al. 2005). The participants 
were provided with stamped self-addressed envelopes and falls diaries to be returned 
monthly. Those not returning their diaries were contacted by the researcher to remind 
them or to collect the data for that month by phone. Participants also had the option of 
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a text or e-mail reminder to be sent fortnightly to optimise falls reporting.  Consistent 
with other studies of this type a faller was classified as a person with two or more falls 
(Gunn et al. 2013a; Etemadi 2016).  
 
 
Statistical Analysis 
All data collected was coded and inputted into an Excel spreadsheet and then analysed 
using SPSS (Version 22). Normality of distribution was assessed using the 
Kolmogorov-Smirnov test. Descriptive statistics and t-tests or Mann-Whitney U tests, 
as appropriate, were used to compare demographic characteristics between groups at 
baseline and to compare outcome measures post assessment. Chi square tests were 
used for categorical variables. All data was presented as mean (standard deviation), 
median (interquartile range) or proportion accordingly. The relationship between 
objective measurement of DTC and fall status, was assessed using binary logistic 
regression to have a comparative methodology to previous studies on this topic (Gunn 
et al. 2013a; Etemadi 2016; Tajali et al. 2017). Chi square test was used to assess if 
self-reported problems with dual-tasking and pattern of CMI were different between 
the groups based on falls status. Risk ratio were calculated for subjective problems 
with dual tasking and for the various patterns of CMI. Missing data were excluded on 
analysis-by-analysis basis. The significance level for all statistics was set at p ≤ 0.05. 
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Results: 
 
Participant Characteristics: 
101 participants were recruited for this study, with falls data collected for 100 
individuals. One participant withdrew from the study after the baseline assessment as 
they felt uncomfortable filling out the monthly falls diaries. A total of 791 falls were 
reported by 56 participants over the three-month reporting period with 34 of these 
individuals having 2 or more falls and meeting our criteria for faller classification. 
There was a diary return rate of 99.7%. In the faller group the number of falls ranged 
from 2 to 164 per faller with a mean number of 22.6 (SD 45.4) falls.  Demographic 
information and clinical characteristics of the recruited participants are displayed in 
Table 4.1.  
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                 Table 4.1: Comparison of demographic information and clinical characteristics of  
                 fallers and non-fallers with Multiple Sclerosis. 
 
Characteristic All Participants 
(n=100) 
Fallers  
(n=34) 
Non-Fallers 
(n=66) 
p Value 
Age (years); 
mean (SD) 
[range] 
52.6 (10.78)  
[29-78] 
48.15 (10.49)  
[29-78] 
54.89 (10.26)  
[31-71] 
0.003a 
Gender; n (%)     
Male 34 15 (44.1) 19 (28.8) 0.13b 
Female 66 19 (55.9) 47 (71.2)  
MS 
Classification; n 
(%) 
    
Primary 
Progressive 
19 6 (17.6) 13 (19.7) 0.77c 
Secondary 
Progressive 
53 18 (52.9) 35 (53)  
Relapsing-
Remitting 
24 10 (29.4) 14 (21.2)  
Benign 2 0 (0) 2 (3)  
Unknown 2 0 (0) 2 (3)  
Use of a Walking 
Aid; n (%) 
    
Yes 73 24 (70.6) 49 (74.2) 0.697b 
No 27 10 (29.4) 17 (25.8)  
EDSS; median 
[IQR] 
6 (2) 5.5 (1.8) 6 (2.5) 0.134d 
Time Since 
Diagnosis (years); 
median [IQR] 
 
14 [13.75] 
 
9 [10.25] 
 
15 [12.25] 
 
0.007d 
Fall in the Past 3 
Months (self-
report at 
baseline); n (%) 
    
Yes 50 26 (76.5) 24 (36.4) <0.001b 
No 50 8 (23.5) 42 (63.6)  
                   SD: Standard Deviation, MS: Multiple Sclerosis, EDSS: Expanded Disability Status Scale,  
                    IQR: Interquartile Range, ap value from independent samples t-test, bp value from chi square test, 
                    cp value from Fisher’s exact test, dp value from Mann-Whitney U test 
 
Primary Outcome - DTC: 
Objective measure of DTC (percentage change between the TUG and TUG-C)- 
For the whole cohort of N=100, the median DTC was -13.19, IQR 21.60 (thus a 13% 
deterioration under dual task conditions as measured by the TUG and TUG-C). The 
range in DTC was from -169.30 to 12.42, indicating that some participants improved 
under dual task conditions and had a faster TUG-C than their TUG time (14 
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participants in total). The majority of participants, 86%, showed deterioration in 
mobility performance under dual task conditions with 46% of the total group 
demonstrating a change in DTC of greater than 15%, of whom 32.6% were fallers. No 
significant difference was found between the DTC of fallers and non-fallers, (Table 
4.2). Binary logistic regression on the association between DTC and odds of falls was 
not significant (OR = 1.00, 95% CI 0.98-1.02, p = 0.90).  
Table 4.2: Comparison of TUG, TUG-C, and DTC scores of people with 
Multiple Sclerosis based on prospective falls status, where faller = person with ≥ 
2 falls. 
Outcome Measure Fallers (n= 34) Non-Fallers (n = 66) 
Symbol Digital 
Modalities Test; 
mean (SD) 
33.53 (12.5) 32.39 (12.3) 
Timed Up and Go 
(seconds); median 
[IQR] 
11.25 [4.8] 11.68 [7.53] 
Timed Up and Go 
Cognitive (seconds); 
median [IQR] 
12.4 [4.06] 13.93 [10.05] 
DTC (%); median 
[IQR] 
-12.12 [22.66] -14.38 [20.88] 
SD: Standard Deviation, IQR: Interquartile Range 
 
Subjective Measure of DTC (yes/no question about difficulty doing two things at 
once)- 
A significantly higher percentage of fallers (65%) subjectively reported problems with 
dual tasking during their initial assessment compared to non-fallers (p=0.01), Table 
4.3.  The risk of falling was doubled if the participants reported problems with dual 
tasking with an associated risk ratio of 2.07 (CI 1.15, 3.71).  
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         Table 4.3: Comparison of self-reported problems dual-tasking between fallers  
         and non-fallers, where faller = person with ≥ 2 falls.  
 
Self-
Reported 
Problems 
with 
Dual-
Tasking 
Faller (N = 34) 
      Non-
Faller (N = 
66) 
 
P 
Value 
 
 
Yes; N 
(%) 
22 (64.7) 25 (37.9) 
 
No; N 
(%) 
12 (35.3) 41 (62.1) 
0.01 
 
 
Patterns of CMI 
Analyses on pattern of CMI were performed for the 88 participants that had that data 
(Table 4.4). Differences between fallers and non-fallers was significant for those using 
pattern No. 6 (changes in gait, numbers correct) (p=0.03). An increased risk of falling 
was highest for those using pattern No.6 (RR=1.82, CI 1.09,3.04) and those using 
pattern No.1 and 2 had a protective effect and were more likely to be non-fallers. As 
seen in Figure 4.1, the most commonly used patterns amongst the whole group were 
No.3 (changes in gait, numbers incorrect) and No.6 (changes in gait, numbers correct). 
The least common pattern was No.5 (synchronise step and think) which involved the 
participant taking a step at the same time as saying the number.  
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Table 4.4: Between-group comparison of percentage of fallers (person with ≥  
2 falls) and non-fallers based on pattern of CMI (n= 88, not assessed for first 12 
participants. Some participants used more than one pattern, n= 2 used 2 patterns, 
n= 1 used 3 patterns).  
 
Falls 
Status 
Pattern 
1 
Pattern 
2 
Pattern 
3 
Pattern 
4 
Pattern 
5 
Pattern 
6 
Total 
Faller; 
N (%) 
4 (12.1) 5 (15.2) 10 (30.3) 5 (15.2) 0 (0) 12 (36.4) 33 (100) 
Non-
Faller; 
N (%)  
12 (21.8) 14 (25.5) 12 (21.8) 4 (7.3) 5 (5.1) 9 (16.4) 55 (100) 
P Value 0.254 0.255 0.374 0.286 0.152 0.033 N/A 
Risk 
Ratio  
(95% CI) 
0.62 
(0.25, 
1.52) 
0.65 
(0.29, 
1.45) 
1.30 
(0.74, 
2.29) 
1.57 
(0.81, 
3.02) 
N/A 
1.82 
(1.09, 
3.0) 
N/A 
 
CMI: cognitive motor interference. 
Pattern 1: no changes in gait, numbers correct, Pattern 2: no changes in gait, numbers incorrect, 
Pattern 3: changes in gait, numbers incorrect, Pattern 4: stop, think and say number, take step, Pattern 
5: synchronise step and think, Pattern 6: changes in gait, numbers correct 
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Discussion: 
 
The primary objective of this study was to investigate if objectively measured DTC, 
calculated as the percentage change between the TUG and TUG-C, was associated 
with falls status in people with MS, and the results suggest that there is no association. 
The subjective measure of DTC examined by asking the question ‘do you have 
problems doing two things at once’ showed a significant difference between fallers 
and non-fallers and demonstrated that participants who report problems dual tasking 
are at twice the risk of falling when compared to those without problems dual tasking. 
Six distinct patterns of CMI were identified among this cohort of older people with 
MS and there was a significant difference between fallers and non-fallers and an 
increased risk of falls for those using pattern No. 6 (changes in gait, numbers correct). 
As the mean age of this study cohort is 52.6 years, they are already starting to 
experience the natural processes that occur with ageing and affect one’s strength and 
mobility such as decreased muscle mass, decreased coordination, slower speed of 
movement and increased movement variability (Seidler et al. 2010). Overall the age-
related changes in the musculoskeletal system will be heightened in this MS cohort 
who already have dysfunction of the central and peripheral nervous system affecting 
mobility and activity performance, with falls being just one of the detrimental 
consequences. Problems such as falls and their sequela become more severe as the 
person with MS ages and these difficulties have been shown to be age related and age 
accelerated (Trojano et al. 2002).  
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The findings of this study regarding objectively measured DTC and falls status are 
consistent  with previous findings from a comparable study population that similarly 
used a change in gait velocity during a mobility assessment to measure DTC (Gunn et 
al. 2013a). Another more recent prospective study that also used change in gait 
velocity to measure DTC but with a study population with relapse-remitting MS 
(RRMS) only and a milder disability level additionally found DTC was unable to 
predict future falls (Tajali et al. 2017).  In contrast to these findings, a study using 
static posturography and electronic walkways found that both the DTC of cognitive 
performance and of walking velocity was associated with an increased risk of recurrent 
falls among people with MS (Etemadi 2016). However, the latter study had some 
noteworthy methodological differences when compared to the other studies. The study 
population was younger with a shorter disease duration and had significant 
methodological differences using more detailed and objective measures in the form of 
static posturography for balance assessment, electronic walkway for gait assessment 
and correct response rate (response rate per second multiplied by percentage of correct 
responses) as the measure of cognitive performance whereas the other studies 
including this one, only used simple timed walks when assessing DTC. However, it is 
often the more simple measures that can be easily performed without the use of 
expensive equipment that translate across to everyday clinical practise.  
 
Our finding that DTC does not predict falls in MS differs to those of studies examining 
this concept in other populations. A study of over 1000 older adults found that an 
objectively measured DTC of 18% or more prospectively predicted fallers (OR = 1.07; 
CI 1.04, 1.10) (Yamada et al. 2011) but a recent systematic review has concluded that 
further prospective studies of older adults are needed to develop recommendations for 
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dual task testing as part of a multi-faceted falls risk assessment (Muir-Hunter and 
Wittwer 2016). In subacute stroke patients dual task assessment of gait has 
demonstrated an altered stride length and step length in fallers versus non-fallers 
(Baetens et al. 2013) and a longitudinal study of people with Parkinson’s disease 
demonstrated that motor DTC significantly predicted future fallers with a sensitivity 
of 71%, specificity of 77% and 2.6 higher odds of being a future faller (Heinzel et al. 
2016). A prospective study examining prediction of falls and near falls in people with 
mild Parkinson’s disease included a subjective question about dual tasking similar to 
our self-report measure of problems dual tasking and simple logistic regression 
showed a self-report of balance problems while dual tasking had an odds ratio of 4.0 
for predicting falls/and or near falls (Lindholm et al. 2015).   
 
To the knowledge of the authors, this is the first study that investigated if self-reported 
problems with dual tasking were linked to falls status in people with MS. Previous 
research among older people with MS has asked about problems with concentration 
and forgetfulness (Finlayson et al. 2006; Peterson et al. 2008) and qualitative 
interviews have identified situations that require divided attention as a factor related 
to falls (Nilsagård et al. 2009), but no research to date has specifically asked about the 
participant’s difficulties in doing two things at once. This concept of asking a simple 
question to help identify falls risk has been previously demonstrated in MS with regard 
to history of falls (Cameron et al. 2013) and in older people where health professionals 
are advised to routinely ask simple questions about fall history, fear of falls and 
feelings of unsteadiness as a quick falls risk screening tool (Stevens and Phelan 2013). 
In this study, a significant difference was identified between fallers and non-fallers in 
relation to subjectively reported problems with dual tasking. One possible reason for 
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this finding may be that when individuals are subjectively reporting problems with 
dual-tasking they are considering all dual-tasks that occur in their daily routine, 
whereas objective measures of dual-tasking ability only look at one dual-task activity 
in a controlled setting. A recent review (Leone et al. 2015) determined that most dual-
task tests in the MS population were conducted at a self-selected speed, similar to the 
task in this study. However, it is suggested that these tests are not representative of 
activities of daily living, when people are more likely to be carrying out tasks at a 
heightened speed and in novel environments, which is likely to place a higher demand 
on motor and cognitive resources. Therefore, asking people with MS if they have 
problems doing two tasks at the same time may provide more accurate information 
regarding the patients’ dual-tasking ability, and subsequently their falls risk, than 
attempting to objectively measure it. 
 
While patterns of CMI have been examined in other neurological conditions such as 
stroke and PD (Kelly et al. 2012; Plummer et al. 2013) this is the first study to research 
patterns of CMI and falls status in MS. Previous research examining the effect of dual 
task activities in people with MS demonstrated significant deteriorations in gait with 
an added cognitive task, including altered swing time variability, increased double 
support time and a large decrease in gait speed (Hamilton et al. 2009; Sosnoff et al. 
2011). Differences between fallers and non-fallers adopting each pattern of CMI in 
this study were significant for Group 6 (changes in gait, numbers correct). This 
subgroup, along with Group 3 (changes in gait and incorrect numbers), was one of the 
most common patterns utilised by participants and this may suggest that people with 
MS are not prioritising the different components of a complex task appropriately 
similar to what has been observed in people with Parkinson’s disease (Bloem et al. 
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2006). This may be as a consequence of the limited processing capacity of the brain 
as highlighted in the attentional capacity theory and the bottleneck theory that have 
both been used to explain CMI behaviour (Wajda et al. 2017). However, these results 
should be interpreted with caution as there were small numbers in each of the 
subgroups using each type of pattern and a much larger sample would need to be 
analysed to draw any strong conclusions.  
 
There were several strengths to this study including a large sample size, a very low 
attrition rate, and use of the gold-standard recommendations of a specific falls 
definition and prospectively recorded falls data (Coote et al. 2014) for a three month 
period. However, the findings from this study should be interpreted with consideration 
of its limitations. The progressive nature of this study cohort with median EDSS score 
of 6, limits the generalisability of the findings and results may not be applicable in a 
milder MS cohort. The cognitive task chosen was one of serial subtraction but it has 
been suggested that verbal fluency tasks may be more appropriate when assessing dual 
task cost in MS (Learmonth et al. 2017) and the investigators had no knowledge of 
baseline arithmetic competency levels of the participants. To fully investigate DTC 
both the cognitive and motor task should be assessed under single and dual task 
conditions (Plummer and Eskes 2015) but only the motor task was assessed under 
single task conditions in this study. Indeed, this seems to be a common issue in MS 
studies examining dual task cost as very few studies to date (Hamilton et al. 2009; 
Allali et al. 2014; Etemadi 2016) have actually reported the single task performance 
of the cognitive task and examined the DTC of cognition as well as motor function. 
No instructions were given to participants regarding task prioritisation and this study 
used the TUG as a measure of mobility while other studies measure objective balance 
103 
 
control (Etemadi 2016) or different versions of timed walks (Gunn et al. 2013a; Tajali 
et al. 2017). It has been advised that dual task assessment needs to be standardised to 
facilitate comparison of results from different studies that will strengthen the evidence 
base and allow for clearer recommendations (Plummer and Eskes 2015; Learmonth et 
al. 2017). Finally, the classifications of pattern of CMI used in this study may be 
considered a methodological limitation. Due to a lack of previously reported patterns 
of CMI for people with MS the six patterns of CMI utilised were identified through 
observing the patterns of the first 12 study participants but this method may have 
missed later characteristics that were not observed in that small initial sample.  
 
Conclusion: 
The findings of this study suggest that objectively measured DTC is not associated 
with falls status in a more progressive MS cohort who are relatively “young” but 
presenting with falls at a rate greater than “older” people. The subjective measurement 
of dual tasking ability is related to falls status and may be an easy method of screening 
for falls risk. Simply asking if they have a problem performing two tasks at once is a 
quick, easy and cost-free method of establishing dual-tasking ability and may be a 
useful adjunct in evaluating falls risk. Additionally, differences appear to exist 
between fallers and non-fallers based on whether they prioritise their cognitive or 
motor task under dual-task conditions. Future research involving more robust analysis 
and classification of patterns of CMI in a larger sample with a standardised method of 
DTC assessment will give a clearer insight into the role of DTC and CMI in falls risk 
assessment and its potential relevance as a component of falls interventions for people 
with MS.  
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Abstract: 
Purpose: to determine which combination of variables has the highest sensitivity and 
predictive validity for identifying falls risk in people with Multiple Sclerosis.  
 
Methods: in this prospective cohort study, consecutive patients attending an outpatient 
Multiple Sclerosis clinic (n=100), with Expanded Disability Status Scale score of 3-
6.5 completed baseline assessment and falls diaries for the subsequent three-month 
study period. Outcome was rate of falls, and predictors were Timed Up and Go, 
Symbol Digit Modalities test, and self-report questions about various symptoms such 
as problems with fatigue, concentration, dual tasking, bladder and bowel control 
among others.  
 
Results: There were 791 falls reported over the three-month period from a total of 56 
fallers. Following multivariable regression analysis, the model with the greatest 
sensitivity (88%) and predictive validity (area under the receiving operating curve 
statistic = 0.72, 95% CI 0.62-0.82), included the variables of history of a fall, no visual 
problems, problems with bladder control and a slower speed on the Timed Up and Go.  
 
Conclusion: this model is quick and easy to use in a clinic setting and could identify 
those at risk of falls, thus prompting earlier referral to appropriate falls prevention 
interventions.   
Key Words: Multiple Sclerosis, Accidental Falls, Risk Assessment 
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Introduction: 
 
Multiple Sclerosis (MS) is a progressive neurological condition with a diverse 
symptom presentation that includes lower limb weakness, spasticity and impaired 
balance (Francis 1997). Mobility and balance deficits present from an early stage of 
the disease (Martin et al. 2006) and impairments in balance and slower gait speed are 
associated with an increased risk of falls (Giannì et al. 2014). Falls are prevalent in 
this population with over 50% of people with MS falling in a three month period (Gunn 
et al. 2013a; Nilsagård et al. 2015) with participants reporting a wide range of falls 
from 1-63, and a high risk of injurious falls (Bazelier et al. 2011; Cameron et al. 2011).  
The number of falls required to be classified a “faller”  varies but it has been argued 
that even one fall is significant with resulting loss of confidence and activity 
curtailment, and may indicate a transitional stage in relation to mobility and worsening 
disability (Matsuda et al. 2011) and hence a need for intervention. 
 
While certain factors such as longer disease duration, impaired cognition, mobility aid 
use and fear of falling are known to be associated with increased falls risk in MS (Gunn 
et al. 2013b; Mazumder et al. 2015), no one particular falls risk tool suitable for 
everyday use in a clinic setting has been identified (Cattaneo et al. 2014). The 
assessment of  balance is recommended in falls research (Cattaneo et al. 2014) but a 
recent systematic review found no currently used clinical balance measure has good 
discriminative ability or clinical utility for identifying falls risk (Quinn et al. 2017). 
One of the most commonly reported measures in that review was the Timed Up and 
Go and it demonstrated a significant difference between fallers and non-fallers in 
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retrospective study designs but did not predict falls in isolation (Quinn et al. 2018) 
suggesting multivariable models may be required to identify those at risk of falls and 
in need of intervention.  
 
Discriminative ability refers to the ability of a measure to differentiate between fallers 
and non-fallers and is reported using the area under the receiving operating curve 
statistic (Moons et al. 2015). Clinical utility examines the usefulness of a specific test, 
usually in relation to patient outcomes and decision-making guidance, and is assessed 
using the summary estimates of sensitivity and specificity (Bossuyt et al. 2012).  
Previous studies using prospective falls diary recording have identified that detailed 
assessments such as the Physiological Profile Assessment (Gunn et al. 2013a; Hoang 
et al. 2014) and instrumented measures such as static posturography (Prosperini et al. 
2013) show good predictive ability for falls status and good sensitivity in identifying 
falls risk. However, these complex assessments are time consuming and require 
specialist equipment and training, thus rendering them unsuitable for everyday use in 
a busy clinic setting. It has been demonstrated that simply asking about history of falls 
in the past has good predictive ability for identifying future falls risk (Cameron et al. 
2013) and recently a prospective study identified that patient reported outcomes are 
more accurate than performance based measures for predicting future falls risk (Tajali 
et al. 2017) suggesting the need to add subjective reporting to objective measures of 
balance when assessing falls risk in MS. 
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Study Aim: 
Thus, the aim of this study is to determine which combination of subjective and 
objective variables, has the highest sensitivity and predictive validity for identifying 
falls risk in people with MS. A falls risk tool of this type would allow the treating 
clinician to identify the risk of falls, communicate the level of risk to the individual, 
and refer onwards for appropriate falls prevention interventions in a timely fashion.  
 
Methods: 
 
Study Design: 
This was a prospective cohort study with falls status monitored using prospective 
diaries. The TRIPOD (Transparent Reporting of a multivariable prediction model for 
Individual Prognosis Or Diagnosis) statement was followed in the conduct and 
reporting of the study (Moons et al. 2015) (appendix 5.1). The study was approved by 
the associated University Ethics Committee and the associated hospital Ethics and 
Medical Research Committee.  
 
Participants: 
Consecutive patients attending the MS clinic in a tertiary hospital were invited to 
participate in the study if they met the following inclusion criteria: (1) A neurologist 
confirmed diagnosis of MS, (2) Expanded Disability Status Scale (Kurtzke 1983) of 
between 3.0 and 6.5  indicating some walking limitations but  an ability to ambulate 
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independently (with or without an aid), (3) adequate cognitive function (as deemed by 
the treating physician) to participate in the assessment and falls diaries for the three-
month study period. Participants under 18 years, pregnant woman or individuals 
unable to provide informed consent were excluded from the study. Recruitment and 
participant assessment was carried out between November 2014 and March 2016 with 
the final falls diaries collected in June 2016.  
 
Outcome: 
The outcome was falls incidence as reported using prospective falls diaries for a three-
month period. Participants were provided with stamped addressed envelopes and falls 
diaries to be returned monthly. Those not returning their diaries were contacted by the 
researcher to remind them or to collect the data for that month by phone. Participants 
also had the option of a text or e-mail reminder to be sent fortnightly to optimise falls 
reporting. A fall was defined as ‘an unexpected event in which you come to rest on 
the ground, floor, or lower level’ (Lamb et al. 2005). There are a variety of 
classifications for faller status currently utilized in the literature (Matsuda et al. 2011), 
and in this study a faller is defined as a person with one or more falls in the three 
month diary period as recommended by the International MS Falls Prevention 
Research Network (Coote et al. 2014). This was chosen as it only takes a single fall to 
cause associated consequences such as fear of falling and activity curtailment, 
additionally history of a single fall is predictive of falling in the future (Cameron et al. 
2013).  
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Predictors: 
Data collected routinely at the clinic was incorporated into the data set for the study 
and included the Expanded Disability Status Scale score (level of disability), age, 
disease duration, self-reported falls in the preceding 3 months, current medications, 
type of MS and walking aid(s) used. Information was also collected on various 
symptoms and their level of interference with daily activities such as depression, pain, 
visual impairment and leg weakness. Additionally, the Symbol Digit Modalities Test, 
a brief assessment of cognition where participants try to match as many numbers and 
symbols as possible based on a given key in a 90 second test period, was used. The 
Symbol Digit Modalities Test demonstrates good sensitivity and discriminative ability 
in MS populations (Drake et al. 2010). Consenting participants then completed a falls 
screening questionnaire (appendix 5.2) that was developed following a literature 
review at time of study design that identified all retrospective and prospective cohort 
studies and any factor with a statistically significant odds ratio for falls status was 
included. The questionnaire consisted of yes/no questions and enquired about 
problems with fatigue, bladder and bowel, balance, doing two things at once, sensory 
disturbance, concentration and forgetfulness, among others. The full data collection 
tool used for the cohort study is in appendix 5.3.  
 
Participants then completed the timed mobility assessment, the Timed Up and Go 
under single and dual task conditions. The Timed Up and Go is widely used in clinical 
practice and has been shown to be both valid and reliable in MS populations (Sebastião 
et al. 2016; Bennett et al. 2017) and discriminates between fallers and non-fallers 
(Sosnoff et al. 2011; Kalron et al. 2017). The measures were performed in the same 
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standardised order for every participant and participants were advised to walk “as 
quickly and safely as possible” while in their usual footwear and using their usual 
mobility device (if applicable). The participant was seated in a standard height chair 
and was instructed to stand up, walk 3 metres to a specific mark on the ground, turn 
around, walk back and sit in the chair again. Timing began when the participant started 
to rise from the chair and ceased when he/she was seated in the chair after walking 
back. The participant had one practice trial and then three recorded trials, with a mean 
value for the three walks used for statistical analysis. The participant then did the 
Timed Up and Go under dual task conditions with an added cognitive task of counting 
backwards in multiples of three. The Timed Up and Go-Cognitive was assessed in the 
same standardised manner as the Timed Up and Go. Both the Timed Up and Go and 
Timed Up and Go-Cognitive have been recommended for use in MS research and 
clinical practice by the American Physical Therapy Association Evidence Database to 
Guide Effectiveness task force (Potter et al. 2014). Dual task cost (DTC) was 
calculated using  
𝐷𝑇𝐶 =
𝑆𝑇 − (𝐷𝑇)
𝑆𝑇
 × 100 
where ST = single task (Timed Up and Go value) and DT = dual task (Timed Up and 
Go-Cognitive value) (Kirkland et al. 2015).  
 
Statistical Analysis:   
Data were coded, entered and analyzed using SPSS Statistics for Windows Version 
22. Counts and frequencies were used to describe categorical variables and normality 
was assessed using the Kolmogorov-Smirnov test.  For numeric variables independent 
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sample T tests were used to test for differences in normally distributed variables 
between fallers (≥ 1 fall) and non-fallers (no falls) and Mann-Whitney tests were used 
to test for differences in skewed distributions. The association between categorical 
variables was tested using chi-squared or Fisher exact tests. Variables were grouped 
into demographic variables, mobility status, medications, MS symptom interference, 
falls screening questionnaire data, dual tasking strategies and objective measures. All 
variables with a p value of ≤ 0.2 from bivariate analysis were considered for inclusion 
in the multivariable logistic regression analysis. 
 
Model building was iterative and guided by interpretability, parsimony, the evaluation 
of the Wald statistic for each variable at each step and measures of goodness of fit and 
clinical utility. This method is recommended over stepwise methods using solely 
significance-based decision-making to improve the stability and quality of the final 
model when using small data sets (Steyerberg et al. 2000). Goodness-of-fit of the final 
reduced model was assessed using the Hosmer and Lemeshow test and the Nagelkerke 
R square value. Odds ratios and 95% confidence intervals (CIs) are reported, a 5% 
level of significance was used. Sensitivity and specificity were calculated to examine 
the clinical utility of the final model. The aim was to find the model with the highest 
sensitivity combined with goodness of fit. Receiver operating curve analysis was 
carried out to determine the area under the receiving operating curve statistic value. 
The area under the receiving operating curve statistic can have any value between 0 
and 1 with a value of 0.5 representing chance, values between 0.7 and 0.9 representing 
moderate discrimination and a value of 1 representing perfect discrimination (Moons 
et al. 2015).  Positive likelihood ratio was calculated using sensitivity/1- specificity 
and negative likelihood ratio was calculated using  1- sensitivity/ specificity (Riddle 
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and Stratford 1999). Falls rate per person-year was calculated using the following 
formula (Ibrahim et al. 2000): falls rate = (total number of falls/total number of person-
days [all participants]) multiplied by 365.  
 
Results: 
 
The sample included 101 people with MS (67 female). One participant withdrew after 
the baseline assessment as they did not wish to monitor their falls using diaries for 
three months, so data was analysed for a total of 100 participants. There was a diary 
return rate of 99.7% with 791 falls reported over the three-month period from a total 
of 56 fallers with a median of 3 falls per faller (IQR 4, range of 1-164). Falls rate per 
person-year was 32.08 falls. Injurious falls were reported by 57% (n= 32) of fallers 
with a median of one injurious fall (IQR 2, range of 0-22) per faller. Demographic and 
clinical characteristics of the sample are reported in table 5.1.   
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Table 5.1: Demographic and Clinical Information for the Sample  
Characteristic All participants (n=100) 
Age (years); mean (SD) [range]   
 
52.6 (10.78) [29-78] 
Gender; n (%)  
Male 34 
Female 
 
66 
MS Classification; n (%)  
Primary Progressive 19 
Secondary Progressive 53 
Relapsing-Remitting 24 
Benign 2 
Unknown 
 
2 
Use of a Walking Aid; n (%)  
Yes 73 
No 
 
27 
EDSS; median [IQR], mean (SD)* 6 (2), 5.3 (1.2)                
Time Since Diagnosis (years); median [IQR], mean 
(SD) 
 
14 [13.75], 14.2 (9.5) 
Fall in the Past 3 Months (retrospective self-
report); n (%) 
 
Yes 50 
No 
 
TUG score (secs); median [IQR], mean (SD) 
TUG Cog score (secs); median[IQR], mean (SD) 
SDMT score; mean (SD) 
DTC score; median [IQR], mean (SD) 
50 
 
11.56 [6], 13.5 (7.0) 
13.35 [6.8], 16.0 (8.5) 
32.8 (12.3),  
-13.2 [21.6], -19.2 (27.4) 
 
SD: Standard Deviation, MS: Multiple Sclerosis, EDSS: Expanded Disability Status Scale, TUG: 
Timed Up and Go, TUG-Cog: Timed Up and Go Cognitive, SDMT: Symbol Digit Modalities test, 
DTC: Dual Task Cost, IQR: Interquartile Range 
*Mean and SD are reported for variables that are normally distributed and both mean and medians 
with IQR are reported for variables that are not normally distributed.  
 
 
After bivariate analysis there were 20 potential predictor variables with a p value ≤ 0.2 
that were deemed suitable for further multivariable analysis (appendix 5.4). Age, 
Expanded Disability Status Scale, MS type, current health status, employment status, 
history of an injurious fall, number and type of walking aids, medication number and 
type, fatigue, leg weakness, pain, poor concentration, problems with bowel control, 
concerns about falling, osteoporosis diagnosis, reduced sensation, fine motor 
problems, Timed Up and Go-Cognitive, dual task cost, and Symbol Digit Modalities 
122 
 
Test were all excluded from regression analysis. Gender had a borderline p value of 
0.21 but was included as an association has been demonstrated between gender and 
falls risk previously (Nilsagård et al. 2015). Further variables were excluded from the 
reduced set of 20 after assessing for collinearity and the final covariates deemed 
suitable for inclusion in the model building process were male gender, MS course over 
the past year, retrospective reporting of a fall in the past, mobility aid use, subjective 
reporting of problems with balance/mobility, depression, not having a visual problem, 
problems with bladder control, stiffness/spasms in the limbs, subjective reporting of 
problems dual tasking,Timed Up and Go score. Table 5.2 shows the full model for 
regression analysis with all eleven variables included.  
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Table 5.2: Full Model for Logistic Regression Analysis (n= 100) to Predict Fallers 
 
MS; Multiple Sclerosis, TUG: Timed Up and Go, IQR: Interquartile Range 
 
 
Table 5.3 shows the final model with four predictor variables, a sensitivity of 88% and 
a specificity of 46%. The area under the receiving operating curve statistic of this final 
model was 0.72 (95% CI 0.62-0.82), see figure 5.1 for the receiver operating 
characteristic curve. The positive likelihood ratio was 1.63 and the negative likelihood 
Predictor 
Non -
Fallers 
(N= 44) 
Fallers  
(N= 56) B S.E Wald df 
P 
value 
 
 
Odds Ratio 
(95% CI) 
Male 
Gender 
12 
(27.2%) 
22 
(39.3%) 
0.94 0.55 2.88 1 0.09 
2.56 (0.87, 
7.58) 
 
Deteriorating 
MS course 
past year 
 
19 
(43%) 
 
35 
(65%) 
 
0.70 
 
0.57 
 
1.52 
 
1 
 
0.22 
2.02 (0.66, 
6.19) 
 
Fall in the 
past 3 
months 
15 
(34.1%) 
35 
(62.5%) 
1.05 .53 4.04 1 0.05 
2.88 (1.03, 
8.08) 
 
Use of a 
mobility aid 
29 
(65.9%) 
44 
(78.6%) 
0.43 0.60 0.51 1 0.47 
1.54 (0.47, 
5.02) 
 
Problems 
with 
balance/ 
mobility 
44 
(100%) 
56 
(100%) 
0.27 0.52 0.28 1 0.60 
1.31 (0.48, 
3.61) 
 
Depression 
14 
(31.8%) 
26 
(46.4%) 
0.72 0.53 1.84 1 0.18 
2.06 (0.73, 
5.85) 
 
No visual 
problems 
29 
(65.9%) 
45 
(80.4%) 
1.72 0.62 7.70 1 0.01 
5.59 (1.66, 
18.82) 
 
Problems 
with bladder 
control 
28 
(63.6%) 
46 
(82.1%) 
0.60 0.58 1.06 1 0.30 
1.81 (0.59, 
5.62) 
 
Stiffness or 
spasms 
33 
(75%) 
48 
(85.7%) 
0.10 0.69 0.02 1 0.89 
1.10 (0.29, 
4.22) 
 
Problems 
dual tasking 
16 
(36.4%) 
31 
(55.4%) 
0.59 0.53 1.26 1 0.26 
 
1.80 (0.65, 
5.04) 
 
TUG  
11.19 
IQR5.2 
11.99 
IQR7.7 
0.01 0.03 0.11 1 0.75 
1.01 (0.95, 
1.08) 
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ratio was 0.26. The model had an adequate fit (Hosmer and Lemeshow test, p=0.97, 
Nagelkerke R Square =0.20). History of a fall in the past three months was associated 
with higher odds of falling (OR 3.33, 95% CI 1.38 to 8.03, p= 0.008). Not having 
visual problems was also associated with higher odds of falling (OR 2.90, 95% CI 1.06 
to 7.90, p= 0.038).  
Table 5.3: Logistic Regression Analysis, Final Model (n=100) to Predict Fallers  
 
Predictor B S.E. Wald df P value Odds ratio (95% CI) 
 
A fall in the past 
3 months 
1.20 0.45 7.13 1 0.01 3.33 (1.38, 8.03) 
 
No visual 
problems 
1.06 0.51 4.31 1 0.04 2.90 (1.06, 7.90) 
 
Problems with 
bladder control 
0.90 0.51 3.20 1 0.07 2.47 (0.92, 6.64) 
 
TUG  
0.02 0.03 0.38 1 0.54 1.02 (0.96, 1.08) 
       
Sensitivity = 88%, Specificity = 46%, AUC = 0.72 (95%CI 0.62-0.82), TUG: Timed Up and Go 
 
Figure 5.1: ROC Analysis of the Final Model, AUC = 0.72. 
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Discussion: 
 
This prospective cohort study is the first study in MS to report the sensitivity and 
predicitve validity of a simple falls screening tool suitable for use in a busy clinic 
setting. Fifty-six people had a total of 791 falls, of which 94 were injurious confirming 
the significance of the problem of falls for people with MS. The findings demonstrate 
that a model containing the predictor variables of a fall in the past 3 months, problems 
with bladder control, no visual problems and Timed Up and Go score is suitable for 
use as a falls screening tool with a sensitivity of 88% and an area under the receiving 
operating curve statistic value of 0.72. This is more sensitive than the Timed Up and 
Go alone which demonstrated an area under the receiving operating curve statistic 
value of 0.60 and sensitivity of 82% when used in isolation for falls risk prediction in 
people with MS (Quinn et al. 2018). While the sensitivity and discriminative ability 
of the model are reasonably good, the specificity is low (46%) indicating that some 
non-fallers may be incorrectly identified as fallers and referred for in- demand 
resources that they may not actually need. However, in a falls risk screening tool of 
this type it is more important to have high sensitivity and definitely capture the 
potential fallers than have a high specificity, as the intervention may be of benefit to 
non-fallers also and would certainly not be harmful.  
 
History of a fall being predictive of future falls is not surprising and has been 
demonstrated to have good discriminative ability in previous studies among people 
with MS (Cameron et al. 2013) and in stroke survivors (Xu et al. 2018). The fact that 
not having a visual problem was an important predictor is in contrast to other studies 
where dynamic visual acuity and visual contrast sensitivity were not significantly 
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different between faller and non-faller groups (Gunn et al. 2013a; Hoang et al. 2014). 
However, both these studies assessed vision objectively whereas our study assessed 
vision by means of self-report only. A study involving qualitative analysis post 
interview found visual impairment was perceived by people with MS to be associated 
with falls (Nilsagård et al. 2009) but the types of visual impairment mentioned were 
double vision or impaired eye and movement coordination whereas in our study we 
simply asked if problems seeing interfered with typical daily activities. The fact that 
our results showed not having a visual problem increases falls risk appears counter 
intuitive but may be to do with increased confidence and risk-taking behaviour when 
no visual problems, whereas a person with an actual visual problem such as double 
vision may be taking extra precautions and adapting their behaviours in a way that 
helps to decrease their falls risk. Future research could explore this domain using both 
objective and self-report measures to determine if the different methods of assessment 
correlate.  
 
Four previous prospective studies examined falls risk prediction in MS using a form 
of balance assessment, with two reporting area under the receiving operating curve 
statistic values ranging from 0.71 (Hoang et al. 2014) to 0.73 (Gunn et al. 2013a) and 
two reporting sensitivity values ranging from 80% (Kasser et al. 2011) to 88% 
(Prosperini et al. 2013) and specificity values ranging from 67% to 83% respectively. 
The former two studies used the Physiological Profile Assessment (Gunn et al. 2013a; 
Hoang et al. 2014) and the latter two used force plate asssement for the centre of 
pressure (Prosperini et al. 2013) and the Sensory Organisation Test (Kasser et al. 
2011). Three of those studies used multivariable models (Kasser et al. 2011; Gunn et 
al. 2013a; Hoang et al. 2014) and one used balance assessment only (Prosperini et al. 
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2013). Our model’s discriminative ability and sensitivity values compare favourably 
with those earlier models and includes measures that are simple and easy to use, 
require no specialist equipment or training and that may translate better to the real-life 
clinical setting. Methodological differences such as the variance in faller classification 
used and length of falls monitoring makes it difficult to truly compare these models 
with our findings. A prospective cohort study (Tajali et al. 2017) that also classified a  
faller as a person with one or more falls, found that patient reported outcomes are 
better at predicting fall risk than performance based measures, and this is confirmed 
in our prediction model.  
 
For Parkinson’s disease and stroke falls risk prediction models have reported varying 
levels of accuracy. A simple three step prediction tool in Parkinson’s disease 
(including history of a fall, freezing of gait and slower walking speed) demonstrated 
high predictive validity with an area under the receiving operating curve statistic of 
0.80 (Paul et al. 2013) and a model for stroke involving upper limb function and a 
history of near falls demonstrated a sensitivity of 60%, specificity of 70% and an area 
under the receiving operating curve statistic of 0.69 (Ashburn et al. 2008). However, 
an external validation study examining the latter model and a second model involving 
falls history and balance assessment using the Berg demonstrated poor discriminative 
ability for both models with area under the receiving operating curve statistic values 
of 0.55 and 0.56 respectively (Walsh et al. 2017). A prospective study with a 6 month 
follow up period involving people with MS, Parkinson’s disease and stroke found that 
risk of falls is associated with disease type with Parkinson’s disease having the highest 
risk, followed by MS and that balance confidence measured with the Activities-
specific Balance Confidence scale is a common predictor of falls for the 3 conditions 
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(Beghi et al. 2018), highlighting the importance of self-report measures when 
identifying falls risk in these patient cohorts.  
 
In community-dwelling elderly populations, numerous models and risk assessment 
tools have been proposed but a recent systematic review and meta-analysis (Lusardi 
et al. 2017) found that no single test or measure demonstrated strong post-test 
probability values (incorporating sensitivity, specificity and likelihood ratios). That 
review suggests that combining simple medical history questions (including history of 
falls and fear of falling) with a self-report measure and a performance based measure 
(including the Timed Up and Go) may be the most reliable type of tool to use and the 
model proposed in this study is in line with that recommendation, though adding a 
measure of fear of falling or balance confidence may further enhance its discriminative 
ability and clinical utility. 
 
Study Limitations: 
 
The strengths of this study include the robust methodology including use of 
prospective falls monitoring and clear reporting of both discrimination and clinical 
utility. A possible limitation is that our cohort had predominantly progressive MS and 
our findings may not be applicable in milder, relapse-remitting cohorts. However, 
more progressive disease is strongly associated with an increased falls risk (Gunn et 
al. 2013b; Giannì et al. 2014) and these are the individuals most in need of falls 
interventions. The sample size of 100 was determined based on previous falls research 
in MS (Gunn et al. 2013a; Prosperini et al. 2013) and was considered a feasible and 
realistic recruitment target, however the wide confidence intervals for the odds ratios 
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reflect the uncertainty in the estimates and are a limitation of the study. The percentage 
of variance not explained by our final model indicates that other factors not considered 
in our data set could potentially affect falls risk and should be examined in future 
research. These factors may include psychosocial variables such as low falls self-
efficacy and level of falls control that have been shown to be common in people with 
MS (Comber et al. 2017) and other co-morbidities and personal/environmental factors. 
More detailed assessment of common symptoms in MS such as pain and sensory 
disturbance is warranted as somatosensory impairment has been shown to be 
associated with limited balance in MS (Jamali et al. 2017) and leg pain was 
significantly associated with frequent falls in previous prospective research (Hoang et 
al. 2014). We found no difference between fallers and non-fallers in cognition but the 
cognition measure used in our study is a quick screening  tool for assessing 
information processing speed (Schependom et al. 2014) whereas a more detailed 
cognitive test that incorporates verbal function, memory and executive function may 
have provided more useful information (Chiaravalloti and DeLuca 2008) .  
 
Conclusion: 
 
A falls risk model including the self-report variables of history of a previous fall, 
problems with bladder control, no visual problems and the objective measure of the 
Timed Up and Go has reasonably good discriminative ability and sensitivity for 
identifying falls risk in people with MS with an area under the receiving operating 
curve statistic value of 0.72 and a sensitivity of 88%. This model does not need any 
specialist equipment or training and is quick and easy to carry out in a typical real-life 
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clinical setting. Future research needs to explore what other potential factors might 
improve the accuracy of this model and external validation with people of varying MS 
subtypes is needed to support its use in a wider context.   
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Introduction: 
 
In preceding chapters  the extent of the problem of falls in MS has been discussed and 
the high prevalence of falls in this condition (Nilsagård et al. 2015) and the detrimental 
consequences associated with falls such as injury, fear of falls, activity curtailment 
and subsequent deconditioning (Peterson et al. 2008; Cameron 2011; Kasser et al. 
2014) have been highlighted. The primary aim of this thesis was to develop a falls risk 
model for people with MS (see chapter five) suitable for use in a busy, clinic setting 
and requiring no specialist training or equipment. The resulting model from a 
prospective cohort study includes the variables of history of a fall, no visual problems, 
problems with bladder control and a slower speed on the Timed Up and Go (TUG). 
This model has reasonably good sensitivity (88%) and predictive validity (area under 
the receiving operating curve statistic, AUC, = 0.72 95% CI 0.62-0.82), but the 
specificity is low (46%) and it explains only a small amount of variance with a 
Nagelkerke R Square value of 0.20.  
 
To help inform future research and determine what other variables should be added to 
the model to improve accuracy, data from three different sources (post hoc exploration 
of existing data sources within the MS research team at University of Limerick) were 
examined  - firstly the output from a literature review of studies using prospective falls 
monitoring in MS, secondly the additional data on causes and consequences of falls 
from three months of falls diaries collected as part of the main longitudinal study (see 
chapter five), and finally a content analysis on qualitative data collected from 
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clinicians’ interviews where participants were asked their opinions on present and 
future falls interventions and discussed what they thought caused falls.  
 
Thus, the aims of the analysis in this chapter are to: 
1) Conduct a narrative review of all studies using prospective monitoring of falls 
in MS to identify other potential predictor variables that might be suitable for 
inclusion in a falls risk model. 
2) Examine the data from three months of falls diaries specifically looking at 
context and causes of falls to determine if any useful information relevant to a 
falls risk model. 
3) Explore the themes arising from a content analysis of clinicians’ interviews 
focusing on aspects related to falls risk assessment and treatment prioritisation 
to determine type of assessments currently in use and what may translate well 
to clinical practice.  
 
Methods: 
 
Method A- Narrative Review: 
The first source of data examined was the current evidence base in relation to falls risk 
prediction for people with MS and all studies using prospective falls monitoring were 
included. The literature search was first carried out in March 2018 and updated in July 
2018. The search terms utilised were “Multiple Sclerosis” AND Fall* OR “Accidental 
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Fall” OR Slip OR Trip OR Imbalance OR “Postural control” OR “Postural instability” 
OR perturbation OR “postural sway” AND Risk OR Predict*OR Correlat* OR 
Associati* OR Screen* OR Probability. Databases searched included Ebsco 
(Academic Search Complete, AMED, CINAHL, Medline, PsychArticles, PsychInfo, 
SportDiscus, Biomedical Reference Collection), Scopus, Web of Science and Embase.  
 
The inclusion criteria for the study selection process were confirmed diagnosis of MS, 
ambulatory with/without an assistive device, prospective cohort/longitudinal studies, 
peer reviewed journal articles. Review papers were excluded. If there was any 
uncertainty about a study, it was discussed with my primary supervisor (SC) until 
consensus was reached. Data was extracted from the studies to populate an excel 
spreadsheet including information on study numbers, fall definition, faller 
classification, follow up period, predictor variables, sensitivity and specificity, AUC 
values, odds ratio values. All predictor variables and models were then included in a 
table examining the discriminative ability, clinical utility and odds ratio of the 
variables in question.  
 
Method B-Data from the 3 months of falls diaries: 
In order to examine other factors that hadn’t been considered in the model the data 
from prospective falls diaries was analysed. These diaries were used to record falls 
during a three-month period as part of a larger study involving combining objective 
measures with clinical variables to develop a falls risk prediction tool for people with 
MS (chapter five). The study was approved by the University of Limerick Ethics 
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Committee and the St. Vincent’s Healthcare Group Ethics and Medical Research 
Committee.  
 
Data from the falls diaries was examined to further explore the consequences of falls 
such as increased healthcare utilisation and to help determine who should be targeted 
for falls prevention interventions i.e. any faller, frequent fallers, injurious fallers. The 
falls diaries collected information on the number of falls and number of injurious falls 
per month, number and type of injuries per month, presence of any relapses, medical 
services utilised due to a fall, presence of a long lie and if any assistance was required 
to get up from the floor. Ecological validity is gaining increasing importance in 
relation to clinical measures and time/location of assessment may be relevant when 
using a falls risk tool. Therefore, for the first two falls of any given month the 
participant was asked to document the time and location of the fall and what they think 
caused them to fall (multiple responses permitted for causes of fall, participants could 
tick the relevant choice from a list of 16 potential causes). An example of a monthly 
falls diary is at the end of this thesis, see Appendix 6.1.  
 
Participants were given stamped addressed envelopes to return the diaries at the end 
of each month to the study site and were also given the option of a fortnightly text or 
email reminder to optimise the return rate. Telephone follow up was used to clarify 
any missing information. Information relating to the circumstances and context of falls 
was examined for any potential variables that may be relevant to a falls risk prediction 
tool. Data was extracted into Excel and analysed using excel and SPSS software, 
version 22.  
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Method C-Content analysis of data from clinicians’ interviews regarding falls 
prevention interventions: 
This section reports a post-hoc analysis of previously conducted semi-structured 
interviews carried out with 12 clinicians as part of a larger research study developing 
fall prevention interventions carried out by colleagues on the MS research team in 
University of Limerick. This study was reviewed and approved by the University of 
Limerick ethics committee. Clinicians were asked about their opinions in relation to 
current and future falls prevention interventions including current interventions used, 
barriers and facilitators, feasibility of future interventions. For this analysis data in 
relation to falls risk assessment was the focus. 
 
Participants were recruited through national physiotherapy and occupational therapy 
networks via an email invitation and the interviews were carried out over the phone or 
in person depending on location of the participant with each interview lasting 
approximately 60 minutes duration. The aim was to have a mix of experienced and 
non-experienced clinicians across a range of work settings, this purposeful sampling 
was undertaken to collect data from clinicians who regularly (n=5) and irregularly 
(n=7) worked with people with MS to provide valuable information in terms of falls 
risk assessment, intervention content and intervention feasibility. Interviews were 
conducted until data saturation was reached. The interviews were recorded, and notes 
were taken throughout by the researchers. The interviewees were provided with a 
summary at the end of the interview and given the opportunity to amend or add to the 
key points from the interview. The interviews were transcribed verbatim and imported 
onto a qualitative analysis software programme, NVivo 11.  
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The analysis for this chapter was a secondary post-hoc analysis of the data to 
specifically find codes that might help inform and refine future falls risk models 
further. Analysis followed the six steps outlined by Braun and Clarke (2006) which 
include familiarisation with the data, generation of initial codes, searching for themes, 
revision of themes, definition and naming of themes and provision of the written 
report. Themes involving falls risk assessment were specifically examined. Treatment 
prioritisation and barriers were also explored. The results from this secondary analysis 
were cross checked by a second member of the research team to ensure credibility of 
the data, by allowing more in-depth analysis and more detailed interpretation of 
findings.  
 
Results: 
 
Results A-Narrative Review: 
Initially there were 24,541 papers, after duplicate removal there was 20,743. After 
scanning the abstracts 47 full texts were read in detail and after applying the inclusion 
criteria there were 26 studies suitable for inclusion in the review. The combined 
studies had a total of 3619 participants (74% female) and a range of MS subtypes with 
relapse-remitting MS the most common across all studies (55% of participants), 
followed by secondary progressive (29% of participants). There was heterogeneity 
evident in relation to study methodology with four different faller classifications used, 
six different fall definitions, sample sizes ranging from 12 to 537 participants and a 
follow up period of falls monitoring ranging from seven weeks to one year.  Multiple 
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risk factors were explored in these studies including clinical and instrumented 
measures of mobility and balance (see Table 6.1), self-report measures (Table 6.2) and 
cognitive and medication related factors (Table 6.3). Only five studies (Nilsagård et 
al. 2009b; Kasser et al. 2011; Cameron et al. 2013b; Gunn et al. 2013; Prosperini et 
al. 2013) reported sensitivity and specificity values for risk factors in relation to 
predicting falls and nine studies (Cameron et al. 2013b; Dibble et al. 2013; Gunn et 
al. 2013; Hoang et al. 2014; Hoang et al. 2016; Nilsagård et al. 2016; Tajali et al. 
2017; Zelaya et al. 2017; Chinnadurai et al. 2018) reported area under the receiving 
operating curve (AUC) values. Of these studies, three reported on actual prediction 
models rather than individual variables (Kasser et al. 2011; Gunn et al. 2013; Hoang 
et al. 2014), see Table 6.2.  
 
A further twelve studies (Nilsagård et al. 2009b; Gunn et al. 2013; Cameron et al. 
2015; Mazumder et al. 2015; Nilsagård et al. 2015; Etemadi 2016; Nilsagård et al. 
2016; Comber et al. 2017; Tajali et al. 2017; Tijsma et al. 2017; Zelaya et al. 2017; 
Gunn et al. 2018) reported on falls risk in terms of odds ratio. Seven of the included 
studies did not report indices of discrimination or clinical utility or risk in terms of 
odds ratio (Stephens et al. 2001; Cameron et al. 2013a; Kasser et al. 2014; Carling et 
al. 2016; Nilsagård et al. 2017; Vister et al. 2017; Cattaneo et al. 2018) but the studies 
in question did not have falls risk prediction as their main objective and rather were 
looking at falls in relation to other variables or at changes pre and post a specific 
intervention. 
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Table 6.1: Discriminative Ability, Clinical Utility and Odds Ratios of Clinical 
and Instrumented Measures of Mobility and Balance 
Variable – 
measure used 
Study 
Author/year 
AUC value 
(95% CI) 
Sensitivity 
(95% CI)  
Specificity 
(95% CI) 
Odds Ratio 
(95% CI) 
Disability level-  
EDSS 
Cameron 2013 
Chinnadurai 
2018 
 
Nilsagard 2009 
 
Gunn 2013 
 
Nilsagard 2015- 
EDSS 6 
                       
EDSS 4 
 
Dibble 2013 
0.60 
0.71 
[0.60,0.83] 
 
NR 
 
NR 
 
 
NR 
 
NR 
 
0.56 
[0.36,0.77] 
NR 
NR 
 
 
48% 
 
NR 
 
 
NR 
 
NR 
 
NR 
NR 
NR 
 
 
82% 
 
NR 
 
 
NR 
 
NR 
 
NR 
NR 
NR 
 
 
1.99 
[1.22,3.4] 
0.81 
[0.49,1.35] 
 
5.10 
[2.08,12.47 
5.30 
[2.23,12.64 
NR 
Clinical measures 
mobility/balance- 
BBS 
 
 
 
 
TUG 
 
 
 
 
DGI 
 
FR 
 
DTC 
 
Dibble 2013 
 
Nilsagard 2009 
 
Prosperini 2013 
 
 
Dibble 2013 
 
Tajali 2017 
 
 
Dibble 2013 
 
Dibble 2013 
 
Tajali 2017 
 
0.72 
[0.52,0.89] 
NR 
 
NR 
 
 
0.66 
[0.46,0.86] 
0.65 
 
 
0.68 
[0.49,0.87] 
0.66 
[0.47,0.84] 
0.48 
 
NR 
 
94% 
 
32% 
[18,48] 
 
NR 
 
NR 
 
 
NR 
 
NR 
 
NR 
 
NR 
 
32% 
 
87% 
[75,94] 
 
NR 
 
NR 
 
 
NR 
 
NR 
 
NR 
 
NR 
 
0.94 
[0.85,1.01] 
NR 
 
 
NR 
 
2.24 
[1.17,4.28] 
 
NR 
 
NR 
 
0.99 
[0.64,1.52] 
144 
 
 
 
 
CSRT 
 
 
 
 
 
 
T25FW 
 
 
 
 
 
FSST 
 
TUG C 
 
2MWT 
 
6MWT 
 
 
 
Etemadi 2017 
 
Gunn 2013 
 
Tijsma 2016 
 
 
Tajali 2017 
 
Cameron 2013 
Chinnadurai 
2018 
 
 Nilsagard 2009 
  
Nilsagard 2009 
  
Tajali 2017 
 
 Nilsagard 2015 
0.49 
 
 
NR 
 
NR 
 
NR 
 
 
0.79 
 
0.71 
0.72 
(0.61,0.82) 
 
NR 
 
NR 
 
0.71 
 
0.67 
[0.50,0.83] 
NR 
 
 
NR 
 
NR 
 
NR 
 
 
NR 
 
NR 
NR 
 
 
60% 
 
73% 
 
NR 
 
NR 
NR 
 
 
NR 
 
NR 
 
NR 
 
 
NR 
 
NR 
NR 
 
 
75% 
 
54% 
 
NR 
 
NR 
1.11 
 [0.72,1.71) 
 
1.23 
 [0.98,4.45] 
1.0 
[0.99,1.0] 
1.69 
[1.27,2.26] 
 
3.77 
[1.86,7.63] 
NR 
NR  
 
 
1.02 
[0.98,1.09] 
1.00 
[0.95,1.08] 
0.44 
[0.26,0.75] 
0.64 
[0.40,1.03] 
Instrumented 
Measures – 
Posturography 
 
 
Cervical VEMP 
 
Ocular VEMP 
 
Lower limb SEP 
 
LOS 
 
 
 
 
Cameron 2013 
Prosperini 2013 
 
 Chinnadurai 
2018  
Chinnadurai 
2018 
 Chinnadurai 
2018 
Kasser 2011 (2 
faller 
classifications) 
 
 
0.62 
NR 
 
0.82 
[0.73,0.91] 
0.79 
[0.68,0.91] 
0.73 
[0.59,0.88] 
 
NR 
 
 
 
NR 
88% 
[74,96] 
NR 
 
NR 
 
NR 
 
 
65% (≥ 1 
fall) 
 
 
NR 
67% 
[53,78] 
NR 
 
NR 
 
NR 
 
 
73% 
 
 
 
NR 
NR 
 
NR 
 
NR 
 
NR 
 
 
NR 
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SOT 
 
 
 
 
PPA 
 
 
 
 
 
Leg strength using 
Biodex 
 
 
 
 
Kasser 2011 (2 
faller 
classifications) 
 
 
Gunn 2013 
 
Gunn 2018 
 
Hoang 2016 
 
Kasser 2011 (2 
faller 
classifications) 
 
 
 
 
NR 
 
 
 
 
0.67 
[0.58,0.76] 
NR 
 
0.64 
 
NR 
76% (≥ 2 
falls) 
 
 
80% (≥ 1 
fall) 
67% (≥ 2 
falls) 
 
56% 
 
NR 
 
NR 
 
81% (≥ 1 
fall) 
67% (≥ 2 
falls) 
 
90% 
 
 
83% 
 
91%  
 
 
74% 
 
NR 
 
NR 
 
56% 
 
91% 
 
NR 
 
 
NR 
 
NR 
 
 
1.9 
[1.34,2.69] 
1.30 
[1.17,1.46] 
NR 
 
NR 
 
NR 
 
AUC = area under the receiver operating characteristic curve statistic, EDSS = Expanded Disability 
Status Score, BBS = Berg Balance Scale, TUG = Timed Up and Go Test, FR = Functional Reach, DGI = 
Dynamic Gait Index, PPA = Physiological Profile Assessment, T25FW: Timed 25 foot walk test, 2MW: 
2-minute walk, DTC: Dual Task Cost, FSST = Four Square Step Test, TUG-C = Timed Up and Go 
Cognitive, LOS = limits of stability, COG =  centre of gravity, 6MWT  = six minute walk test, CSRT = 
Choice Stepping Reaction time, VEMP = vestibular evoked myogenic potential, SEP = somatosensory 
evoked potential, SOT = sensory organisation test. CI = confidence interval, CI is stated when 
reported, NR = not reported.  
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Table 6.2: Discriminative Ability, Clinical Utility and Odds Ratio of Self Report 
Variables and Previous Models  
Variable – 
measure used 
Study 
Author/year 
AUC value 
(95% CI) 
Sensitivity 
(95% CI)  
Specificity 
(95% CI) 
Odds Ratio 
(95% CI) 
Self-report – 
ABC 
 
 
 
 
 
 
FES-I 
 
 
 
 
 
 
 
 
 
 
 
MSWS-12 
 
 
 
 
 
 
 
History of fall 
 
 
 
 
Tajali 2017 
 
Cameron 2013 
Chinnadurai 
2018 
 
Dibble 2013 
 
Gunn 2013 
 
Tajali 2017 
 
Cameron 2013 
Chinnadurai 
2018 
 
Gunn 2018 
 
Mazumder 2015 
 
Tajali 2017 
 
Cameron 2013 
Chinnadurai 
2018 
 
Nilsagard 2009 
 
Cameron 2013 
Nilsagard 2009 
Gunn 2013 (2 
faller 
classifications) 
0.92 
 
0.69 
0.63 
[0.50,0.75] 
 
0.68 
[0.48,0.87] 
NR 
 
0.89 
 
0.66 
0.59 
[0.47,0.72] 
 
NR 
 
NR 
 
0.91  
 
0.69 
0.62 
[0.51,0.72] 
 
NR 
 
0.75 
NR 
NR (≥1 fall) 
 
NR (≥2 falls) 
NR 
 
NR 
NR 
 
 
NR 
 
NR 
 
NR 
 
NR 
NR 
 
 
NR 
 
NR 
 
NR 
 
NR 
NR 
 
 
52% 
 
89% 
NR 
NR 
 
NR 
NR 
 
NR 
NR 
 
 
NR 
 
NR 
 
NR 
 
NR 
NR 
 
 
NR 
 
NR 
 
NR 
 
NR 
NR 
 
 
82% 
 
56% 
NR 
NR 
 
NR 
0.06 
[0.02,0.18] 
NR 
NR 
 
 
NR 
 
1.01 
[0.96,1.06] 
9.27 
[3.93,21.9] 
NR 
NR 
 
 
1.05 
[1.03,1.07] 
1.22 
[1.04,1.43] 
11.85 
[4.59,30.59] 
NR 
NR 
 
 
1.01 
[0.98,1.04] 
NR 
2.04 [0.8,5.3] 
2.46 
[0.89,6.83] 
10.62 
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MFIS 
 
Bladder 
dysfunction -
general 
-specifically, 
urinary 
urgency with 
incontinence 
 
 
Chinnadurai 
2018 
 
Tajali 2017 
 
Gunn 2013 
 
 
Zelayna 2017 
 
 
0.64 
[0.53,0.75] 
 
0.87 
 
NR 
 
 
0.82 
 
 
NR 
 
 
NR 
 
NR 
 
 
NR 
 
 
NR 
 
 
NR 
 
NR 
 
 
NR 
 [4.65,24.22] 
 
NR 
 
 
7.32 
[3.29,16.29] 
2.77 [1.4,5.48] 
 
 
57.57 
[3.43,966.05] 
Integrated 
Measures/Mo
dels- 
1) PPA, 
Ashworth, 
EDSS 
2)Sway with 
eyes closed, 
poor 
coordinated 
stability and 
decreased fine 
motor control 
(assessed with 
9HPT) 
3)Different 
COG leans 
4)COG motion  
 
 
 
Gunn 2013 
 
 
Hoang 2014 
 
 
 
 
 
 
 
 
Kasser 2011 
 
Kasser 2011 
 
 
 
0.73 
[0.65,0.81] 
 
0.71 
[0.64,0.79] 
 
 
 
 
 
 
 
NR 
 
NR 
 
 
 
69% 
 
 
NR 
 
 
 
 
 
 
 
 
70% 
 
71% 
 
 
 
70% 
 
 
NR 
 
 
 
 
 
 
 
 
71% 
 
88% 
 
 
 
NR 
 
 
NR 
 
 
 
 
 
 
 
 
NR 
 
NR 
 
AUC = area under the receiver operating characteristic curve statistic, ABC = Activities specific 
Balance Confidence Scale, EDSS = Expanded Disability Status score, FES- I = Falls Efficacy Scale 
International, PPA = Physiological Profile Assessment, MSWS-12: 12-item multiple sclerosis walking 
scale, MFIS: modified fatigue-impact scale, 9HPT = nine-hole peg test, COG = centre of gravity. CI = 
confidence interval, CI is stated when reported, NR = not reported.   
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Table 6.3: Discriminative Ability, Clinical Utility and Odds Ratio of Cognitive 
and Medication related variables  
Variable – 
measure used 
Study 
Author/year 
AUC 
value 
(95% CI) 
Sensitivity 
(95% CI)  
Specificity 
(95% CI) 
Odds Ratio 
(95% CI) 
Cognitive 
Measures- 
SDMT 
 
Gunn 2013 
 
NR 
 
NR 
 
NR 
 
1.00 
[0.97,1.05] 
Medications- 
No of 
medications, 
 
 
Nervous system 
medications, 
Alimentary tract 
and metabolism 
medications, 
SSRI and SNRI 
antidepressants,  
DMTS 
(protective, 
↓risk of falls), 
Genitourinary 
and sex 
hormone 
medications, 
Centrally acting 
muscle 
relaxants 
 
Cameron 
2015 
Gunn 2013 
 
Cameron 
2015 
 
Cameron 
2015 
 
Cameron 
2015 
Cameron 
2015 
 
Comber 
2017 
 
 
Comber 
2017 
 
NR 
 
NR 
 
NR 
 
 
NR 
 
 
NR 
 
NR 
 
 
NR 
 
 
 
NR 
 
NR 
 
NR 
 
NR 
 
 
NR 
 
 
NR 
 
NR 
 
 
NR 
 
 
 
NR 
 
NR 
 
NR 
 
NR 
 
 
NR 
 
 
NR 
 
NR 
 
 
NR 
 
 
 
NR 
 
1.13 
[1.0,1.28] 
1.01 
[0.92,1.12] 
1.43 
[1.09,1.93] 
 
2.64 
[1.20,7.23] 
 
1.96 
[1.7,3.71] 
0.52 
[0.28,0.95] 
 
5.15 
[1.43,18.61] 
 
 
5.18 
[1.55,17.36] 
AUC = area under the receiver operating characteristic curve statistic, SSRI = serotonin reuptake 
inhibitors, SNRI = serotonin-norepinephrine reuptake inhibitors, DMT = disease modifying therapy, 
SDMT = symbol digit modalities test. CI = confidence interval, CI is stated when reported, NR = not 
reported.  
From Tables 6.1 and 6.2 above the most commonly reported variables are the Falls 
Efficacy Scale International (FES-I), Expanded Disability Status score (EDSS) and 
the 12-item Multiple Sclerosis walking scale (MSWS-12). The only four variables that 
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have sensitivity, specificity, AUC and odds ratio values all reported are the EDSS, 
MSWS-12, history of a fall and Physiological Profile Assessment (PPA). History of a 
fall is the only variable with a sensitivity of ˃ 80%, AUC ˃ 0.7 and odds ratio ˃ 1, but 
across two different studies.   
 
From the models reported only one reports sensitivity, specificity and AUC value and 
that model includes the PPA, Ashworth and EDSS (Gunn et al. 2013) and indeed that 
study, along with the study examining the variable of history of a fall (Cameron et al. 
2013b) are the only two to report sensitivity, specificity and AUC values within the 
one study cohort.   
 
The variables with an AUC value of ≥0.7 representing moderate discrimination 
include urinary urgency with incontinence, vestibular evoked myogenic potential, 
history of fall, the MSWS-12, the 2-minute walking test, the Activities specific 
Balance Confidence scale (ABC), FESI, EDSS, Berg Balance Scale (BBS), modified 
fatigue impact scale and timed 25-foot walk (T25FW) (reported in 3 studies). Two of 
the integrated models (one of PPA, Ashworth and EDSS; the other of sway with eyes 
closed, poor coordinated stability and decreased fine motor control) also demonstrate 
an AUC of ≥0.7.   
 
When looking at sensitivity values ≥ 80%, the relevant variables are history of a fall, 
posturography, the sensory organisation test, lower limb strength using the Biodex and 
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the BBS. None of these variables are reported with high sensitivity in more than one 
study.  
 
If looking at odds ratios of ≥ 1.0, the variables worth examining include the choice 
stepping reaction time, dual task cost (DTC), the PPA, modified fatigue impact scale, 
TUG, T25FW, urinary urgency with incontinence, general bladder dysfunction, 
history of a fall, nervous system medications, alimentary tract medications, anti-
depressants, genitourinary medications, muscle relaxants, the FESI and EDSS. The 
FESI, EDSS, DTC, history of a fall and PPA are all reported with odds ratios of ≥ 1.0 
in more than one study.  
 
Results B- Data from the falls diaries: 
Falls diaries were completed by 100 participants during the three-month study period. 
There was a diary return rate of 99.7%. 
 
Falls and Injurious Falls:  At the end of the study period there was a total of 791 falls 
(range from 1-164) reported from 56 participants. There were 94 injurious falls 
reported from 32 fallers (range of 0-22). There were 34 participants (61% of 
fallers)with 2 or more falls. The most common injuries were leg bruises (31%), arm 
bruises (26%) and arm cuts/scrapes (12%) with 6 people requiring medical attention 
due to a fall. There was only one significant injury in the form of a fracture. Of the top 
five most frequent fallers (range of 34-164 falls per faller), four reported injurious falls 
but none of those highly frequent fallers required medical attention. The faller with 
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the most injurious falls (22) did not require medical attention for injuries.  Eleven 
participants reported an MS relapse during the study period with two participants 
reporting relapses in more than one month. 82% of those reporting a relapse were 
fallers. No participants had a long lie (greater than 60 minutes on the floor) but 34% 
of fallers did require assistance to get up from the floor.  
 
Causes and Context of Falls: The most common cause of falls reported were poor 
balance (25%), weakness in the legs (22%) and fatigue (14%). Afternoon time (37%) 
was the most common time of day to fall, followed by evening (28%), with 24% of 
falls occurring in the morning and only 11% at night. Most falls occurred inside the 
home (63%), with 21% occurring outside the home and only 16% away from the 
home.  
 
Results C- Data from the clinicians’ interviews: 
A total of 12 clinicians were interviewed from a variety of different work settings, see 
Table 6.4 with participant demographics.  Only 2 participants had availed of specific 
falls training in the past. When asked how often they encounter people with MS (from 
their MS client base) who have experienced a fall or at risk of falling, 2 participants 
said often, 5 said always and 5 said sometimes.  
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Table 6.4: Participant Demographics for Clinician Interviews 
 
After the stages of open and axial coding the refined themes identified were: 
dimensions of assessment in falls prevention, dimensions of intervention for falls 
prevention, barriers and facilitators to implementing falls prevention programmes.  
When looking more closely at the content of the data in relation to falls risk 
assessment, some of the most common topics mentioned include fall cause (9 out of 
12 sources), balance assessment (11 out of 12), strength assessment (5 out of 12), 
cognitive function (7 out of 12), fall frequency (6 out of 12), fall characteristics (4 out 
of 12) and environmental assessment (4 out of 12).  
 
Participant  Age 
 
Gender Years 
qualified  
Setting of 
employment  
Job title  Percentage 
MS clients  
1 31 F 9 Hospital  Clinical 
specialist 
physiotherapist 
100% 
2 38 M 14 MS Society  Senior 
physiotherapist 
100% 
3 33 F 10 Hospital  Senior 
physiotherapist  
33%  
4 31 F 8 Primary Care Senior 
physiotherapist  
1% 
5 35 F 10 Primary Care Senior 
physiotherapist 
70%  
6 32 F 10 Hospital  Senior 
physiotherapist  
10% 
7 50 F 15 Primary Care Senior 
physiotherapist 
33% 
8 28 F 6 Hospital  Senior 
physiotherapist 
40%  
9 36 F 12 Hospital  Practice 
physiotherapy 
tutor  
5% 
10  28  F 6 Hospital  Staff grade 
physiotherapist 
10% 
11 34 F 12 Primary Care  Senior 
physiotherapist 
15% 
12 31 F 8 Primary Care Staff grade 
occupational 
therapist 
5% 
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In relation to objective assessment balance and strength were frequently discussed- 
‘So again, having your assessment is important and then if they have minor balance 
or mobility problems or strength problems you would try address those before they 
become bigger problems or before they fall’. (Participant 1) 
In relation to balance and gait certain outcome measures were mentioned extensively 
including the Berg Balance Scale, Dynamic Gait Index, the Mini Best test and the 
Tinetti. In relation to fear of falls and self-report measures, the only one mentioned 
was the Falls Efficacy Scale International.  
 
Environmental assessment and continence issues were also deemed to be important-  
‘there’s you know an environmental assessment, everything is kind of looked at so 
medications are looked at, vision is looked at, the environment is looked at, there’s a 
balance assessment done on the person am we look at things like continence so in a 
case that someone was rushing to the toilet and that’s why they fell or am and then 
kind of looking at their support network that kind of thing.’ (Participant 7) 
 
Cognitive assessment and the role of cognitive impairment emerged as an important 
topic in relation to dual tasking and cognitive motor interference, and how that may 
affect falls -  
‘I use it at the moment like I think dual tasking is a big thing and especially with 
patients who would have cognitive problems’ (Participant 1) 
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Asking about falls at all stages of the disease and highlighting the importance of falls 
risk assessment and falls prevention for GPs and Neurologists was also discussed, 
emphasising the need for falls risk assessment at an early stage of the disease in order 
to ensure earlier intervention and prevention of further deterioration at later stages-  
‘I suppose I would always ask even new diagnosis or people who would have mild 
disabilities about falls or near falls just to pick up on problems that hopefully we can 
prevent and stop them from becoming a bigger problem.’ (Participant 1) 
 
Using a person’s falls risk as a potential screening criteria and prioritisation criteria to 
access services was identified and may be one method of facilitating earlier access to 
physiotherapy and occupational therapy interventions-  
‘I think as things currently stand, so falls are a little bit of a hidden agenda. Within 
that, people with MS are further down the list and not getting referred. I just think that 
if there is some way, they are already out there living with the condition, and managing 
their falls and trips and slips and everything so is there a way they could be targeted 
as a population independent of their healthcare provider.’ (Participant 4) 
 
When asked about barriers to implementing falls prevention interventions time was 
mentioned by 10 of the participants and equipment was mentioned by 5 participants-  
‘Time [laughs] is the first one anyway, just with our caseload, sharing the gym space 
at the same time as well, so we don't always have all the equipment that you want 
available at that time.’ (Participant 10) 
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‘So we should have, and unfortunately in MS Ireland, we also don’t have enough 
equipment to run those kind of programmes because we don’t have even steps or stairs 
you know things like that.’ (Participant 2) 
This emphasises the fact that a practical falls risk screening tool that would be 
translatable for everyday use in clinical practise needs to be easy to administer, quick 
to carry out and involve low cost equipment.  
 
Discussion: 
 
This study used three data sources to explore what additional variables might further 
explain the variance in the falls prediction model. From data source A, the narrative 
literature review, essentially results are inconclusive due to poor methodological 
standards with no new predictor variable (as history of a fall is already included in the 
model) demonstrating an AUC value of greater than 0.7, sensitivity of greater than 
80% and an odds ratio of greater than 1.0. Variables that do display any of these 
properties in isolation tend to have the value reported from one study cohort only. The 
information from data source B, the falls diaries, highlights the high rate of falls in this 
cohort, with more than half of fallers suffering injurious falls and 80% of those who 
suffered a relapse during the study period also reporting falls. This may indicate that 
full multi-disciplinary management is required at time of relapse and falls prevention 
interventions should be offered post relapse if indicated. The causes of falling listed 
are in line with the variables examined in the literature review and the location and 
timing of falls is important and may be relevant when considering falls risk assessment 
setting. The findings from data source C, the clinician interviews are in line with the 
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literature review also as common themes discussed are similar to some of the predictor 
variables examined including leg weakness, balance, cognition and dual task cost.  
 
From the results of the literature review it is reassuring to see that it confirms the 
findings in relation to falls history as history of a fall in the past year was one of only 
two variables to have an AUC value ≥0.7 and a sensitivity ≥80% (Cameron et al. 
2013b). The other variable was the Berg balance scale but it did not have sensitivity 
and discrimination reported from the one study cohort and had a conflicting sensitivity 
of 32% reported in a different cohort (Prosperini et al. 2013).  The poor predictive 
ability of clinical measures of balance for identifying falls risk in MS was previously 
highlighted in the systematic review earlier in this thesis (chapter two).  
 
Our findings in relation to the importance of bladder issues and asking the person with 
MS about the presence of bladder dysfunction are similarly confirmed. It is evident 
from the literature review here that the presence of urinary incontinence with urgency 
has good discrimination (AUC = 0.82) and a very high odds ratio of 57.57 (Zelaya et 
al. 2017). Of the other variables with acceptable discrimination of ≥0.7 those with the 
highest discrimination include the ABC scale (0.92), the MSWS12 (0.91) and the FESI 
(0.89)(Tajali et al. 2017). This would indicate that to improve the accuracy of our falls 
risk model a self-report measure that examines balance confidence or fear of falls may 
be warranted. However, all of these measures demonstrated this high discrimination 
in one study cohort (Tajali et al. 2017) (n=84) only which was mainly relapse remitting 
MS with a younger mean age and shorter disease duration than other studies examining 
falls risk prediction (Nilsagård et al. 2009b; Gunn et al. 2013) meaning results may 
157 
 
not be applicable in all disease sub types and in older cohorts.  It may be possible that 
two different falls risk models are required; one for younger people with milder disease 
status and a different one for older, more progressive cohorts.  
 
A simple clinical assessment that might improve the accuracy of our model is the 
Ashworth scale for spasticity as it demonstrated reasonable discrimination with an 
AUC value of 0.73 for a model including this variable (Gunn et al. 2013) whereas for 
the development of our falls risk tool we only asked a simple yes/no question about 
presence of spasticity. However, sensitivity of Gunn et al’s model was not greater than 
80% and another study using the Ashworth scale demonstrated a low sensitivity of 
58% (Nilsagård et al. 2009b). Comparison between studies is difficult due to wide 
heterogeneity in methodology with different fall definitions, different faller 
classifications and different durations of prospective monitoring. These studies did use 
the same monitoring period of 3 months but had different fall definitions and different 
faller classifications. Until reporting standards improve with specific protocols 
followed it is difficult to truly determine which variable is most sensitive or reliable 
to use for falls prediction.   
 
Other clinical variables that possibly should be examined in more detail in a falls risk 
assessment tool include balance, lower limb weakness and fatigue. Balance and lower 
limb weakness were both frequently mentioned in the clinicians’ interviews and all 
three of those predictors were found to be the most common cause of falls in the data 
from the falls diaries. From the literature review we know that to  improve the accuracy 
of our falls risk tool we could  include a more objective measure of balance using 
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instrumented data (Prosperini et al. 2013), a more objective measure of leg weakness 
e.g. using the Biodex system (Kasser et al. 2011) and a more detailed assessment of 
fatigue such as the Modified Fatigue Impact scale that has been shown to have good 
discriminative ability in previous research (Tajali et al. 2017). However, high tech 
equipment such as force plate posturography and Biodex systems are not going to be 
readily available in the usual healthcare setting in this country and therefore are not 
practical to include as components of a falls risk tool. A simple clinical measure of 
balance or mobility may be more feasible for use in an everyday clinic setting. 
 
The type of clinical measure used to assess balance and gait is important and we now 
know from the narrative literature review and our paper in chapter three that the TUG 
did not demonstrate good discriminative ability or sensitivity for identifying falls risk 
and was not referenced by any of the clinicians in the interview data, indeed recent 
research has suggested the TUG is more reliable as a functional measure of mobility 
rather than an actual assessment of balance (Sebastião et al. 2016). From the results 
of the literature review the T25FW seems to have the greatest discriminative ability 
reported from multiple study cohorts and is recommended for use in clinical trials and 
to monitor disability progression as part of the MS functional composite measure 
(Fischer et al. 1999; Rudick et al. 2001). However, it looks at straight line walking 
only in a single task domain and does not measure balance dimensions in any detail.  
From this narrative review there does not appear to be any clinical measure of balance 
with appropriate levels of clinical utility and discriminative ability for identifying falls 
risk in MS.  
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Cognition measured with the Symbol Digit Modalities test (SDMT), was not 
statistically significant between fallers and non-fallers and was therefore not suitable 
for inclusion in the original model, and the literature review here agrees with our 
findings as it was not a predictor variable shown to demonstrate good levels of 
discrimination or high sensitivity for identifying falls risk. It may be argued that a 
different measure of cognitive impairment might be more appropriate than the SDMT 
but the SDMT has been shown to be more valid and reliable than the Paced Auditory 
Serial Attention Test (Sonder et al. 2014) and measures information processing speed 
and working memory that are the main domains involved in the type of cognitive 
impairment seen in people with MS (Parmenter et al. 2007). Possibly cognitive 
impairment as demonstrated in relation to dual task cost is a more relevant variable 
when considering falls risk.  
 
The findings in relation to the location and timing of the fall is similar to other falls 
research in MS (Nilsagård et al. 2009b; Gunn et al. 2014), as are the findings in 
relation to the common causes of falls (Nilsagård et al. 2009a; Gunn et al. 2014). 
These studies and our data highlight the importance of timing of the assessment and 
location of the assessment. Ecological validity (Wegener and Blankenship 2007), a 
construct more commonly discussed in the behavioural sciences, is recently being 
examined more in relation to mobility assessment in MS and in particular walking 
capacity assessments. Recent research has demonstrated poor ecological validity for 
short walking tests such as the 10 metre walk test (Stellmann et al. 2015) and it is 
known that there is great variability day to day in mobility function for people with 
MS which limits the sensitivity of  performance measures currently in use (Feys et al. 
2012). Treating clinicians need to ask people with MS more detail about fall 
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characteristics such as rate of falls, presence of any injuries, location and time of falls. 
Potentially for a falls risk assessment to be most reliable and sensitive it should be 
carried out in the person’s own home at the time of day when they have had previous 
falls or mobility limitations.  
 
Conclusion: 
 
From this analysis of three sources of data, it is suggested that the most appropriate 
additional variables for future studies identifying falls risk at a screening stage are a 
self-report question about bladder function (specifically urinary urgency with 
incontinence) and a measure of balance confidence such as the ABC or FESI. None of 
the clinical measures of balance demonstrate high levels of discriminative ability or 
clinical utility in more than one study and thus cannot be recommended. While more 
detailed objective measures such as the PPA or force plate posturography may be 
useful in a laboratory setting they are not readily available in primary care or tertiary 
centres and thus are not a realistic option in the current health care context of this 
country. Setting and timing of the falls risk assessment is also important and may 
provide more useful information if carried out in the person’s own home at a time of 
day when previous falls have occurred.  
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Introduction:  
This discussion chapter will firstly summarise key findings from each chapter of the 
thesis and will then explore the clinical and research implications of these findings. It 
will discuss methodological issues including faller classification, length of prospective 
falls monitoring, standardisation of dual task assessment and specific limitations of 
the thesis including sample size and recruitment bias. Methodological considerations 
for future studies will be examined as will considerations for research including public 
and patient involvement, model validation and implementation and considerations for 
clinical practice including treatment prioritisation. Throughout the chapter key 
learning points and reflection on potential changes and methods for improvement will 
be explored.       
 
Key Findings of the Thesis: 
Chapter 2-  
The results of the systematic review show that currently no clinical measure of balance 
used with people with MS has sufficient levels of clinical utility or discrimination to 
be recommended to use to identify falls risk, but reporting standards are poor and 
methodological heterogeneity make true comparisons difficult. Some of the most 
common measures reported in the systematic review (chapter 2) include the Berg 
Balance Scale (BBS), the Timed Up and Go (TUG), the Falls Efficacy Scale 
International (FESI) and the Activities-specific Balance Confidence Scale 
(ABC)(Quinn et al. 2017). While these measures do show differences between fallers 
and non-fallers, this is mainly in studies using retrospective recall to establish falls 
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status and discriminative ability is commonly not reported. Retrospective recall is not 
the optimal method for reporting fall prevalence as previous studies of falls in people 
with MS have reported discrepancies between reported fall prevalence using 
retrospective recall and fall incidence using prospective diaries (Nilsagård et al. 2009; 
Dibble et al. 2013; Gunn et al. 2013a). This is not surprising considering the high 
prevalence of cognitive dysfunction in people with MS (Benedict and Zivadinov 
2011). From measures that did have levels of discrimination reported,  the ABC scale 
had the highest area under the receiving operating characteristic curve (AUC) value 
(0.92) but studies did not report sensitivity or specificity values, and the BBS had a 
high sensitivity value reported in one study (Nilsagård et al. 2009) but a contrasting 
value of 32% reported in a second study (Prosperini et al. 2013). As the TUG is 
significantly different between fallers and non-fallers in studies using retrospective 
falls recall, is commonly used and is quick and easy to carry out it warranted further 
investigation in a study using prospective monitoring of falls.  
 
Chapter 3- 
Chapter 3 describes that further investigation of the TUG through exploration of the 
discriminative ability and clinical utility of the TUG and TUG-Cognitive in people 
with MS where falls status was established with prospective diaries. Results suggest 
that it should not be used as a stand-alone measure for identifying falls risk. Both forms 
of the measure have an AUC value of less than 0.7 and while sensitivity scores are 
reasonable (82% and 77%) specificity values are low (34% and 30%) (Quinn et al. 
2018). This is the first prospective study to report both values of discrimination and of 
clinical utility for the TUG in people with MS and the low AUC value demonstrated 
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is similar to that seen in other populations such as older people (Kojima et al. 2015) 
and people with Parkinson’s disease (Kerr et al. 2010). For the TUG’s sensitivity and 
discriminative ability to be improved it may need to be more objectively quantified, 
e.g. using body worn motion sensors and more accurate ways of objectively measuring 
balance will be discussed in a later section of this chapter.  
 
Chapter 4-  
While the TUG and TUG-Cognitive alone are not sensitive enough to reliably identify 
falls risk, another useful variable that is gaining increasing interest from researchers is 
dual task cost (DTC) and cognitive-motor interference (CMI). Motor impairment and 
cognitive dysfunction are two of the most common symptoms in MS (McDonald and 
Compston 2006), and have both been identified as falls risk factors in a previous 
systematic review (Gunn et al. 2013b). While CMI is known to be common in this 
condition (Leone et al. 2015) there is a scarcity of prospective studies examining the 
role of CMI and DTC and it’s association to falls in people with MS. In chapter 4, the 
results of an analysis on objective DTC and subjective problems with dual task 
activities demonstrated no significant difference for objectively measured DTC 
between fallers and non-fallers, but those who subjectively reported difficulty doing 
two things at once had a 2-fold increased risk of falling with a RR of 2.07 (95% CI 
1.15, 3.71).  
 
In addition to analysis of DTC in the paper that constitutes chapter 4 of this thesis, six 
different patterns of CMI were identified and the risk of falling was greatest for those 
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using pattern no.6 (changes in gait, numbers correct, RR = 1.82), suggesting that 
walking performance deteriorates at the expense of prioritising the cognitive task. 
Patterns of CMI have previously been reported in people post stroke and found to be 
similar for fallers and non-fallers in retrospective study designs (Plummer et al. 2013), 
but this is the first prospective study to report on patterns of CMI seen in people with 
MS. Awareness of specific CMI patterns may have implications for treatment 
regarding educating the individual so as to increase efficiency of their gait pattern and 
minimise falls risk. However, the type of CMI patterns demonstrated might have been 
more objectively established using video analysis and discussion from a team of 
experts and these patterns need to be further validated in a larger cohort. Previous 
analysis of gait during dual task conditions has involved analysis of spatial-temporal 
parameters in specific MS subtypes (Learmonth et al. 2014; Dujmovic et al. 2017) but 
this type of analysis is not possible outside of a laboratory setting and therefore does 
not translate well to clinical practice.  
 
Chapter 5-  
To derive a simple, low-tech procedure that would translate well to everyday practice 
was an important objective for the main falls risk model development study (chapter 
5). After analysing various subjective and objective variables, the model with the 
greatest sensitivity (88%) and predictive validity (AUC = 0.72, 95% CI 0.62-0.82) 
included the variables of history of a fall, no visual problems, problems with bladder 
control and a slower speed on the Timed Up and Go. This model’s sensitivity and 
discriminative ability values compare favourably with earlier models developed for 
use in MS (Kasser et al. 2011; Gunn et al. 2013a; Hoang et al. 2014) and unlike those 
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earlier models does not require any expensive specialist equipment or training. 
However, the specificity and amount of variance explained by this model is low and 
indicates that other factors not considered in our data set could potentially affect falls 
risk and should be examined in future research. The fact that the specificity is low 
means that some non-fallers may be referred for in demand resources that they do not 
actually need, but in a falls risk screening tool it is more important to have a high 
sensitivity and definitely identify the potential fallers, as it would cause more harm to 
miss potential fallers than to provide an intervention to non-fallers that may actually 
benefit from the intervention also.  
 
Chapter 6- 
Other potential falls risk variables that warrant further investigation were discussed in 
chapter 6 of this thesis, where three data sources (a narrative literature review, data 
from prospective falls diaries and a content analysis from clinicians’ interviews) were 
used to explore other variables that might be added to future studies to further explain 
the variance of the model. The findings from those data sources demonstrate that to 
improve the sensitivity of our model it may be useful to include a self-report question 
specifically about bladder urgency rather than just asking about general bladder issues 
and a self-report measure in relation to balance confidence (e.g. the ABC scale or 
FESI). From the literature review it was evident that no predictor variable 
demonstrated an AUC value of greater than 0.7, sensitivity of greater than 80% and 
an odds ratio of greater than 1.0 in a single study cohort. From the falls diaries the high 
rate of falls and injurious falls was highlighted, causes of falls were in line with the 
variables from the literature review, location and timing of fall may be important. 
171 
 
Themes evident in data from the clinicians’ interviews were similar to variables 
reported in the literature review and the importance of ecological validity in relation 
to assessment became evident. Timing and location of assessment is important and 
needs to be considered by the clinician when using a falls risk tool of this type. 
 
In summary, the key findings of the results in the thesis were: 
1) No clinical measure of balance currently in use is suitable to identify falls risk 
in MS. 
2) The TUG and TUG-Cognitive should not be used in isolation to assess falls 
risk.  
3) A self-report measure of difficulty dual tasking may be useful to identify 
fallers.   
4) A model including the variables of no visual problems, problems with bladder 
control, history of a previous fall and a slower speed on the TUG demonstrates 
reasonably good sensitivity and discriminative ability for identifying fallers in 
MS but has poor specificity and explains 20% of the model variance.  
5) To improve the amount of variance explained by the model it may be useful to 
add a question specifically about bladder urgency rather than general bladder 
issues and to incorporate a measure of balance confidence or fear of falls such 
as the ABC scale or FESI.  
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Considerations for Clinical Practice: 
General Clinical Implications- 
One of the most significant findings from this thesis is the high rate of falls among 
people with MS. From the prospective cohort study, a total of 791 falls were recorded 
from 56 participants, of which 34 were recurrent fallers who reported 2 or more falls 
during the 3-month study period. This high rate of falls may serve to increase the risk 
of other adverse outcomes including injuries, decreased confidence, lower levels of 
participation and an overall decrease in quality of life (Peterson et al. 2007; Peterson 
et al. 2008; Coote et al. 2013). Clinicians need to consider falls risk when treating 
people with MS and need to carry out comprehensive falls risk screening from an early 
stage of the disease; to help identify the level of risk sooner and refer for falls 
prevention interventions earlier when they can be of most benefit.  
 
From the findings of this thesis it is clear that all health care professionals in contact 
with people with MS need to regularly ask about history of falls, the number of falls 
and injurious falls. They also need to enquire about specific problems with bladder 
urgency, determine if any visual problems are present and ascertain if the person 
reports problems doing two things at once. In combination with those self-report 
measures an assessment of gait speed using the TUG may be useful and will help the 
clinician to determine the individual’s fall risk profile and to monitor changes over 
time. It is important for clinicians to be aware of the multifactorial nature of falls and 
not to rely on the use of one measure in isolation when assessing falls risk. Ecological 
validity is also relevant when assessing balance and mobility in people with MS and 
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clinicians must consider the wide variability day to day in level of function and 
symptom presentation when considering the setting and timing of their assessment.  
 
As discussed in chapter 6 when exploring the variance of the falls risk model, 
biopsychosocial factors such as fear of falls are important and need to be considered 
in the context of falls risk assessment. A person’s thoughts, emotions and behaviours 
may have a large impact on the type of coping mechanism they use to manage their 
symptoms and to minimise their falls risk; and indeed, the response and carryover they 
demonstrate in relation to falls prevention interventions. Social factors including 
economic, environmental and cultural aspects may also be important and this was not 
an area that was fully explored in the cohort study in this thesis. When designing the 
protocol for this study, the type of data collection tool utilised was based more so on 
the ICF framework with an emphasis on body functioning and structures and activities 
with balance, mobility and specific physical symptoms explored. Data exploring the 
person’s level of participation and other environmental and social factors may have 
been useful and provided more insight into the individual’s risk of falls in relation to 
their daily activities and quality of life. A falls risk assessment and intervention that 
incorporates biopsychosocial factors may have a more meaningful effect on the 
participation levels of the person with MS, and previous qualitative research has 
demonstrated that people with MS believe that improving participation-based 
outcomes are just as important as decreasing falls incidence when determining 
effectiveness of falls intervention trials (Gunn et al. 2017). The lack of 
biopsychosocial context is acknowledged as a limitation of the current model.  
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The Role of Prediction Tools in Treatment Prioritisation- 
Clinical prediction models play an important role in healthcare by helping to calculate 
estimates of the likelihood of the occurrence of a particular patient outcome from 
multiple predictor variables and can help clinicians to make individualised diagnostic 
and therapeutic decisions (Steyerberg and Vergouwe 2014; Han et al. 2016). In 
chapter 5 the development of the falls risk model was reported, and results were 
discussed in terms of discriminative ability and clinical utility. While that chapter 
reported the sensitivity and predictive validity of the model as a falls risk screening 
tool, it did not explore how the model may be potentially used to help prioritise waiting 
lists and enable faster access to falls prevention interventions. Previous research has 
demonstrated limited access to physiotherapy services for those requiring neurological 
rehabilitation and an imbalance between increasing service demands and limited 
physiotherapy capacity (Adams et al. 2015). When service demand exceeds supply, 
prioritisation or triage systems are used to help clinicians to allocate their services 
appropriately and determine who needs to be seen first, how the service should be 
provided or indeed if treatment is required at all (Irion 1997; Gauthier et al. 2006). 
However, a systematic review of triage systems for allied health services found a 
paucity of evidence in relation to this topic and concluded that reliability may be 
improved if objective priority tools are used rather than relying on clinician judgement 
which may be quite subjective in nature (Harding et al. 2009).  
 
In the Irish context there is limited formal information available in relation to 
prioritisation criteria, with many hospital outpatient clinics and primary care centres 
devising their own triage systems based on resource capacity and service 
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demands/needs. Members of the MS Society of Ireland reported access to 
physiotherapy services as their greatest unmet need in a 2005 market research survey. 
Similarly in the UK, a survey of people with MS demonstrated that advice about 
exercise was the most requested information source (Somerset et al. 2001) and that 
lack of information about physiotherapy services and excessive waiting list times was 
one of the most negative aspects of their overall management (Markwick et al. 2014). 
In a profiling study of physiotherapy services for people with MS in Ireland it was 
found that 47% of people with MS accessing physiotherapy used mobility aids and 
there was a short duration of physiotherapy received (mean of 3.6 hours) (Coote et al. 
2010). This would indicate that people with MS are receiving far less than the 8-12 
hours received by participants in studies that have demonstrated positive benefits of 
physiotherapy and exercise interventions (Cattaneo et al. 2007; Hoang et al. 2016b; 
Hugos et al. 2016). If a falls risk screening tool such as the one developed in this thesis 
was used to prioritise patients trying to access physiotherapy services such as a 
targeted falls prevention programme, they may receive a greater duration and more 
effective physiotherapy input, as such programmes tend to be 8 weeks or longer in 
duration.  
 
The National Clinical Programme for Neurology (2016) recommends that people with 
MS have access to physiotherapy at all stages of the disease and that physiotherapy 
can play a role in monitoring disease progression, exercise prescription and advice 
regarding self-management (National Clinical Programme for Neurology  2016). Yet 
a recent survey of physiotherapists working on neurology services in primary care in 
Ireland showed that there are significant challenges and barriers to providing a quality 
service for people with neurological conditions in this country (McDaid et al. 2017), 
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that result in poorer patient outcomes and notable occupational stress for the clinician. 
A significant mismatch between their ideal service and the actual service provided was 
noted. A simple falls risk screening tool like the one developed in this study (chapter 
5) may help to triage waiting lists more successfully and enable earlier access to falls 
prevention interventions for those at high risk. How the translation of this falls risk 
model to clinical practice may be facilitated will be discussed later in this chapter in 
the section on implementation of the model. 
 
Considerations for Future Research: 
Before contemplating model implementation or validation, the first consideration for 
future research should be revision of the falls risk model and incorporation of data that 
reflects the biopsychosocial aspects of falls risk. The model could be revised as 
suggested in chapter 6, by adding a measure of balance confidence and specifically 
asking about bladder urgency rather than general bladder issues, and then validating 
and implementing the revised model. Biopsychosocial data could be collected in the 
model revision study by changing the data collection tool (appendix 5.3) to incorporate 
questions about environmental and social factors including family support, home 
environment, education level and regular leisure pursuits. This may result in a more 
holistic falls risk model that explores more meaningful and important participation-
based outcomes, which may have greater significance for the individual with MS.  
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Modifications to the Falls Risk Model - 
Apart from more objective measures of mobility or balance using smartphone or 
accelerometer technology (as discussed in the later section on methodological 
considerations for future research), a further variable that could be added to the falls 
risk model is a self-report measure of balance confidence or fear of falls. These self-
report measures link in with the biopsychosocial aspects of falls and add greater 
context to the impairment-based model in its current format.  In chapter 6 both the 
ABC scale and FESI were commonly used self-report measures in falls risk studies 
and both had AUC values of ≥ 0.7 (Tajali et al. 2017). In addition, the FESI also 
demonstrated odds ratio values of ≥ 1 in multiple studies (Gunn et al. 2013a; 
Mazumder et al. 2015; Tajali et al. 2017). While a simple yes/no question about 
bladder control is included in the final falls risk model, it may be more sensitive to 
specifically ask about bladder urgency with incontinence as this demonstrated an odds 
ratio value of 57 in a recent prospective study (Zelaya et al. 2017).  
 
Public and Patient Involvement (PPI)- 
In relation to study design people with MS people should have been included from the 
initial stages of the cohort study as engagement of service users in research can lead 
to research of greater quality, impact and relevance (Chalmers 1995; Entwistle et al. 
1998; Brett et al. 2014a). Public and patient involvement (PPI) is now considered a 
central component of the research process and results in the researcher developing a 
greater understanding and insight into their specialist area and service-users feeling 
empowered and more confident with greater control over their condition (Brett et al. 
2014a; Brett et al. 2014b). PPI should have a much stronger focus in any model 
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revision and validation studies that would be carried out in the future. People with MS 
tend to readily engage with researchers and important information around falls risk 
and falls context has been obtained from previous qualitative analysis and interview 
methodologies (Peterson et al. 2007; Peterson et al. 2009; Carling et al. 2018). Thus, 
people with MS would be a useful resource in relation to the design of the falls 
screening questionnaire and the layout of the falls diaries in any future model revision 
or validation studies, to ensure the most appropriate and relevant information is 
collected. While different methods of engagement exist- focus groups, interviews, 
surveys, serving on a study board- the best method to achieve engagement has not 
been clarified and most studies use convenience sampling (Domecq et al. 2014). 
Ideally in a future model validation study focus groups and interviews with both 
service users and health care professionals could be utilised to ensure relevance of the 
variables being explored and to build relationships to aid knowledge translation and 
implementation at a later stage of the study. 
 
Indeed building trust is one of the core principles of participatory research, along with 
finding a shared interest, power-sharing and building on existing strengths (Dalal et 
al. 2009). Empowering service users through a sense of responsibility is important in 
both research and general healthcare especially in chronic conditions such as MS that 
require lifelong therapy and greater healthcare utilisation (Rieckmann et al. 2015). The 
needs, wants and abilities of the people for whom an intervention or screening tool is 
targeted need to be considered and addressed and user (in the case of the falls risk 
screening tool both the clinician and the person with MS) perspective is important in 
the design and development of services (Hale et al. 2012). Involving health care 
professionals from an earlier stage of the falls model development study may have 
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provided greater insight into the usability of a falls risk screening tool of this type and 
indicated if it may be helpful in prioritising waiting lists and access to services, a topic 
which was explored earlier in the section regarding considerations for clinical practice. 
Involving clinicians and service users throughout the study phases may make 
dissemination and implementation of study findings easier and ensure the research 
findings translate well to everyday clinical practice. Implementation of the falls risk 
model could be carried out after model validation and impact analysis which will be 
discussed further in the following section.  
 
Validation of the Falls Risk Model- 
While many risk prediction models are developed and reported on in healthcare 
literature, very few are externally validated and actually used on a clinical basis, and 
when external validation is carried out it tends to demonstrate worse predictive 
performance (Siontis et al. 2015). In a recent paper examining how often newly 
developed risk prediction models undergo external validation, over 127 prediction 
models were examined and only 25% of those had external validation studies with 
AUC estimates significantly decreasing during external validation in comparison to 
the development study (Siontis et al. 2015). The predictive ability of a model often 
tends to be overestimated during the model development study, usually due to 
overfitting if the sample size is small and there are too few outcome events relative to 
the number of predictor variables (Moons et al. 2015). External validation involves 
applying the model to a new cohort of individuals that were not involved in the model 
development study and assessing its predictive performance. This can be done in 
several different ways; in temporal external validation individuals can be from the 
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same site as the development cohort but at a later time period, in geographical external 
validation participants are from a completely different institution or even country, and 
in  domain validation new individuals are very different from the original individuals 
for which the model was first developed (Moons et al. 2012). To externally validate 
our falls risk model, temporal or geographical methods could be utilised, preferably 
using multiple recruitment sites across acute care and primary care settings. This 
would result in a larger sample size,  which is required as a minimum of 100 events 
and 100 non-events are recommended for external validation studies (Vergouwe et al. 
2005), and a more varied cohort than the original development study.   
 
To the best of the author’s knowledge none of the other models developed for 
assessing falls risk in MS (Kasser et al. 2011; Gunn et al. 2013a; Hoang et al. 2014) 
have been externally validated or had model impact analysis. Falls risk models 
developed for use in other cohorts have been externally validated to a certain extent 
but validation is not routinely reported. A recent systematic review of falls risk 
prediction models post stroke found only two studies reported any form of validation 
and none of the validated models demonstrated an acceptable performance (Walsh et 
al. 2016).  A further study that externally validated two different falls risk prediction 
models in people post stroke found both models demonstrated poor predictive 
performance with AUC values of 0.56 and 0.55 (Walsh et al. 2017). A 3-step falls 
prediction model developed for people with Parkinson’s disease (Paul et al. 2013) was 
externally validated in a prospective study and demonstrated comparable and 
acceptable discriminative ability to the development study with an AUC value of 0.74 
(Lindholm et al. 2015). An external validation study of a falls risk tool for older people 
demonstrated good predictive ability in the validation cohort and also tested feasibility 
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of the tool by providing education and training to clinicians and having them complete 
an evaluation in relation to utility of the tool after a 3-month trial period (Tiedemann 
et al. 2010). This would be a worthwhile component to add to a future validation study 
of the falls risk model for people with MS and would demonstrate usability and 
applicability of the tool for those intended to use it. The next step after model 
validation would be impact analysis and  model implementation (Keogh et al. 2014).  
 
Impact Analysis- 
Following model revision as discussed in the preceding paragraphs, model impact 
analysis and implementation could be carried out. Model impact studies are 
recommended after external validation to assess the impact on the change in behaviour 
of clinicians and also on cost effectiveness and on health outcomes (Moons et al. 
2012). How frequently clinical prediction rules and models are used in clinical practice 
is unknown, and very few prediction models have undergone formal impact analysis 
to explore if they actually improve outcomes when used in clinical practice (McGinn 
et al. 2000). When considering prediction models the falls risk model in this thesis is 
currently level 1 evidence i.e. derivation of the prediction rule, but to be used in a 
variety of clinical settings with confidence regarding it’s sensitivity and effectiveness, 
it would need to be level 5 evidence i.e. broad impact analysis studies would have 
been carried out (Reilly and Evans 2006). When measuring the impact of a prediction 
model it is not enough to only include analysis of the traditional predictive values (e.g. 
sensitivity, specificity, AUC), but impact studies must also consider safety and 
efficiency (Reilly and Evans 2006). In this context safety is defined as the percentage 
of all individuals experiencing the predicted outcome who receive the targeted 
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intervention and efficiency is defined as the percentage of all individuals not 
experiencing the predicted outcome who do not receive the targeted intervention. This 
would indicate that falls prevention intervention programmes should be analysed in 
conjunction with use of the falls risk model to determine the appropriateness of the 
individuals receiving the targeted intervention.   
 
Implementation of the Model-  
Following model validation and impact analysis, implementation of the falls risk 
model involves dissemination of the research findings and practical approaches to 
implement the model and increase its use in a clinical setting. Some dissemination has 
already been carried out through poster and oral presentations at conferences, through 
presentations to the Neurology team in the recruiting hospital, to physiotherapy 
colleagues in the recruiting hospital, and to people with MS through updates in the MS 
Ireland research ezine. There are several different frameworks and models of 
implementation with the goal of knowledge transfer exchange. One of the best known 
frameworks is the Consolidated Framework for Implementation Research (CFIR) 
which recommends focusing on five domains to enhance implementation 
effectiveness (Damschroder et al. 2009)- the intervention, inner setting, outer setting, 
the individuals involved and the process for achieving implementation. Generally 
passive dissemination of information is not effective and to encourage implementation 
specific strategies are required such as educational outreach visits, interactive 
educational workshops, audit and feedback, use of local opinion leaders and 
multifaceted interventions (Bero et al. 1998; Boaz et al. 2011).  
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Another well-known framework is the PARiHS model (Promoting Action on Research 
Implementation in Health Services) which identifies three core elements necessary for 
successful implementation- the level and nature of the evidence, the context, and the 
process in which implementation is facilitated (Kitson et al. 1998). This framework is 
best used as a 2-stage process; a diagnostic and evaluative approach so that the 
intervention is shaped by key stakeholders for the specific situation in question, and 
that implementation is planned from the early stages of study design and considered 
at all stages of the study (Kitson et al. 2008). The task of trying to decide on an 
implementation framework to use can be daunting as there are over 60 models of 
implementation for knowledge transfer exchange (KTE) designed for various areas of 
health care (Prihodova et al. 2018). A recent review evaluated various models and 
highlighted 6 key components for successful implementation- the message, the 
stakeholders, the inner context, wider social context, cultural and economic context, 
and evaluation of the KTE process (Prihodova et al. 2018). The same research group 
involved in that review have now developed an Evidence-based Model for the Transfer 
and exchange of Research Knowledge (EMTReK) and they recommend a multifaceted 
strategy combining different approaches to achieve successful KTE (EMTReK, an 
Evidence-based Model for the Transfer and exchange of Research Knowledge 2017).  
 
Following on from those recommendations, in order to achieve successful 
implementation of the falls risk model into clinical practice a multifaceted approach 
is required. The main message from the study must be highlighted and key 
stakeholders including Neurologists, MS nurse specialists, physiotherapy and 
occupational therapy managers and people with MS must all be involved in the 
implementation process. Ideally these stakeholders would be involved from the outset 
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(as discussed earlier in the section on PPI) and a relationship based on trust and shared 
interests would be established and help to facilitate knowledge transfer. The context 
and setting for dissemination should be considered and will involve different locations 
depending on the stakeholders involved. Those settings may include journal club 
meetings, interactive training sessions and patient workshops across the acute and 
primary care setting. Social media platforms also play a role in dissemination of 
research findings (Scanfeld et al. 2010; Keller et al. 2014) and previous research has 
demonstrated internet usage to be high among people with MS with many using online 
platforms to obtain health related information and to get peer support (Lejbkowicz et 
al. 2010). After carrying out strategies to encourage implementation, evaluation of 
KTE should be explored and this may be done through participant feedback and 
evaluation post workshops, through clinician and individual surveys and through 
service audit at a later date to evaluate any change in clinical practice. The model in 
its current state is not ready for validation, impact analysis or implementation and this 
is partly related to certain methodological issues that will be discussed in the following 
section.   
 
Methodological Issues: 
Faller Classification- 
The most significant methodological issue, that comes to light firstly in the systematic 
review in chapter 2 but is applicable throughout the whole thesis, is the variability and 
lack of clarity relating to the definition and classification of a ‘faller’. The number of 
falls necessary during the monitoring period to classify a person as a faller remains 
unclear, and variability in different studies makes comparison and analysis of study 
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findings difficult. Some researchers examining falls risk in MS define a faller as a 
person with 1 or more falls (Coote et al. 2013; Nilsagård et al. 2016), others define it 
as the occurrence of 2 or more falls (Gunn et al. 2013a; Kalron and Allali 2017) and 
still others classify a faller as a person with 3 or more falls (Hoang et al. 2014). When 
looking in more detail at the reasoning behind why a particular faller definition is 
chosen the findings are contrasting in nature. Some studies don’t give any justification 
for their choice of definition (Cameron et al. 2013b; Vister et al. 2017) and of those 
that do the reasoning referenced varies.  
 
The definition of a faller as a person with 1 or more falls is recommended by the 
International MS Falls Prevention Research Network (IMSFPRN) as it only takes one 
fall to cause injury and related consequences such as fear of falling or activity 
curtailment (Coote et al. 2014) and some subsequent studies have based their faller 
definition on this recommendation (Tajali et al. 2017). Gunn et al (Gunn et al. 2013a) 
based their definition (faller with 2 or more falls) on recommendations from the 
Prevention of Falls Network in Europe, ProFaNE (Lamb et al. 2005) but these 
recommendations for falls research in older people do not state fallers should always 
be classified as a person with 2 or more falls but rather that multiple categories should 
be explored and reported including fallers/non-fallers/frequent fallers. More recent 
studies (Kalron and Allali 2017; Hershkovitz et al. 2019) in falls risk in MS then went 
on to base their faller definition on the Gunn (2013a) study. Hoang et al (2014) discuss 
the concept that greater than two falls are more likely to indicate physiological 
impairment and represent chronic conditions but the reference for this statement is 
based on falls in older people and is quite dated at this stage (Nevitt et al. 1989). That 
group then go on to define a faller as a person with 3 or more falls because of the high 
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prevalence of falls in MS with a prevalence greater than that seen in older people. The 
same reasoning of 2 falls being more indicative of physiological impairment and 
chronic disease based on the same cited study is used by Kasser et al (2011) but they 
do also report risk findings in relation to a faller being a person with 1 or more falls to 
allow for evaluation of all falls versus no falls. 
 
This reporting of multiple faller categories is seen in other recent studies investigating 
falls risk in MS (Mazumder et al. 2015; Hoang et al. 2016a; Zelaya et al. 2017) and 
may possibly represent the optimal method for reporting faller data and provide the 
most transparent findings. Indeed, in the recommendations from the IMSFPRN they 
recommend using the term ‘multiple faller’ or ‘frequent faller’ for any participant with 
2 or more falls and also propose reporting the number of falls per person per year as a 
primary outcome in falls research trials (Coote et al. 2014). Reporting of this 
computation is also recommended in the elderly (Lamb et al. 2005) and may help 
overcome issues of confusion and heterogeneity around faller classification categories. 
The IMSFPRN (Coote et al. 2014) recommend collecting data on injurious falls and 
on all type of injuries , not just those requiring medical attention, as many falls among 
people with MS are not reported to a healthcare professional (Matsuda et al. 2011) and 
minor injuries can still have a significant impact on the person in relation to time off 
work or psycho-social constructs such as fear of falls (Peterson et al. 2008). Previous 
research has shown the prevalence of injurious falls to be greater in people with MS 
than in healthy controls (Mazumder et al. 2014) with varying prevalence rates of 34% 
(Matsuda et al. 2011) to 58% (Hoang et al. 2014) reported across studies. The injury 
rates in this longitudinal study were lower than previously reported findings, with 33% 
of participants reporting injurious falls (only 3% accessed medical services for 
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injuries) over the 3-month monitoring period and thus injurious falls was not deemed 
a significant faller classification to base the falls risk model analyses on.  The different 
levels of significance assigned to all fallers (person with 1 or more falls), multiple 
fallers (person with 2 or more falls) and injurious fallers will be discussed further in a 
later section of this chapter in relation to treatment prioritisation.  
 
Length of Prospective Falls Monitoring- 
The monitoring period for collecting data on falls events varies considerably between 
studies with some researchers collecting data using falls diaries for a three-month 
period (Nilsagård et al. 2009; Gunn et al. 2013a; Prosperini et al. 2013; Hoang et al. 
2016a; Zelaya et al. 2017) and others for longer periods of up to 6 months (Cameron 
et al. 2013b; Mazumder et al. 2015; Etemadi 2016; Tajali et al. 2017; Vister et al. 
2017) or even a year (Dibble et al. 2013; Kasser et al. 2014). Six and three-month 
follow up periods tend to be both commonly reported, whereas a 12 month follow up 
is less frequent. Even within different studies from the same researcher discrepancies 
arise with research groups using three months in one study (Cameron et al. 2013a; 
Hoang et al. 2016a) and then the same group using  6 months in a different study 
(Cameron et al. 2013b; Hoang et al. 2014). 
 
Of the studies to date in MS using prospective monitoring of falls only four of them 
reference or explain their reasoning for choosing a specific monitoring period. Two 
studies (Hoang et al. 2014; Tijsma et al. 2017) base their choice on the 
recommendations for falls prevention trials in older people (Lamb et al. 2005), but the 
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ProFaNE recommendations do not actually specify a length of time for falls 
monitoring but rather advise a minimum of monthly reporting with a 12 month period 
recommended for falls intervention studies that may have a delayed effect and require 
a longer follow up time point to demonstrate evidence of effect. Cameron et al (2013a) 
base their method on a cross-sectional study that doesn’t actually mention prospective 
falls monitoring periods at all (Finlayson et al. 2006).   
 
Another reference cited in relation to falls monitoring  was Perry et al  (2012) who 
examined the correct completion and return rate of falls diaries in a cohort of older 
adults. They found that 60% of diaries returned over a 6-month monitoring period 
were correctly completed and that those at a higher risk of falling (as measured using 
the Falls Risk Assessment Tool, FRAT) were both less likely to return diaries and 
more likely to report falls. This may indicate that a certain proportion of fallers are 
missed when using falls diaries to monitor falls rate. However, this was not an issue 
with our falls risk model study as there was a falls diary return rate of 99.7% and 
telephone follow-up was utilised to clarify any missing data from diaries and to 
confirm any unusual findings reported (chapter 5).  
 
When deciding the reporting period for falls diaries it is important to have a balance 
between accurate data collection and burden or inconvenience for the study 
participant. The reporting period needs to be long enough to capture an accurate 
representation of falls rates but short enough to avoid placing an excessive burden on 
the study participant. As the prevalence of falls in MS is greater than that seen in older 
people (Campbell et al. 1990), the International MS Falls Prevention Research 
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Network (IMSFPRN) recommends a three-month monitoring period in MS falls 
related trials (Coote et al. 2014) but advise the aim of the intervention must also be 
considered when deciding on a follow up time point. While the optimal time period 
for falls monitoring has not been reported in either older adults or in MS (Ganz et al. 
2005; Matsuda et al. 2011), it is widely accepted and agreed upon that prospective 
falls monitoring is more reliable than retrospective recall and that a minimum of 
monthly reporting with telephone or face to face interview should be used to clarify 
any missing data (Lamb et al. 2005; Hannan et al. 2010; Coote et al. 2014). If the 
computation of number of falls per person per year is reported (as discussed earlier in 
the faller classification section), then the length of prospective monitoring chosen is 
not so relevant and comparison of results from different studies is easier.  
 
Standardisation of Dual Task Assessment- 
Similar to variety in faller classification and falls monitoring periods, significant 
variation is also present in the methods used to assess an important variable related to 
falls risk; dual task cost (DTC). There is a growing body of evidence exploring the 
role of DTC and cognitive motor interference in people with MS but recent reviews 
suggest methodological limitations make comparison of results difficult, and highlight 
the need for a standardised dual task assessment that measures the DTC of both the 
motor and cognitive task and that gives clear instructions regarding task prioritization 
and speed selection (Leone et al. 2015; Postigo-Alonso et al. 2018). A form of gait 
assessment is the most common motor task reported, some analysing spatial temporal 
parameters using the GAITRite walkway (Kalron et al. 2010; Learmonth et al. 2014; 
Motl et al. 2014) while others use more traditional timed tests including the 10 metre 
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walk test (Gunn et al. 2013a) and the timed 25 foot walk (Tajali et al. 2017). The DTC 
of cognition is commonly not reported but is gaining increasing attention with recent 
studies highlighting a worsening of cognitive performance under dual task conditions 
(Downer et al. 2016; Etemadi 2016). A variety of cognitive tasks have been utilised 
including word list generation (Sosnoff et al. 2011; Wajda et al. 2013) and various 
counting tasks such as counting backwards in serial 3s or serial 7s (Gunn et al. 2013a; 
Kirkland et al. 2015) or pre-recorded digit-span sequences (Butchard-MacDonald et 
al. 2017). Interestingly that latter study is the only study, apart from our analysis 
reported in chapter 4, that uses a form of subjective assessment of dual task cost where 
they used a 10-item Dual Tasking Questionnaire. However no significant correlation 
was found between the self-report measure of dual tasking ability and decrement 
scores of objectively measured balance task performance under dual task conditions 
(Butchard-MacDonald et al. 2017). As there was no measure of falls rate in that study 
it is impossible to draw conclusions about findings from the self-report measure of 
dual tasking ability and association to falls risk. 
 
Studies that examined objectively measured DTC in relation to falls risk demonstrate 
conflicting results (Gunn et al. 2013a; Wajda et al. 2013; Etemadi 2016). In a cross 
sectional study Wajda et al (2013) found a significant correlation between falls risk 
(measured using the Physiological Profile Assessment) and dual task cost of walking, 
and the same group in a later study reported a significant association between the DTC 
of cognition and balance confidence, measured with the Activities-specific Balance 
Confidence Scale (Wajda et al. 2016) which is a measure known to be predictive of 
future falls risk (Tajali et al. 2017). This may indicate that the dual task of cognition 
191 
 
is associated with falls risk and this variable has been assessed in recent studies using 
prospective diaries for falls monitoring, as explained in the following paragraph. 
 
In studies using prospective diaries for falls monitoring conflicting results have been 
reported regarding DTC with some researchers finding no significant difference 
between fallers and non-fallers in relation to the DTC of the motor task (Gunn et al. 
2013a; Tajali et al. 2017) assessed using timed walks, whereas a study that used the 
Timed Up and Go Cognitive did find it was predictive of falls (Nilsagård et al. 2009) 
and a recent study found the DTC of cognition was related to recurrent falls risk 
(Etemadi 2016). When assessing DTC the cognitive task chosen is important and must 
represent a significant cognitive load to actually cause cognitive motor interference 
(CMI) (Srygley et al. 2009). The cognitive task utilised when assessing DTC 
represents a limitation of our analysis of DTC and its association to falls (chapter 4). 
The cognitive task used involved counting backwards in serial threes and may not have 
constituted a large enough cognitive load to truly cause significant CMI. The dual task 
of cognition should also have been measured as this variable has been shown to be 
associated with falls (Etemadi 2016) and both motor and cognitive DTC needs to be 
assessed to determine which task the individual is prioritising and how that choice 
may affect their mobility. Previous research in Parkinson’s disease demonstrated that 
people with Parkinson’s prioritise the cognitive task to the detriment of their walking 
performance (Bloem et al. 2006) and this has also been reported in studies of people 
with MS even when instructions have been given to give equal attention to both tasks 
(Allali et al. 2014). A recent systematic review (Postigo-Alonso et al. 2018) 
recommended that verbal fluency is the most sensitive cognitive task to use when 
assessing CMI in people with MS, as it has a greater cognitive load than counting tasks 
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and depends on frontal and temporal lobe processes that are commonly impaired in 
people with MS and that share neural networks with those involved in gait control 
(Gazzaley and D'Esposito 2006; Yogev et al. 2008). Apart from the assessment of 
DTC, further limitations of this thesis will be discussed in the following section.  
 
Limitations of the Thesis: 
Sample Size- 
On reflection, certain methodological factors regarding the main longitudinal study 
(chapter 5) may be considered as limitations. The sample size for model development 
was not considered at the protocol stage but rather the sample size of 100 was chosen 
based on previous falls research in MS (Prosperini et al. 2013; Kasser et al. 2014) and 
was considered a feasible and realistic recruitment target for a single site study. As the 
sample size was calculated post hoc this represents a limitation of the study. In 
recommendations regarding sample size calculation for risk prediction model 
development studies, there is a lack of clarity. If the number of predictor variables is 
much greater than the number of outcome events (in this instance fallers), there is a 
risk of overestimating/overfitting the predictive ability of the model in question (Han 
et al. 2016). Many go by the rule of thumb of 10 events per variable i.e. at least 10 
events (in this study fallers) per predictor variable (Peduzzi et al. 1995), but others 
think that rule is too strict (Vittinghoff and McCulloch 2007) especially if adequate 
control of confounding has been undertaken.  
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The sample size used directly affects the choice of statistical analysis methods suitable 
for use and meant that it was possible to do regression analysis based on a faller 
classification as a person with 1 or more falls only. As there were 56 fallers with 1 or 
more falls (chapter 5) this classification was chosen to allow model development with 
a potential of 5 variables as a minimum of 10 events is usually recommended per 
variable (Ogundimu et al. 2016). Ideally analysis for both faller and multiple faller 
(person with 2 or more falls) classifications would be carried out and reported on as 
recommended by the IMSFPRN (Coote et al. 2014), however the multiple faller 
classification would have resulted in 34 fallers which would limit the potential number 
of predictor variables to three. The issue of faller classification is complex (as 
discussed earlier in the first section about general methodological issues) but is a 
concept that needs consideration from the start of study design and will affect the 
choice of analysis method and may alter the significance of results. To make 
comparisons of results from different studies easier, large sample sizes should be used 
to allow analysis of both faller and multiple faller classifications that would facilitate 
reporting in the format recommended by both the IMSFPRN (Coote et al. 2014) and 
ProFaNE (Lamb et al. 2005).   
 
A further limitation of this thesis is that multiple uses of data and various forms of 
data analyses were carried out on data collected from the same sample. Ideally the 
different analyses explored for each chapter would have been done using data from 
different cohorts, but realistically considering the time frame for the overall thesis and 
the length of time required for participant recruitment and data collection this was not 
possible.  
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Recruitment Bias- 
There was also potentially a recruitment bias in this study; the role of screening for 
study eligibility fell to the treating doctor or nurse specialist in clinic and they may 
have only considered the falls risk study when assessing more progressive patients. 
This would partly explain the large predominance of secondary progressive MS in the 
study cohort but is also related to the inclusion criteria which stated participants must 
have an EDSS level of 3-6.5 which would exclude less impaired people with the 
relapse-remitting sub type. If the principal investigator was present at the screening 
stage, there may have been a wider range of MS subtypes and mobility levels recruited 
that would have improved the applicability of the model to the general MS population. 
Unfortunately, due to the recruitment setting being a busy outpatient clinic based in a 
large tertiary hospital this was not logistically possible. Potential changes to the 
recruitment process to improve the generalisability of the model and help external 
validity will be discussed in following sections.  
 
Methodological Considerations for Future Studies:  
Increase the Sample Size- 
Following on from the discussion on study limitations above the first consideration is 
the need for a larger sample size. If a larger study cohort were recruited from multiple 
sites (e.g. acute care, primary care, patient organisations), it would potentially result 
in a wider variety of MS sub types, age range and mobility levels and would improve 
the applicability of the model for a wider MS context. A larger sample size would also 
enable more detailed analysis of both faller and multiple faller classifications and 
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would allow reporting of results in line with recommendations from international falls 
research networks (Lamb et al. 2005; Coote et al. 2014). This would strengthen the 
significance and robustness of our study findings and allow more comparison with 
other studies on falls risk in MS that reported results based on multiple faller 
classifications (Kasser et al. 2011; Mazumder et al. 2015; Zelaya et al. 2017). 
 
Change of Balance Measure- 
Based on the findings regarding the discriminative ability and clinical utility of the 
TUG (chapter 3) (Quinn et al. 2018) it is now reasonable to state that it was not an 
appropriate measure of balance to use in a falls model development study.  However, 
at the time of study design it was chosen as it has good face validity for assessing falls 
risk involving turning and mobility transitions that are commonly associated with falls 
in people with MS (Gunn et al. 2014) and is recommended for use in both research 
settings and clinical practice by the American Physical Therapy Association Evidence 
Database to Guide Effectiveness Task Force (Potter et al. 2014). Furthermore, the 
TUG has been shown to be associated with global cognitive function and executive 
function in older adults (Herman et al. 2011; Donoghue et al. 2012) and in people with 
MS (Allali et al. 2012). The TUG and TUG Cognitive require no specialist equipment 
or training and the TUG Cognitive had been shown to be associated with falls risk in 
MS  in a previous longitudinal study (Nilsagård et al. 2009). However, more recent 
prospective studies have shown it does not demonstrate significant discriminative 
ability or good predictive validity for identifying future falls risk in people with MS 
(Tajali et al. 2017; Quinn et al. 2018) and may be more appropriate as a functional 
measure of mobility (Sebastião et al. 2016) and possibly to monitor disease 
196 
 
progression (Kalron et al. 2017). If used to assess falls risk some form of instrumented 
TUG using body worn sensors may be more appropriate and has been shown to be 
sensitive and reliable in MS (Craig et al. 2017; Hershkovitz et al. 2019) but further 
prospective studies of association with fall risk are required. Instrumented objective 
measures of balance such as the I-TUG and static posturography may be more 
sensitive for identifying falls risk (Mancini and Horak 2010; Prosperini et al. 2013) 
and if these systems became less expensive and more readily available outside of the 
laboratory setting they may be an option worth considering for clinicians working in 
the area of falls risk assessment and treatment. More objective and quantifiable 
methods of balance assessment will be discussed further in the following paragraphs.   
 
Objective Measures of Balance and Smartphone Systems- 
Body worn motion sensors are more readily available than laboratory based force 
platforms and are reasonably low cost and suitable for use in community and clinic 
settings (Shanahan et al. 2018). They have been previously used to monitor gait and 
balance impairment in people with MS (Moon et al. 2017; Sun et al. 2018). The 
instrumented TUG has been explored in MS cohorts and has been shown to be reliable, 
associated with disease stage and more sensitive than traditional timed tests alone 
(Spain et al. 2012; Greene et al. 2015). While it has not been examined in prospective 
studies evaluating falls risk in people with MS, it has been shown to be reliable for 
identifying falls risk when combined with clinical variables in a large cohort of older 
people (Greene et al. 2017) and a recent smaller study with 6 months of prospective 
falls monitoring showed promising results for identifying falls risk in people with 
Parkinson’s disease (Greene et al. 2018).  
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While force platform systems that give measures of static and dynamic posturography 
are expensive and usually laboratory based they have been shown to be reliable in 
predicting falls (Kasser et al. 2011; Prosperini et al. 2013). A standardised objective 
measure of balance such as posturography has many advantages over simple clinical 
measures including decreased variability in test performance (both across raters and 
across multiple sites), decreased subjective nature of scoring and an increased 
sensitivity to even very small changes (Mancini and Horak 2010). The main drawback 
to these systems is the high cost to acquire the equipment and a need for specialist 
training for staff, but a recent review of force platform measures in MS suggested 
using a commercially available low-cost device such as the Nintendo balance board 
(Prosperini and Pozzilli 2013) and a study exploring its use for posturography analysis 
showed it can be successfully used to gain a wide range of measures (Severini et al. 
2017). It has been used in previous pilot intervention trials in MS (Brichetto et al. 
2013; Pau et al. 2015) and a recent randomised controlled trial found the Nintendo 
Wii Fit is comparable to traditional balance interventions (Robinson et al. 2015) but 
qualitative analysis exploring it’s usability recommend modifications to commercial 
games to improve its ability to accommodate different functional levels (Plow and 
Finlayson 2014).  
 
A different form of technological adjunct that may have improved the strength of the 
falls model in terms of sensitivity and variance is a smartphone app using some form 
of built in motion sensor. Motion wearable devices including accelerometers, 
gyroscopes and pedometers can be embedded into smartphone apps and provide an 
unobtrusive method of monitoring and assessment that could provide the clinician 
with real time data over a period of days from a variety of different settings (Sparaco 
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et al. 2018). This form of falls monitoring would potentially have greater ecological 
validity than a clinic based assessment as most falls tend to occur in the person’s own 
home during activities of daily living (Carling et al. 2018). However, certain 
limitations in relation to accelerometer devices must be highlighted- there can be many 
false positives as the accelerometer may not be able to distinguish real falls from 
activities such as sitting quickly or jumping (Li et al. 2009) and location of the device 
affects accuracy with devices usually recommended to be worn at the waist (Kangas 
et al. 2008). Much of the evidence pertaining to falls detection algorithms using 
accelerometers or gyroscopes has been explored in simulated falls situations and when 
studies do evaluate their systems on real falls data the sensitivity is much lower than 
what was demonstrated with the simulated falls (Bagala et al. 2012). To determine if 
these accelerometer devices are more reliable and superior for monitoring falls than 
traditional falls diaries, their performance in longitudinal studies with large sample 
sizes must be evaluated and compared to falls data collected from diaries for the same 
cohort over the same specified time period.  
 
An advantage of smart phone technology with a built in accelerometer is that not only 
can it detect the fall, but it can also record location of the fall and report the fall to the 
system and user and caregiver via an alert system that typically involves an audible 
alarm, a text message or automatic voice call (Lee and Carlisle 2011). A recent review 
of smartphone based solutions for falls detection and prevention concluded that the 
quality of inbuilt sensors may not be adequate for accurate falls detection, there may 
be placement and usability issues and battery life can be a limitation (Habib et al. 
2014). However, a customised app specifically designed for falls detection may be 
more accurate and it is known that there is a high level of smartphone usage among 
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people with MS in Ireland and they are amenable to using them for health related 
purposes (Griffin and Kehoe 2018). In the initial protocol for the falls model 
development study (chapter 5), one of the study aims was to test the feasibility and 
clinical utility of an Android phone app used during the TUG. Data on sway, 
acceleration and angle of sway were collected during the assessment phase via a 
specially designed smartphone app but unfortunately this data has not been analysed 
due to the withdrawal of a staff member from the Computer Engineering Department 
at UL who had initially been involved in the study. In future studies to refine this 
model and improve its predictive ability further this smartphone data may be a useful 
additional variable.  
 
 
Conclusion: 
In conclusion this thesis provides new and valuable information in relation to falls risk 
assessment in people with MS. It highlights the poor sensitivity of clinical measures 
of balance for identifying falls risk in isolation and recommends use of a multi variable 
model that includes self-report measures when screening for falls risk. In the section 
on methodological considerations possible ways to improve this model further are 
explored and these potential modifications should be applied before validating and 
implementing the model in clinical practice. For future studies on falls in MS it is 
important to clarify the variability around faller classification and length of falls 
monitoring. To overcome this limitation multiple faller categories should be explored 
and reported on using prospective falls monitoring for a minimum of 3 months, and 
the number of falls per person per year should be reported for all faller categories. 
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When examining dual task cost a standardised assessment should be utilised that 
carefully considers the cognitive task chosen and that gives clear instructions 
regarding task prioritisation. 
 
To develop the findings from this thesis further the falls risk model could be revised 
to incorporate a self-report measure of balance confidence and other biopsychosocial 
aspects. The next step would be a validation study with a large sample size, recruited 
from multiple sites including acute care and primary care settings to allow for 
reporting of model sensitivity in relation to different faller classifications and to 
determine if the model is applicable to a more heterogeneous MS cohort with a wider 
range of EDSS levels and varying disease sub types. In the model revision and 
validation studies there should be public and patient involvement throughout as 
information from clinicians and service users will be invaluable in relation to usability 
and implementation of the model. If the falls risk model is successfully implemented, 
it could have a significant impact on clinical practice by identifying those at risk of 
falls earlier and by enabling earlier access to falls prevention interventions through 
better prioritisation systems. This could result in positive outcomes for the individual 
with the condition regarding increased confidence, greater participation and decreased 
number of falls, but would also potentially have a wider socioeconomic benefit 
resulting from decreased healthcare utilisation and increased work productivity.    
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Appendices 
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 o
f 
cr
o
ss
-s
ec
ti
o
n
a
l 
st
u
d
ie
s 
A
u
th
o
r,
 y
ea
r 
St
u
d
y 
D
e
si
gn
 
El
ig
ib
ili
ty
 C
ri
te
ri
a 
R
e
cr
u
it
e
d
 
A
ss
es
sm
e
n
t 
M
ea
su
re
s 
o
f 
Fa
lls
 
an
d
 B
al
an
ce
 
Fa
ll 
D
e
fi
n
it
io
n
 a
n
d
 
C
la
ss
if
ic
at
io
n
 
C
am
er
o
n
 e
t 
al
, 2
0
1
4
 
St
u
d
y 
d
es
ig
n
 n
o
t 
re
p
o
rt
ed
. 
N
o
t 
re
p
o
rt
ed
 
5
6
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
  
Fa
lle
rs
: N
o
n
-f
al
le
rs
 =
 2
8
: 2
6
 
R
et
ro
sp
ec
ti
ve
 f
al
ls
 r
ec
al
l (
o
ve
r 
p
as
t 
2
 a
n
d
 1
2
 m
o
n
th
s)
, 
M
in
i-
B
ES
Te
st
. 
Fa
ll 
d
ef
in
it
io
n
 n
o
t 
st
at
ed
. 
Fa
lle
r 
cl
as
si
fi
ca
ti
o
n
 n
o
t 
st
at
ed
. 
C
ar
lin
g 
e
t 
al
, 2
0
16
 
B
as
el
in
e 
d
at
a 
fr
o
m
 a
 
R
an
d
o
m
is
ed
 C
o
n
tr
o
lle
d
 
tr
ia
l  
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.M
u
lt
ip
le
 S
cl
er
o
si
s
d
ia
gn
o
si
s 
ac
co
rd
in
g 
to
M
cD
o
n
al
d
 c
ri
te
ri
a
2
.W
al
ki
n
g 
d
is
ta
n
ce
 n
o
t
ex
ce
ed
in
g 
2
0
0m
 (
w
it
h
 o
r
w
it
h
o
u
t 
an
 a
id
)
3
.A
b
le
 t
o
 t
ra
n
sf
er
 f
ro
m
ch
ai
r 
to
 p
lin
th
 w
it
h
m
in
im
al
 a
ss
is
ta
n
ce
 (
to
 b
e
ab
le
 t
o
 p
ar
ti
ci
p
at
e 
in
 t
h
e
in
te
rv
en
ti
o
n
).
Ex
cl
u
si
o
n
 C
ri
te
ri
a:
 
1
.C
o
gn
it
iv
e 
im
p
ai
rm
en
t
lim
it
in
g 
ab
ili
ty
 t
o
p
ar
ti
ci
p
at
e 
in
 t
h
e 
st
u
d
y
2
.R
ec
en
t 
m
ed
ic
al
 c
ar
e 
in
th
e 
p
as
t 
3
 m
o
n
th
s 
re
la
te
d
to
 w
al
ki
n
g 
im
p
ai
rm
en
t
3
.B
al
an
ce
 r
eh
ab
ad
m
in
is
te
re
d
 b
y 
a 
h
ea
lt
h
5
1
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
 
M
al
e:
 F
em
al
e 
=
 1
6
:3
5
 
1
2%
 h
ad
 r
e
la
p
se
 r
em
it
ti
n
g,
 
6
3%
 h
ad
 s
ec
o
n
d
ar
y 
p
ro
gr
es
si
ve
 M
u
lt
ip
le
 
Sc
le
ro
si
s,
 
M
ea
n
 a
ge
 5
8
 (
1
0
.2
4
),
 
M
ea
n
 E
xp
an
d
ed
 D
is
ab
ili
ty
 
St
at
u
s 
sc
o
re
 6
.1
1
 (
0
.4
9
) 
8
6%
 u
se
d
 a
 w
al
ki
n
g 
ai
d
, 
D
is
ea
se
 d
u
ra
ti
o
n
 =
 2
0
.8
5 
ye
ar
s 
(1
2
),
 
5
3%
 r
ep
o
rt
ed
 r
e
tr
o
sp
ec
ti
ve
 
fa
lls
 h
is
to
ry
. 
Fa
lle
rs
: N
o
n
-f
al
le
rs
 =
 2
8
:2
4
 
R
et
ro
sp
ec
ti
ve
 f
al
ls
 s
ta
tu
s 
re
p
o
rt
ed
 a
t 
st
ar
t 
o
f 
st
u
d
y 
(t
im
e 
p
er
io
d
 n
o
t 
st
at
e
d
),
 a
ls
o
 
p
ro
sp
ec
ti
ve
 f
al
ls
 r
ep
o
rt
in
g 
b
u
t 
b
as
el
in
e 
d
at
a 
u
se
d
 b
as
ed
 o
n
 
re
tr
o
sp
ec
ti
ve
 f
al
le
r/
n
o
n
-f
al
le
r 
st
at
u
s.
  
B
er
g 
b
al
an
ce
 s
ca
le
. 
Ti
m
ed
 U
p
 a
n
d
 G
o
 
Fa
lls
 E
ff
ic
ac
y 
Sc
al
e 
In
te
rn
at
io
n
al
 
Fa
ll 
d
ef
in
ed
 a
s 
an
 u
n
ex
p
ec
te
d
 
ev
en
t 
in
 w
h
ic
h
 p
ar
ti
ci
p
an
ts
 
co
m
e 
to
 r
e
st
 o
n
 t
h
e 
gr
o
u
n
d
, 
fl
o
o
r,
 o
r 
lo
w
e
r 
le
ve
l. 
Fa
lle
r 
cl
as
si
fi
ca
ti
o
n
 n
o
t 
sp
ec
if
ie
d
. 
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p
ro
fe
ss
io
n
al
 in
 t
h
e 
p
as
t 
3
0
 
d
ay
s 
4
.O
n
 m
ed
ic
at
io
n
 w
it
h
 4
-
am
in
o
p
yr
id
in
e 
in
 t
h
e 
p
as
t
3
0
 d
ay
s.
C
at
ta
n
eo
 e
t 
al
, 2
0
02
 
R
et
ro
sp
ec
ti
ve
 c
as
e
-
co
n
tr
o
l. 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.A
b
le
 t
o
 w
al
k
in
d
ep
en
d
en
tl
y 
o
r 
w
it
h
 a
ca
n
e.
2
.N
o
 c
o
gn
it
iv
e 
o
r
o
rt
h
o
p
ae
d
ic
 im
p
ai
rm
en
ts
.
5
0
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
  
M
ea
n
 a
ge
 o
f 
fa
lle
rs
 4
0
 
(1
1
.1
),
 m
ea
n
 a
ge
 o
f 
n
o
n
-
fa
lle
rs
 4
3
.5
 (
11
.6
),
 
 M
al
e:
 F
em
al
e
=
38
:6
2
 in
 t
h
e 
fa
lle
rs
, 5
3
:4
7
 in
 n
o
n
-f
al
le
rs
,  
M
ea
n
 d
is
ea
se
 d
u
ra
ti
o
n
 1
3
.4
 
(1
2
.7
) 
in
 f
al
le
rs
, 1
5
.6
 (
1
2
.2
) 
in
 n
o
n
-f
al
le
rs
,  
3
2%
 o
f 
n
o
n
-f
al
le
rs
 u
se
d
 a
 
ca
n
e,
 5
9
%
 o
f 
fa
lle
rs
 u
se
d
 a
 
ca
n
e.
 
Fa
lle
rs
: N
o
n
-f
al
le
rs
 =
 1
7
:3
3
 
R
et
ro
sp
ec
ti
ve
 f
al
ls
 r
ec
al
l (
2
-
m
o
n
th
 p
er
io
d
 p
re
-a
ss
es
sm
en
t)
, 
Eq
u
is
ca
le
 T
es
t.
 
N
o
 f
al
l d
ef
in
it
io
n
 s
ta
te
d
. 
Fa
lle
r 
= 
p
er
so
n
 w
it
h
 2
 o
r 
m
o
re
 f
al
ls
. 
C
at
ta
n
eo
 e
t 
al
, 2
0
06
 
C
ro
ss
-s
ec
ti
o
n
al
 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.A
b
ili
ty
 t
o
 s
ta
n
d
in
d
ep
en
d
en
tl
y 
m
o
re
 t
h
an
3
 s
ec
o
n
d
s.
2
.A
b
ili
ty
 t
o
 w
al
k 
fo
r 
6
 m
ev
en
 w
it
h
 a
n
 a
ss
is
ti
ve
d
ev
ic
e.
Ex
cl
u
si
o
n
 C
ri
te
ri
a:
 
1
.C
o
gn
it
iv
e 
im
p
ai
rm
en
t
5
1
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
  
M
ea
n
 a
ge
 4
5
.3
 (
18
.1
),
 
M
al
e:
 F
em
al
e=
 1
6
:3
5
,  
M
ea
n
 d
is
ea
se
 d
u
ra
ti
o
n
 1
5
.6
 
(7
.6
),
  
1
5
 p
ar
ti
ci
p
an
ts
 u
se
d
 a
 
w
al
ki
n
g 
ai
d
. 
Fa
lle
rs
: N
o
n
-f
al
le
rs
 =
 2
0
: 3
1
 
R
et
ro
sp
ec
ti
ve
 f
al
ls
 r
ec
al
l (
1
-
m
o
n
th
 p
re
-a
ss
es
sm
en
t)
, 
B
er
g 
b
al
an
ce
 s
ca
le
, 
Ti
m
ed
 U
p
 a
n
d
 G
o
, 
D
yn
am
ic
 G
ai
t 
In
d
ex
, 
D
iz
zi
n
es
s 
H
an
d
ic
ap
 In
ve
n
to
ry
, 
A
ct
iv
it
ie
s-
sp
ec
if
ic
 B
al
an
ce
 
C
o
n
fi
d
en
ce
 S
ca
le
. 
Fa
ll 
d
ef
in
ed
 a
s 
an
y 
ev
en
t 
th
at
 
le
d
 t
o
 a
n
 u
n
ex
p
ec
te
d
 
co
n
ta
ct
 w
it
h
 a
 s
u
p
p
o
rt
 
su
rf
ac
e.
 
Fa
lle
r 
cl
as
si
fi
ca
ti
o
n
 n
o
t 
st
at
ed
. 
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2
.V
is
u
al
 p
ro
b
le
m
s 
o
r
im
p
ai
rm
en
t 
o
f 
V
III
 c
ra
n
ia
l
n
er
ve
.
C
at
ta
n
eo
 e
t 
al
, 2
0
1
2
 
C
ro
ss
-s
ec
ti
o
n
al
 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.A
b
ili
ty
 t
o
 s
ta
n
d
in
d
ep
en
d
en
tl
y 
u
p
ri
gh
t 
fo
r
3
0
 s
ec
o
n
d
s.
2
.A
b
ili
ty
 t
o
 w
al
k 
fo
r 
6
 m
ev
en
 w
it
h
 a
n
 a
ss
is
ti
ve
d
ev
ic
e.
4
7
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
  
M
ea
n
 a
ge
 5
2
.0
1
 (
1
2
.0
1
),
  
M
al
e:
 F
em
al
e=
20
:2
7
,  
M
ea
n
 d
is
ea
se
 d
u
ra
ti
o
n
 1
7
.0
 
(9
.9
) 
Ex
p
an
d
ed
 D
is
ab
ili
ty
 S
ta
tu
s 
Sc
al
e 
m
ed
ia
n
 5
 (
ra
n
ge
 2
.5
-
7
.5
) 
Fa
lle
r:
 N
o
n
-f
al
le
r 
= 
1
1
: 2
6
 
R
et
ro
sp
ec
ti
ve
 f
al
ls
 r
ec
o
rd
 (
2
 
m
o
n
th
s 
p
ri
o
r 
to
 a
ss
es
sm
en
t)
, 
B
er
g 
b
al
an
ce
 s
ca
le
, 
D
yn
am
ic
 G
ai
t 
In
d
ex
. 
Fa
ll 
d
ef
in
ed
 a
s 
an
 u
n
ex
p
ec
te
d
 
co
n
ta
ct
 o
f 
an
y 
p
ar
t 
o
f 
th
e 
b
o
d
y 
ex
ce
p
t 
fo
r 
th
e 
fe
et
 
w
it
h
 t
h
e 
gr
o
u
n
d
. 
Fa
lle
r 
= 
p
er
so
n
 w
it
h
 1
 o
r 
m
o
re
 f
al
ls
.  
C
at
ta
n
eo
 e
t 
al
, 2
0
16
 
B
as
el
in
e 
d
at
a 
fr
o
m
 a
 
ra
n
d
o
m
is
ed
 c
o
n
tr
o
lle
d
 
tr
ia
l. 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.A
b
ili
ty
 t
o
 s
ta
n
d
in
d
ep
en
d
en
tl
y 
u
p
ri
gh
t 
fo
r
3
0
 s
ec
o
n
d
s 
w
it
h
 e
ye
s
o
p
en
.
2
.A
b
ili
ty
 t
o
 w
al
k 
fo
r 
6
 m
ev
en
 w
it
h
 a
n
 a
ss
is
ti
ve
d
ev
ic
e.
Ex
cl
u
si
o
n
 C
ri
te
ri
a:
 
1
.A
b
ili
ty
 t
o
 m
ai
n
ta
in
si
n
gl
e 
le
g 
st
an
ce
 f
o
r 
1
0
se
co
n
d
s.
2
.A
b
ili
ty
 t
o
 m
ai
n
ta
in
ta
n
d
em
 s
ta
n
ce
 f
o
r 
3
0
se
co
n
d
s.
1
19
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
  
M
ea
n
 a
ge
 4
8
.9
 (
1
1
.1
) 
in
 t
h
e 
in
te
rv
en
ti
o
n
 g
ro
u
p
, 4
6
.7
 
(1
1
.4
) 
in
 t
h
e 
co
n
tr
o
l, 
 
M
al
e:
 F
em
al
e=
36
:8
3
,  
M
ea
n
 d
is
ea
se
 d
u
ra
ti
o
n
 1
4 
(8
.6
) 
in
 t
h
e 
in
te
rv
en
ti
o
n
 
gr
o
u
p
, 1
2
.9
 (
1
0
.4
) 
in
 t
h
e 
co
n
tr
o
l, 
Fa
lle
r:
 N
o
n
-f
al
le
r 
=2
8:
 9
1
 
R
et
ro
sp
ec
ti
ve
 f
al
ls
 r
ec
al
l (
o
ve
r 
p
re
vi
o
u
s 
2
 m
o
n
th
s)
, 
B
er
g 
b
al
an
ce
 s
ca
le
, 
D
yn
am
ic
 G
ai
t 
In
d
ex
, 
Ti
m
ed
 U
p
 a
n
d
 G
o
, 
A
ct
iv
it
ie
s-
sp
ec
if
ic
 B
al
an
ce
 
C
o
n
fi
d
en
ce
 S
ca
le
. 
Fa
ll 
d
ef
in
ed
 a
s 
an
 e
p
is
o
d
e 
o
f 
u
n
in
te
n
ti
o
n
al
ly
 c
o
m
in
g 
to
 
re
st
 o
n
 t
h
e 
gr
o
u
n
d
 o
r 
lo
w
er
 
su
rf
ac
e 
th
at
 w
as
 n
o
t 
th
e 
re
su
lt
 o
f 
d
iz
zi
n
es
s,
 f
ai
n
ti
n
g,
 
su
st
ai
n
in
g 
a 
vi
o
le
n
t 
b
lo
w
, l
o
ss
 
o
f 
co
n
sc
io
u
sn
es
s 
o
r 
o
th
er
 
o
ve
rw
h
el
m
in
g 
ex
te
rn
al
 f
ac
to
r.
 
Fa
lle
r 
= 
p
er
so
n
 w
it
h
 1
 o
r 
m
o
re
 f
al
ls
. 
Fr
eq
u
en
t 
fa
lle
r 
=
 p
er
so
n
 w
it
h
 
2
 o
r 
m
o
re
 f
al
ls
.  
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3
.C
o
gn
it
iv
e 
im
p
ai
rm
en
t
th
at
 w
o
u
ld
 li
m
it
p
ar
ti
ci
p
at
io
n
 in
 t
h
e
as
se
ss
m
en
t/
in
te
rv
en
ti
o
n
.
C
o
o
te
 e
t 
al
, 2
0
1
3
 
B
as
el
in
e 
an
d
 p
o
st
 
tr
ea
tm
en
t 
d
at
a 
fr
o
m
 a
 
ra
n
d
o
m
is
ed
 c
o
n
tr
o
lle
d
 
tr
ia
l. 
N
o
 d
et
ai
ls
 g
iv
en
. 
Th
es
e 
d
at
a 
w
er
e 
p
ar
t 
o
f 
th
e 
b
as
el
in
e 
as
se
ss
m
en
ts
 
o
f 
1
 a
rm
 o
f 
an
 e
xe
rc
is
e 
tr
ia
l, 
th
e 
m
et
h
o
d
s 
o
f 
w
h
ic
h
 
h
ad
 b
ee
n
 p
u
b
lis
h
ed
 
p
re
vi
o
u
sl
y.
 
1
11
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s;
  
M
ea
n
 a
ge
 o
f 
fa
lle
rs
 5
5
.6
 
(1
0
.4
),
 m
ea
n
 a
ge
 o
f 
n
o
n
-
fa
lle
rs
 5
4
.7
 (
11
.1
),
  
M
al
e:
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em
al
e=
17
:3
8 
in
 t
h
e 
fa
lle
rs
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ro
u
p
, 2
3
:3
2
 in
 t
h
e 
n
o
n
-f
al
le
rs
, 
M
ea
n
 d
is
ea
se
 d
u
ra
ti
o
n
 1
6
.6
 
(5
)
in
 t
h
e 
fa
lle
rs
, 1
4
.1
 (
3
) 
in
n
o
n
-f
al
le
rs
.
Fa
lle
r:
 N
o
n
-f
al
le
r 
= 
5
6
: 5
5
R
et
ro
sp
ec
ti
ve
 f
al
ls
 r
ec
al
l (
o
ve
r 
p
as
t 
3
 m
o
n
th
s)
, 
B
er
g 
b
al
an
ce
 s
ca
le
. 
Fa
ll 
d
ef
in
ed
 a
s 
an
 u
n
ex
p
ec
te
d
 
co
n
ta
ct
 o
f 
an
y 
p
ar
t 
o
f 
th
e 
b
o
d
y 
w
it
h
 t
h
e 
gr
o
u
n
d
. 
Fa
lle
r 
= 
p
er
so
n
 w
it
h
 1
 o
r 
m
o
re
 f
al
ls
.  
G
an
es
an
 e
t 
al
, 2
01
5 
C
ro
ss
-s
ec
ti
o
n
al
 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.E
xp
an
d
ed
 D
is
ab
ili
ty
St
at
u
s 
Sc
al
e 
sc
o
re
 o
f 
4
.
2
.A
b
le
 t
o
 s
ta
n
d
 a
n
d
 w
al
k
w
it
h
o
u
t 
an
y 
ai
d
 o
r 
o
rt
h
o
si
s
at
 le
as
t 
50
0 
m
et
er
s,
3
.N
o
 r
el
ap
se
 w
it
h
in
 t
h
e
la
st
 t
h
re
e 
m
o
n
th
s,
4
.N
o
rm
al
 o
r 
co
rr
ec
te
d
 t
o
n
o
rm
al
 v
is
io
n
Su
b
je
ct
s 
w
it
h
o
u
t 
M
u
lt
ip
le
 
Sc
le
ro
si
s 
1
8
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
 
M
ea
n
 a
ge
 5
2
.7
 (
12
.2
) 
M
al
e:
 F
em
al
e=
4
:1
4
,  
M
ea
n
 d
is
ea
se
 d
u
ra
ti
o
n
 1
8
.8
 
(9
.4
) 
 
Fa
lle
r:
 N
o
n
-f
al
le
r 
= 
8
: 1
0
 
R
et
ro
sp
ec
ti
ve
 f
al
ls
 r
ec
al
l (
o
ve
r 
p
re
vi
o
u
s 
1
2
 m
o
n
th
s)
, 
B
er
g 
b
al
an
ce
 s
ca
le
, 
A
ct
iv
it
ie
s-
sp
ec
if
ic
 B
al
an
ce
 
C
o
n
fi
d
en
ce
 S
ca
le
. 
N
o
 f
al
l d
ef
in
it
io
n
 s
ta
te
d
. 
Fa
lle
r 
= 
p
er
so
n
 w
it
h
 2
 o
r 
m
o
re
 f
al
ls
. 
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1
.A
ge
 a
n
d
 g
en
d
er
m
at
ch
ed
 t
o
 M
S
p
ar
ti
ci
p
an
ts
.
Fo
rs
b
er
g 
et
 a
l, 
20
1
3
 
M
u
lt
i-
ce
n
tr
e 
cr
o
ss
 
se
ct
io
n
al
. 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.S
u
b
je
ct
iv
el
y 
an
d
o
b
je
ct
iv
el
y 
ex
p
er
ie
n
ce
b
al
an
ce
 a
n
d
 w
al
ki
n
g
lim
it
at
io
n
s.
2
.A
b
ili
ty
 t
o
 w
al
k 
1
0
0
 m
w
it
h
 a
n
 a
ss
is
ti
ve
 d
ev
ic
e
(s
im
ila
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 t
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d
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 c
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at
io
) 
C
ro
ss
 s
ec
ti
o
n
al
 
In
cl
u
si
o
n
 C
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 D
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 d
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 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
 
M
al
e:
 F
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 D
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 d
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 f
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at
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d
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 c
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 f
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 d
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d
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 c
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 r
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em
it
ti
n
g 
fo
rm
. 
K
al
ro
n
 e
t 
al
, 2
0
17
 
C
ro
ss
-s
ec
ti
o
n
al
 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.D
ef
in
it
e 
d
ia
gn
o
si
s 
o
f
M
u
lt
ip
le
 S
cl
er
o
si
s.
2
.E
xp
an
d
ed
 D
is
ab
ili
ty
St
at
u
s 
Sc
al
e 
o
f 
le
ss
 t
h
an
 7
o
r 
ab
le
 t
o
 w
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 f
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 d
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 f
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 d
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 p
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M
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 F
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 D
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 d
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 r
e
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 f
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at
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 d
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p
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, f
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 c
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 C
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 r
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is
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b
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 f
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 c
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 p
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 D
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 f
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b
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l d
ef
in
it
io
n
 s
ta
te
d
. 
Fa
lle
r 
= 
p
er
so
n
 w
it
h
 2
 o
r 
m
o
re
 f
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 C
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b
ili
ty
 t
o
 w
al
k 
at
 le
as
t
1
00
 m
 w
it
h
o
u
t 
re
st
 b
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 m
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p
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d
en
ce
 S
ca
le
,  
Ti
m
ed
 U
p
 a
n
d
 G
o
,  
D
yn
am
ic
 g
ai
t 
In
d
ex
, 
Fo
u
r 
Sq
u
ar
e 
St
ep
 t
es
t.
 
Fa
ll 
d
ef
in
ed
 a
s 
an
 u
n
ex
p
ec
te
d
 
co
n
ta
ct
 o
f 
an
y 
p
ar
t 
o
f 
th
e 
b
o
d
y 
w
it
h
 t
h
e 
gr
o
u
n
d
. 
Fa
lle
r 
= 
p
er
so
n
 w
it
h
 1
 o
r 
m
o
re
 f
al
ls
. 
237
2
.O
n
go
in
g 
re
la
p
se
af
fe
ct
in
g 
b
al
an
ce
.
3
.A
n
o
th
er
 d
is
ea
se
p
re
ve
n
ti
n
g 
th
em
 f
ro
m
co
m
p
le
ti
n
g 
th
e 
m
ea
su
re
s.
R
o
ss
 e
t 
al
, 2
0
16
 
C
ro
ss
 s
ec
ti
o
n
al
 c
o
h
o
rt
 
In
cl
u
si
o
n
 C
ri
te
ri
a
: 
1
.P
ri
m
ar
y 
d
ia
gn
o
si
s 
o
f
M
u
lt
ip
le
 S
cl
er
o
si
s.
2
.M
ed
ic
al
ly
 s
ta
b
le
.
3
.I
n
d
ep
en
d
en
tl
y 
m
o
b
ile
w
it
h
 o
r 
w
it
h
o
u
t 
an
 a
id
.
4
.O
ve
r 
th
e 
ag
e 
o
f 
1
8
.
5
2
 p
eo
p
le
 w
it
h
 M
u
lt
ip
le
 
Sc
le
ro
si
s:
 
M
ea
n
 a
ge
 o
f 
to
ta
l g
ro
u
p
 
4
5
.7
3
 (
5
.6
5
),
 
M
al
e:
 F
em
al
e 
=
 1
5
:3
7
, 
M
ea
n
 d
is
ea
se
 d
u
ra
ti
o
n
 
1
0
.8
7
 (
8
.4
8
),
 
M
o
b
ili
ty
 a
id
 u
se
: 3
8%
 o
f 
th
e 
gr
o
u
p
, 
8
1%
 o
f 
th
e 
gr
o
u
p
 h
ad
 
re
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b
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b
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 D
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 r
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 f
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b
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 f
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b
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 d
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Appendix 5.1: TRIPOD Checklist, Prediction model Development 
Section/ 
Topic     
Ite Checklist Item Page 
Title and abstract 
Title 1 
Identify the study as developing and/or validating a 
multivariable prediction model, the target population, and 
the outcome to be predicted. 
108 
Abstract 2 
Provide a summary of objectives, study design, setting, 
participants, sample size, predictors, outcome, statistical 
analysis, results, and conclusions. 
110 
Introduction 
Background 
and objectives 
3a 
Explain the medical context (including whether diagnostic or 
prognostic) and rationale for developing or validating the 
multivariable prediction model, including references to 
existing models. 
111,112 
3b 
Specify the objectives, including whether the study describes 
the development or validation of the model or both. 
113 
Methods 
Source of data 
4a 
Describe the study design or source of data (e.g., 
randomized trial, cohort, or registry data), separately for the 
development and validation data sets, if applicable. 
113,114 
4b 
Specify the key study dates, including start of accrual; end of 
accrual; and, if applicable, end of follow-up.  
113 
Participants 
5a 
Specify key elements of the study setting (e.g., primary care, 
secondary care, general population) including number and 
location of centres. 
113 
5b Describe eligibility criteria for participants.  113 
5c Give details of treatments received, if relevant.  NA 
Outcome 
6a 
Clearly define the outcome that is predicted by the 
prediction model, including how and when assessed.  
114 
6b 
Report any actions to blind assessment of the outcome to be 
predicted.  
NA 
Predictors 
7a 
Clearly define all predictors used in developing or validating 
the multivariable prediction model, including how and when 
they were measured. 
115 
7b 
Report any actions to blind assessment of predictors for the 
outcome and other predictors.  
NA 
Sample size 8 Explain how the study size was arrived at. 116 
Missing data 9 
Describe how missing data were handled (e.g., complete-
case analysis, single imputation, multiple imputation) with 
details of any imputation method.  
116 
Statistical 
analysis 
methods 
10a Describe how predictors were handled in the analyses.  117 
10b 
Specify type of model, all model-building procedures 
(including any predictor selection), and method for internal 
validation. 
117 
10d 
Specify all measures used to assess model performance and, 
if relevant, to compare multiple models.  
117 
Risk groups 11 Provide details on how risk groups were created, if done.  NA 
Results 
Participants 13a 
Describe the flow of participants through the study, 
including the number of participants with and without the 
outcome and, if applicable, a summary of the follow-up time. 
A diagram may be helpful.  
118 
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13b 
Describe the characteristics of the participants (basic 
demographics, clinical features, available predictors), 
including the number of participants with missing data for 
predictors and outcome.  
Table 
5.1, 
pg 119 
Model 
development  
14a 
Specify the number of participants and outcome events in 
each analysis.  
120, 
121 
14b 
If done, report the unadjusted association between each 
candidate predictor and outcome. 
Append
ix 5.3 
Model 
specification 
15a 
Present the full prediction model to allow predictions for 
individuals (i.e., all regression coefficients, and model 
intercept or baseline survival at a given time point). 
122 
Table 
5.3 
15b Explain how to the use the prediction model. 127 
Model 
performance 
16 
Report performance measures (with CIs) for the prediction 
model. 
121,122 
Discussion 
Limitations 18 
Discuss any limitations of the study (such as 
nonrepresentative sample, few events per predictor, missing 
data).  
126 
Interpretation   19b 
Give an overall interpretation of the results, considering 
objectives, limitations, and results from similar studies, and 
other relevant evidence.  
124, 
125 
Implications 20 
Discuss the potential clinical use of the model and 
implications for future research.  
128 
Other information 
Supplementary 
information 
21 
Provide information about the availability of supplementary 
resources, such as study protocol, Web calculator, and data 
sets.  
NA 
Funding 22 
Give the source of funding and the role of the funders for the 
present study.  
Title 
page 
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Appendix 5.2: Falls Screening Questionnaire 
Please answer yes or no to the following questions: 
Gender, male   
Do you have concerns or worries about falling?   
Do you use a cane or a walker at any time?  
Do you use more than one mobility aid over the course of a typical 
week? 
 
Is your MS course stable?   
Do you have problems with your balance?  
Do you have problems with your bladder or bowel?  
Do you have problems with poor concentration or forgetfulness?  
Have you had a fall in the last three months?  
Do you have stiffness or spasms in your limbs?  
Have you been told you have osteoporosis?  
Do you have fatigue that interferes with everyday tasks?  
Do you have reduced strength in your legs?  
Do you have problems with reduced or abnormal sensations?  
Do you have problems doing fiddly things with your hands?  
Do you have problems doing two things at once?  
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Appendix 5.3 Data Collection Tool for Prospective Cohort Study  
 
 
 
 
 
“Development of a Falls Risk Prediction Tool for 
Use with People with Multiple Sclerosis” 
 
 
Clinical Report Form 
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Patient Demographic Information 
1. Participant Code: _______SVFP_____________ 
 
2. Date of Birth:  __________________________ 
 
3. Gender:  Male   ☐ 
Female  ☐ 
 
4. EDSS:   __________________________ 
 
5. Length of time since diagnosis (Months):___________________ 
 
6. Length of time since symptoms first experienced (Months):______________ 
 
 
7. Type of Multiple Sclerosis:  Primary Progressive  ☐ 
Secondary Progressive  ☐ 
Relapsing Remitting  ☐ 
Benign    ☐ 
Unknown   ☐ 
 
 
8. Over the last year the participant’s MS has been:  Stable  ☐ 
Improving ☐ 
Deteriorating ☐ 
Variable ☐ 
 
9. In general, would you consider your health to be:  Excellent ☐ 
Good  ☐ 
Fair  ☐ 
Poor  ☐ 
Unsure ☐ 
 
10. Do you ever use a walking aid:   Yes  ☐ 
No  ☐ 
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**If participant answered “No” to question 10, progress straight to question 14** 
11. Type of walking aid(s) used: One walking stick  ☐  
Two walking sticks  ☐ 
Tripod    ☐ 
Zimmer Frame ☐ 
Three wheeled walker ☐ 
Four wheeled walker ☐ 
One elbow crutch  ☐ 
Two elbow crutches  ☐ 
Scooter   ☐ 
Wheelchair   ☐ 
Other (Please specify) ☐_____ 
 
12. When do you use your aid(s):  At all times   ☐ 
Only indoors   ☐ 
Only outdoors   ☐ 
Only on uneven surfaces ☐ 
Other (Please specify) ☐_______ 
 
13. Length of time since participant began using their primary aid (Months): 
_________________________________________________________ 
14. Current employment status:   Full Time  ☐ 
Part Time  ☐ 
Student  ☐ 
Homemaker  ☐ 
Unemployed  ☐ 
Retired  ☐ 
Unable to work due to MS ☐ 
 
15. Are you currently taking any prescribed medication:  Yes ☐ 
No  ☐ 
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➢ Please list all prescribed medications currently being taken: 
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________ 
 
16. Have you experienced any falls in the last 3 months: Yes ☐ 
No ☐ 
 
➢ How many falls have you had: 
 _______________________________ 
➢ Did you sustain any injuries:       Yes ☐ No ☐ 
➢ Did you experience more than one fall in one day:   Yes ☐ No ☐ 
 
17. Please rate how much each of the following MS symptoms interferes with 
your typical daily activities; is the symptom not a problem for you, interferes 
a little bit, interferes a great deal or are you unsure: 
 
 
 Not a 
problem for 
you 
Interferes a 
little bit 
Interferes a 
great deal 
Unsure 
Fatigue 0 1 2  
Problems with balance or mobility 0 1 2  
Leg weakness 0 1 2  
Depression 0 1 2  
Pain 0 1 2  
Problems seeing 0 1 2  
Poor concentration or 
forgetfulness 
0 1 2  
Problems with bladder control 
(e.g. urgency, incontinence) 
0 1 2  
Problems with bowel irregularity 
(e.g. constipation, incontinence) 
0 1 2  
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Falls screening questionnaire 
Please answer yes or no to the following questions: 
Gender 
 
 
Do you have concerns or worries about falling?  
 
 
Do you use a cane or a walker at any time? 
 
 
Do you use more than one mobility aid over the course of a 
typical week? 
 
 
Is your MS course stable?  
 
 
Do you have problems with your balance? 
 
 
Do you have problems with your bladder or bowel? 
 
 
Do you have problems with poor concentration or forgetfulness? 
 
 
Have you had a fall in the last three months? 
 
 
Do you have stiffness or spasms in your limbs? 
 
 
Have you been told you have osteoporosis? 
 
 
Do you have fatigue that interferes with everyday tasks? 
 
 
Do you have reduced strength in your legs? 
 
 
Do you have problems with reduced or abnormal sensations? 
 
 
Do you have problems doing fiddly things with your hands? 
 
 
Do you have problems doing two things at once? 
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Symbol Digit Modalities Test 
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Scoring Sheet 
Participant Code: ______SVFP____________ 
 
SDMT 
Trial (90 sec) Score 
1  
 
 
TUG 
Walking Aid used_______________________________ 
Trial Time(seconds) 
Practice  
1  
2  
3  
 
 
TUG-Cognitive 
Walking Aid used: ________________________________ 
Trial Time(seconds) 
Practice  
1  
2  
3  
 
 
Cognitive Strategies 
No change 
in gait, 
correct 
numbers 
Gait 
similar, 
number 
errors 
Errors in 
numbers 
and gait but 
carry on 
regardless 
Stop think 
step 
Synchronise 
step and 
think 
Gait  
wrong, 
numbers 
correct 
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Appendix 5.4:  Variables for Inclusion in Model; 20 Potential Predictor 
Variables with a p value ≤ 0.2 after Bivariate Analysis 
 Variable No falls 
(n=44) 
One or more falls 
(n=56) 
  
P-value 
DEMOGRAPHIC 
INFORMATION: 
   
 Gender 12 M (27.2%) 
32 F (72.7%)  
 22 M (39.3%) 
34 F (60.7%)  
0.21 
 MS course past year Stable or 
improving 18 
(41%) 
Deteriorating 19 
(43%) 
Variable 7 (16%) 
 Stable or improving 
14 (25%) 
 
Deteriorating 35 
(63%) 
Variable 7 (13%) 
 0.15 
Fall in past 3 months (yes) 15 (34.1%) 35 (62.5%) 0.01 
MOBILITY STATUS:    
Uses a walking aid (yes) 29 (65.9%)  44 (78.6%) 0.16  
MEDICATIONS:    
Currently taking 
prescribed meds (yes) 
43 (97.7%)  51 (91.1%)  0.16 
Taking Category 
G/Genitourinary and Sex 
Hormones (yes) 
5 (11.4%) 18 (32.1%) 0.01 
Taking Category J/anti-
infectives (yes) 
1 (2.3%) 6 (10.7%) 0.10 
MS SYMPTOM 
INTERFERENCE: 
   
Problems with balance or 
mobility 
Interferes a little 
24 (54.5%) 
Interferes a 
great deal 20 
(45.5%) 
Interferes a little 20 
(35.7%) 
Interferes a great 
deal 36  
(64.3%) 
0.06 
Depression Not a problem 
30 (68.2%) 
Interferes a little 
or interferes a 
great deal 14 
(31.8%) 
Not a problem 30 
(53.6%) 
Interferes a little 
Interferes a great 
deal 26 (46.4%) 
0.14 
Problems seeing Not a problem 
29 (65.9%) 
Interferes a little 
or interferes a 
great deal 15 
(34.1%) 
Not a problem 45 
(80.4%) 
Interferes a little or 
interferes a great 
deal 11  
(19.6%) 
0.10 
Problems with bladder 
control 
Not a problem 
16 (36.4%) 
Interferes a little 
14 (31.8%) 
Interferes a 
great deal 14 
(31.8%) 
Not a problem 10 
(17.9%) 
Interferes a little 26 
(46.4%) 
 
Interferes a great 
deal 20 
(35.7%) 
0.10 
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FALLS SCREENING 
QUESTIONNAIRE (Yes/No 
ANSWERS): 
   
 Uses a cane/walker (yes)  28 (63.6%) 44 (78.6%)  0.10 
Is MS course stable (yes)  20 (45.5%) 16 (28.6%) 0.08 
Problems with 
bladder/bowel (yes) 
32 (72.7%) 50 (89.3%)  0.03 
Fall in past 3 months (yes)  15 (34.1%) 34 (60.7%) 0.01 
 Stiffness/spasms in limbs 
(yes) 
 33 (75%) 48 (85.7%)  0.18 
 Problems dual tasking 
(yes)  
 16 (36.4%) 31 (55.4%)  0.06  
STRATEGIES WHEN DUAL 
TASKING: 
*12 missing (not 
done for 1st 12 
participants) 
  
No change in gait, correct 
numbers 
9 (25%) 7 (13.5%) 0.17 
Gait wrong, numbers 
correct 
5 (13.9%) 16 (30.8%) 0.07 
OBJECTIVE MEASURES:    
TUG  Median 11.19 
(8.56, 13.71) 
Median 11.99  
(9.53, 17.21)  
  
0.09 
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Appendix 6.1 Falls Diary 
 
May 2015 
 
 MON TUE WED THUR FRI SAT SUN 
   
  
1 2 3 
Number of falls        
Number of falls 
causing injury 
       
 4 5 6 7 8 9 10 
Number of falls        
Number of falls 
causing injury 
       
 11 12 13 14 15 16 17 
Number of falls        
Number of falls 
causing injury 
       
 18 19 20 21 22 23 24 
Number of falls        
Number of falls 
causing injury 
       
 25 26 27 28 29 30 31 
Number of falls        
Number of falls 
causing injury 
       
 
       
Number of falls        
Number of falls 
causing injury 
       
Throughout this month, please write the number of falls you have each 
day and the number of falls that cause any injury. Please consider a 
fall as “an unexpected event in which you come to rest on the ground, 
floor, or lower level”. If you don’t have a fall put in 0 rather than 
leaving the box blank. 
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Please write down the number of each type of injury as a result of 
any fall this month  
 
 No injuries this month 
 Head Body Arms Legs 
Bruises     
Cuts/scrapes     
Sprain/Strain     
Dislocation     
Broken Bone     
 
 
Please mark on the body where any fractures or broken bones 
occurred 
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Did you use any of the following medical or other services because 
of any falls this month?   
 YES                        NO  
Medical Service or Other Care 
Number of 
times  
Nurse visit  
Primary Care provider   
Specialist doctor visit (hospital or privately)  
What type of specialist? 
 
Emergency Department  
Admission to hospital  
How many days were you hospitalised?  
 
Other (please state)  
 
If you fell, for the first 2 falls, please answer the following 
questions 
 Fall 1 Fall 2 
What time of day did you 
fall? 
Morning               
Afternoon  
Evening 
Night 
Morning               
Afternoon  
Evening 
Night 
Where did you fall?  
 Inside at home 
Outside at home 
Away from home 
Inside at home 
Outside at home 
Away from home 
 
Did you have a MS relapses this month? 
 NO   YES    → If yes please provide information on; 
When did the relapse start? _____________________________ 
How long did it continue? _______________________________ 
What symptoms did you notice? __________________________ 
Did you visit a healthcare professional? ____________________ 
What treatment did you have? ___________________________ 
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What do you think caused you to fall? (Check more than one if 
necessary) 
 Fall 
1 
Fall 
2 
Poor balance   
Weak legs or legs gave way   
Not using walking aid at all or using it incorrectly or using 
wrong walking aid 
  
Tripped/Slipped   
Transfer from surface to surface went wrong   
Not paying attention or being distracted   
Miscalculated a distance, under or overreaching   
Another medical problem unrelated to my MS   
Doing something risky   
Weather - Ice, rain, snow or wind   
Poor vision (didn't see an obstacle)    
Felt dizzy/faint   
Overheated (too hot)   
Fatigued   
I'm not sure   
Other (please give details)   
Did you lay on the ground or floor for more than 10 minutes 
because of any falls this month?   
 YES                        NO  
IF YES, please complete this chart 
Time on the ground or floor Number of 
times  
Between 10 and 30 minutes  
Between 30 and 60 minutes  
For more than 60 minutes  
Did you need help to get up after any falls this month?   
 YES                        NO  
IF YES, please complete this chart 
Type of help 
Number of 
times  
Help from a friend, family member or neighbour  
Help from the emergency service (e.g. 
Ambulance, Fire fighter) 
 
   
